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Mammalian oocytes enter meiosis during embryonic development and arrest at
prophase I until a preovulatory surge of lutenizing hormone (LH) from the pituitary
stimulates meiotic resumption. Meiotic arrest is maintained by high levels of cAMP
generated in the oocyte by the constitutively active receptor, GPR3. It is unknown how
GPR3 activity in the oocyte is regulated and whether the receptor is desensitized and
endocytosed by GPCR kinase (GRK)-LQGXFHGSKRVSKRU\ODWLRQDQGȕ-arrestin
recruitment. In the mouse oocyte, endocytic inhibition increased cAMP levels and
inhibited spontaneous maturation. We hypothesize that GPR3 signals from the cell
surface and inhibiting endocytosis causes GPR3 to accumulate at the cell surface and
increase cAMP levels. In order to directly compare the localization and signaling of
GPR3, we extended our studies in HEK293 cells. Endocytic inhibition increased cell
surface-ORFDOL]HG*35DQGF$03OHYHOVZKLOHRYHUH[SUHVVLRQRI*5.DQGȕ-arrestin-2
decreased cell surface-localized GPR3 and cAMP levels. Mutation of potential
phosphorylation sites in the third intracellular loop dramatically increased cAMP
production compared to WT; however, these sites are not targeted by GRK2 for
desensitization. Mutation of serines in the C-terminus did not change cAMP levels but
did decrease the membrane localization of GPR3. We conclude that GPR3 signals at the
cell membrane and does not continue to signal following internalization, although
placement at the plasma membrane may not be required for cAMP production and GPR3

may be able to signal prior to membrane insertion. Further studies are required to
determine if GPR3 is phosphorylated and targeted for regulation by other kinases or G
protein-coupled interacting proteins.
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CHAPTER ONE
U

I.

U

Introduction

Meiotic Transition in Mammalian Oocytes

Prior to fertilization, diploid germ cells reduce their number of chromosomes in
half, a process defined as meiosis. In the female, oocytes enter meiosis during embryonic
development but arrest at the diplotene stage of prophase I. Oocytes remain arrested until
reproductive maturity, which may last months to years depending on the mammalian
species (Eppig et al., 2004a). During the estrus or menstrual cycle, the oocyte completes
growth and achieves meiotic competence. In response a preovulatory surge of luteinizing
hormone (LH), released from the pituitary gland, the oocyte is stimulated to resume
meiosis. The oocyte arrests again at metaphase II until fertilization causes the completion
of meiosis (Mehlmann, 2005b).
During development, the oocyte is surrounded by one or more layers of granulosa
cells, a structure referred to as an ovarian follicle (Gougeon, 1996). At the earliest stage,
the primordial follicle contains an oocyte surrounded by one layer of squamous pregranulosa cells. The primordial follicle transitions to a primary follicle, a process in
which the granulosa cells change from squamous to cuboidal. During follicular growth,
the granulosa cells divide, forming several layers around the oocyte to become a
secondary, preantral follicle. Oocytes within primary and preantral follicles are
meiotically incompetent. In response to the pituitary gonadotropin, follicle-stimulating
hormone (FSH), the granulosa cells continue to proliferate, the oocyte enlarges, and a
fluid-filled antrum begins to form between the granulosa cells producing a tertiary, antral
follicle (Gougeon, 1996). The antrum separates the granulosa cells into two separate
1

compartments: the outer mural granulosa cells that line the basement membrane of the
follicle and the inner cumulus cells that surround the oocyte. During this time, the
follicle also develops LH receptors on the outer mural granulosa cells. The oocyte
achieves meiotic competence around the time of antrum formation when the oocyte has
reached its full size (~75 μm diameter in mouse) and when a sufficient amount of cell
cycle proteins are synthesized (Mehlmann, 2005b).

Meiotic Arrest is Mediated by High Levels of cAMP in the Oocyte
Prophase I arrest in a fully grown, competent oocyte is achieved by high levels of
cyclic adenosine 3’ 5’-monophosphate (cAMP) (Conti et al., 2002). cAMP is produced
by the constitutively active G-protein coupled receptor, GPR3 (mouse) or GPR12 (rat)
(Mehlmann et al. 2002; Mehlmann et al, 2004; Hinckley et al. 2005; Ledent et al. 2005;
Vaccari et al. 2008). GPR3 is also expressed in Xenopus, human, and porcine oocytes,
suggesting a conserved function across species (Deng et al., 2008; DiLuigi et al., 2008;
Rios-Cardona et al., 2008; Yang et al., 2012). GPR3/12 activates the GĮ s G protein,
R

R

which in turn activates adenylate cyclase type 3 to synthesize cAMP (Horner et al. 2003;
Freudzon et al. 2005; Hinckley et al. 2005; Mehlmann 2005b). Removal or inactivation
of any of the components of this signaling pathway causes the oocyte to resume meiosis
in the absence of the LH signal (Mehlmann et al. 2002; Horner et al. 2003; Mehlmann et
al. 2004; Ledent et al. 2005; Mehlmann 2005b; DiLuigi et al. 2008; Vaccari et al. 2008).
Elevated cAMP levels prevent meiotic maturation by inhibiting the activity of
downstream cell cycle regulatory proteins referred to as meiosis promoting factor (MPF).
MPF is a serine/threonine kinase protein heterodimer composed of a catalytic subunit,
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cyclin-dependent kinase 1 (CDK1), and a regulatory subunit, cyclin B. cAMP activates
protein kinase A (PKA), which indirectly regulates MPF activity by controlling the
activities of the phosphatase CDC25B (Lincoln et al., 2002; Pirino et al., 2009) and the
kinases WEE1 and MYT1 (Han and Conti, 2006; Stanford and Ruderman, 2005). PKA
activates the WEE1 and MYT1 kinases that phosphorylate CDK1 on Thr14 and Tyr15
residues to render it inactive (Duckworth et al., 2002). PKA also phosphorylates
CDC25B, causing the phosphatase to be sequestered in the cytoplasm, and keeping
CDK1 in the nucleus inactive (Oh et al., 2010). When cAMP in the oocyte decreases,
CDC25B is no longer phosphorylated by PKA, it becomes active and translocates to the
nucleus, where it dephosphorylates CDK1(Morgan, 1995; Oh et al., 2010).
Dephosphorylation of CDK1, association with cyclin B, and a change in cyclin B levels
result in MPF activation and meiotic resumption (Clarke and Karsenti, 1991; Ledan et al.,
2001).

cGMP from the Somatic Cells of the Follicle Maintains Meiotic Arrest
Although the oocyte contains all the components necessary to produce cAMP,
meiotic arrest is under the control of the surrounding follicle cells. Evidence of this came
from early experiments in which removal of the oocyte or cumulus-enclosed oocyte
complexes from the follicle caused the oocyte to resume meiosis spontaneously
(Edwards, 1965; Pincus and Enzmann, 1935). Spontaneous maturation occurs due to a
decrease in cAMP in the oocyte (Vivarelli et al., 1983) and can be prevented by
membrane permeable cAMP analogs (Cho et al., 1974) or phosphodiesterase (PDE)
inhibitors (Magnusson and Hillensjo, 1977). Recent studies support the hypothesis that
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the level of cAMP in the oocyte is regulated by PDE3A, the main PDE isoform expressed
in the mouse oocyte (Masciarelli et al., 2004; Shitsukawa et al., 2001; Tsafriri et al.,
1996) that in turn is regulated by a signal from the somatic cells. Consistent with this
hypothesis, it has been demonstrated that the follicle supplies the oocyte with cyclic
guanosine 3’, 5’-monophosphate (cGMP), a competitive inhibitor of PDE3A (Jaffe and
Norris, 2010). cGMP levels in the follicle are controlled by a paracrine loop in which
granulosa cells express natriuretic peptide precursor type C (NPPC). NPPC activates the
NPPC receptor (NPR2), a membrane-bound guanylate cyclase, on the cumulus and
granulosa cells that stimulates the generation of cGMP (Zhang et al., 2010). cGMP
diffuses into the oocyte via gap junctions and inhibits PDE3A, thus maintaining cAMP at
a high level necessary for meiotic arrest (Jaffe and Norris, 2010; Norris et al., 2009).

LH Initiates Meiotic Resumption by Stimulating PDE3A Activity in the Oocyte
The follicle is not only important for maintaining arrest, but is also important for
meiotic resumption stimulated by LH. The oocyte does not express LH receptors,
instead, LH binds to receptors located on the theca and outer granulosa cells (Eppig et al.,
1997; Peng et al., 1991). It is now well accepted that LH causes cGMP levels to
significantly decrease in the somatic cells and in the oocyte, thereby allowing PDE3A
activation (Norris et al., 2009; Vaccari et al., 2009) and subsequent cAMP degradation in
the oocyte. Following 1-1.4 hours after LH treatment, cAMP decreases from ~700 nM
to ~140 nM in in vitro antral follicle-enclosed oocytes and this is in within the range to
decrease PKA activity (Norris et al., 2009). cGMP in the oocyte decreases due to the
decrease in cGMP in the somatic cells and also due to gap junction closure between
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granulosa cells that prevents cGMP from diffusing into the oocyte (Jaffe and Norris,
2010; Norris et al., 2008; Norris et al., 2009; Zhang et al., 2010). The level of cGMP
decreases in the somatic cells following LH due to the decrease in NPR2 activity
(Robinson et al., 2012) and the decrease in expression of NPPC transcripts (Kawamura et
al., 2011). In summary, LH treatment or removal of the oocyte from the follicle leads to
a decrease in cGMP in the oocyte and relieves the inhibition of PDE3A. As a result,
cAMP levels in the oocyte decrease and meiotic resumption occurs.

Cytoplasmic Changes Occur during Meiotic Resumption that are Important for
Fertilization and Early Development
Following meiotic resumption, the oocyte progresses to metaphase II where it
undergoes a second meiotic arrest. This transition involves coordinated nuclear and
cytoplasmic changes such that when the egg is ovulated it is at the appropriate stage to be
fertilized and begin early embryonic development (Eppig et al., 2004a). In the appendix
of this dissertation, nuclear and cytoplasmic changes are examined in oocytes that have
been vitrified and matured in vitro. Because cryopreservation and in vitro maturation
(IVM) are becoming promising technologies for assisted reproduction, it is important to
understand if nuclear and cytoplasmic changes are preserved during these processes as
indicators of developmental competence.
Morphologically, meiotic resumption is characterized by the disappearance of the
nuclear envelope, or germinal vesicle (GV); this is called germinal vesicle breakdown
(GVBD). Changes in chromatin configuration, formation of microtubule organization
centers, and restructuring of microfilaments occur during this time (Schuh and Ellenberg,
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2007). The first meiotic division progresses unequally with most of the cytoplasm
retained in the egg and the extrusion of the first polar body. Several cytoplasmic changes
also occur during meiotic maturation that are important for the ability of an egg to
respond to inositol 1,4,5-trisphosphate (IP 3 ) and release Ca 2+ at fertilization (Carroll et
R

R

P

P

al., 1994; Goud et al., 1999; Jones et al., 1995; Mehlmann and Kline, 1994). We will
focus on one major cytoplasmic change that is the dramatic reorganization of the
endoplasmic reticulum (ER), the major site of Ca 2+ storage. ER structure can be easily
P

P

visualized by dicarbocyanine dyes (DiI) and confocal microscopy (Kline, 2000);
therefore, this profound reorganization has been well documented.
IP 3 sensitivity and Ca 2+ release are indicators of developmental competence
R

R

P

P

because they are important for events that lead to early embryo development, including
resumption and completion of meiosis, the prevention of polyspermy, and recruitment of
mRNAs required for activation of the embryo genome (Ducibella et al., 2006). The
development of a metaphase II-like Ca 2+ release does not seem to depend on meiotic
P

P

progression because oocytes arrested spontaneously at MI produce continuous Ca 2+
P

P

oscillations similar to a fertilized MII egg (Jones et al., 1995). This underscores the
importance of cytoplasmic changes that occur during oocyte maturation for fertilization
and early embryonic development.

II.

U

Studies on the Constitutively Active G protein-Coupled Receptor 3

Identification of GPR3 as an Activator of G s for Meiotic Arrest
R

R

As discussed previously, GPR3 is essential for maintaining prophase I arrest in
mouse and porcine oocytes (Hinckley et al., 2005; Ledent et al., 2005; Mehlmann et al.,
6

2004; Yang et al., 2012) and may play a role in meiotic arrest in human and Xenopus
oocytes (Deng et al., 2008; DiLuigi et al., 2008; Rios-Cardona et al., 2008). Prior to the
identification of GPR3, it was well acknowledged that prophase I arrest is dependent
upon high levels of cAMP in the oocyte, LQZKLFKDGHQ\ODWHF\FODVHLVDFWLYDWHGE\*Į s ,
R

R

but how this signaling pathway is activated was unknown. As G s does not exhibit
R

R

constitutive activity, it was thought that a GPCR in the oocyte was present to keep it
active. GPR3 was identified as a candidate for this receptor by searching for GPCRs in
an EST database from a cDNA library of fully grown prophase-arrested mouse oocytes.
Fifteen putative GPCRs were identified, many of which were orphan receptors with no
known function (Mehlmann et al., 2004). Of these, GPR3 was of interest because it
elevates cAMP when transfected into cultured cells (Eggerickx et al., 1995; Hinckley et
al., 2005).
To confirm that GPR3 is the G s -linked receptor that maintains meiotic arrest in
R

R

mouse oocytes, histological sections of ovaries from Gpr3 knockout mice were
examined. Although the ovaries from these mice appeared to be normal and displayed
normal ovulation and luteinization, the oocytes within antral follicles had resumed
meiosis and contained metaphase chromosomes (Mehlmann et al., 2004). Oocytes in
preantral follicles remained arrested until antral spaces formed and the oocytes achieved
meiotic competence, at which point the oocytes spontaneously resumed meiosis.
Premature maturation is due to the absence GPR3 in the oocyte because it can be rescued
by injection of Gpr3 mRNA into preantral or early antral follicle-enclosed oocytes
(Mehlmann et al., 2004). Furthermore, oocyte-specific knockdown of Gpr3 using RNA
interference (RNAi), or reduction of GPR3 using morpholinos, stimulated premature
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maturation (Mehlmann, 2005; Hinckley et al., 2005). Thus, in the absence of oocytespecific GPR3, the oocyte can no longer produce cAMP required to maintain arrest and
premature meiotic resumption occurs.
Following the identification of GPR3 in the oocyte, it was subsequently shown
WKDW*35DFWLYDWHV*Į s in the oocyte and that GPR3 activity does not depend on the
R

R

presence of the follicle cells (Freudzon et al., 2005). GPR3 is also not a target for LHinduced meiotic resumption. It was thought that LH could provide an inverse agonist that
would turn off GPR3 and reduce cAMP levels in the oocyte. However, treatment of
follicle-HQFORVHGRRF\WHVZLWK/+GLGQRWFDXVHDFKDQJHLQ*Į s activity (Norris et al,
R

R

2007). Thus, the follicle does not appear to produce an agonist or antagonist that affects
GPR3 activity, nor does LH stimulate meiotic resumption by terminating GPR3-G s
R

R

signaling. In addition, it seems as though GPR3 remains constitutively active at least
until metaphase II. Gpr3 mRNA is present in oocytes, eggs, and early embryos at the one
and two cell stage. A trace amount of Gpr3 mRNA is detected in morulae and it is absent
in blastocysts (Ledent, 2005).
In addition to premature maturation, Gpr3-deficient mice are subfertile and
display a progressive reduction in litter size with advancing maternal age. Aging Gpr3deficient females exhibit an increase in the number of fragmented oocytes, reduced
developmental capacity of embryos, and increased signs of reproductive aging. This
phenotype presumably occurs because the coordination of meiotic progression and
fertilization is disrupted. Consequently, Gpr3-deficient mice may constitute a relevant
model of premature ovarian failure (Ledent et al., 2005). Several studies have examined
whether mutations in GPR3 are present in women with premature ovarian failure.

8

However, no perturbations were found in the coding region of GPR3 in the populations
included in these studies (Kovanci et al., 2008; Zhou et al., 2009). Whether GPR3
expression or activity in the ovary is abnormally regulated in these women remains to be
explored.

GPR3 also has Functions in the Central Nervous System
GPR3 is not only important for female fertility, but also has several functions in
the brain. Two studies by the same group demonstrated that GPR3 regulates neurite
outgrowth and postnatal cerebellar development, two processes that require elevated
cAMP levels (Tanaka et al., 2007; Tanaka et al., 2009). Within the past several years
there have been additional studies linking GPR3 to several other neurological processes
in the brain. For example, GPR3 appears to be a novel actor in emotional-like responses,
involved in the development of neuropathic pain, and modulates early phases of cocaine
reinforcement (Ruiz-Medina et al., 2011; Tourino et al., 2012; Valverde et al., 2009).
GPR3 was also found to modulate Amyloid-Beta peptide generation in neurons, a
pathological hallmark of Alzheimer’s disease. GPR3 is highly expressed in regions of
the human brain associated with Alzheimer’s disease and its expression is increased in
the sporadic Alzheimer’s disease brain (Thathiah et al., 2009). In summary, GPR3
appears to have other functions in the brain and has been implicated in both physiological
and pathological processes.

GPR3 is an Orphan Receptor that Mediates cAMP Production in the Absence of an
Agonist

9

Human GPR3 and mouse Gpr3 were originally identified from genomic libraries
by low-stringency PCR using degenerate oligonucleotide primers against conserved
regions corresponding to the second, third, sixth, and seventh transmembrane regions of
GPCRs (Eggerickx et al., 1995; Saeki et al., 1993; Song et al., 1994). Gpr3 mRNA is
highly expressed in the whole brain with lower expression in the ovary, testis, and eye
(Eggerickx et al., 1995; Saeki et al., 1993). The open reading frame of GPR3 is 990
nucleotides and encodes a protein that is 330 amino acids with seven 20-25-amino-acid
hydrophobic segments typical of GPCRs. It has a predicted molecular mass of 35.5 kD,
but the actual molecular mass of the mature protein may be higher because GPR3
contains a potential glycosylation site in the amino-terminus. GPR3 also contains two
potential sites for phosphorylation by protein kinase C (PKC) as well as several
serine/threonine residues that could be targets for G protein-receptor kinases (GRKs) in
the desensitization pathway (Eggerickx et al., 1995; Saeki et al., 1993). Human and
mouse GPR3 have 91-93% amino acid identity scores (Eggerickx et al., 1995; Song et al.,
1995).
GPR3 is closely related to GPR6 and GPR12 and share ~60% amino acid identity.
These receptors are classified as rhodopsin-like GPCRs (Class A) belonging to a
subgroup of GPCRs that includes the orphan receptors EDG1, rCNL3, AGR16, R334,
and the melanocortin, adrenocorticotropic, and central and peripheral cannabinoid
receptors (Eggerickx et al., 1995; Song et al., 1995). GPR3/6/12 also show sequence
similarities to ACTH receptors, adenosine receptors, and H2 histamine receptors (Saeki
et al., 1993). GPR3 and its subgroup share specific structural features and lack distinct
motifs when compared to other receptor classes. For example, these receptors lack a
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conserved cysteine residue in the second extracellular loop that is believed to form a
disulfide bridge in most GPCRs, a Glu-Asn motif is present rather than Gly-Asn in the
first transmembrane segment, and no proline residue exists in the fifth transmembrane
segment (Eggerickx et al., 1995).
Following the molecular cloning of GPR3, extensive studies were performed to
examine its activity when transfected into cultured cells as well as to identify a potential
ligand. Through these studies, it was demonstrated that GPR3 behaves similarly to a
constitutive activator of adenylate cyclase. When GPR3 is transfected into a variety of
cell lines originating from different species, it induces a significant increase in cAMP
production compared to empty vector cells or cells transfected with G s -coupled GPCRs
R

R

without agonist stimulation (Eggerickx et al., 1995). For example, in CHO cells, basal
cAMP is 0.2 pmol/mL and increases to 40-55 pmol/mL in response to GPR3 expression.
This dramatic stimulation of adenylate cyclase is similar to that obtained by GPCRs fully
stimulated by their corresponding ligands. cAMP levels can be increased even further to
80-120 pmol/mL upon stimulation with forskolin, suggesting that the signaling pathway
could be further modified upwards or downwards by ligands (Eggerickx et al., 1995).
*35KDVDOVRGHPRQVWUDWHGGXDOFRXSOLQJDQGVLJQDOLQJWR*Į i DQG*Į s in HEK293
R

R

R

R

cells (Uhlenbrock et al., 2002).
The finding that GPR3 stimulates cAMP accumulation in the absence of a ligand
presents two possibilities: (1) GPR3 has constitutive activity; or (2) an agonist is
produced by the cells, in the assay medium, or in a component of the assay. It is unlikely
that the ligand was present in the assay medium because culturing cells in 1% Fetal
Bovine Serum (FBS), 10% (FBS), serum-free, or defined media did not have significant
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effects on cAMP levels. The ligand was also unlikely to be secreted by the cells because
extensive washing and co-culture experiments did not affect cAMP production
(Eggerickx et al., 1995). These experiments, however, cannot rule out a membranebound ligand. Due to the sequence similarity of GPR3 to the cannabinoid receptor and its
ligand anandamide, it is possible that the ligand for GPR3 could be a membrane-derived
or membrane-bound lipid that is ubiquitously expressed across cell types. It is also
possible that an internal ligand present in the cytoplasm activates GPR3.
A number of potential ligands for GPR3 have been tested inconclusively
(Eggerickx et al., 1995; Saeki et al., 1993; Yin et al., 2009). A small effect of
sphingosine 1-phosphate (S1P) has been reported on GPR3 activity with <20% increase
in cAMP over basal levels (Hinckley et al., 2005; Uhlenbrock et al., 2002), although it
has not been definitively established that the stimulatory effect of S1P on cAMP
production is due to GPR3 or a S1P receptor expressed endogenously. There are also
conflicting results in the literature on the effect of serum-containing lipids on GPR3
activity (Eggerickx et al., 1995; Hinckley et al., 2005; Uhlenbrock et al., 2002). Because
constitutive signaling is still dramatic in serum-free medium, it suggests that a lipid is not
the only ligand or that GPR3 is a true constitutively active receptor. The effect of S1P on
GPR3 activity may be cell-specific, because S1P does not enhance GPR3 activity in CHO
cells (Valverde et al., 2009), whereas it does in HEK293 cells (Uhlenbrock et al., 2002;
Yang et al., 2012). Furthermore, S1P has been reported to induce GPR3 internalization
in HEK293 cells, and it has been hypothesized that GPR3 internalization may transport
S1P to subcellular compartments to activate additional signaling pathways (Yang et al.,
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2012). Thus, the idea of S1P as a ligand for GPR3 is controversial and GPR3 remains an
orphan receptor.
The second possibility is that GPR3 exhibits constitutive activity. It has been
proposed that constitutively active receptors favor an active conformation or some
intermediate conformation between the inactive and the active state (Lefkowitz, 1993).
Several “hot spots”, when mutated on wild-type, inactive GPCRs, are known to confer
constitutive signaling. One of these hot spots is known as the DRY (Asp-Arg-Tyr) motif
and is located at the interface of transmembrane domain III and the second intracellular
loop. It is the most highly conserved motif in the GPCR family and many studies have
shown that mutation of this element renders receptors that are normally inactive to
become constitutively active (Cohen et al., 1993; Pauwels and Wurch, 1998; Scheer et
al., 1997). GPR3 contains the entire DRY motif; therefore, differences in this region that
might explain constitutive activity can be excluded (Eggerickx et al., 1995; Saeki et al.,
1993; Song et al., 1995; Uhlenbrock et al., 2002). Another hot spot associated with
constitutive signaling is the interface of transmembrane domain VI and the end of the
third intracellular loop. It is thought that this region contains residues critical for the
interaction of the receptor with G proteins. Mutation of these sites results in permanent
exposure of the GPCR to G proteins, thereby resulting in constitutive signaling (Gether et
al., 1997; Huang et al., 2001). Whether GPR3 has alternative amino acids at these sites,
or any other site that would allow for permanent coupling to G s , cannot be answered until
R

the crystal structure of GPR3 is resolved.

Regulation of Constitutively Active GPCRs
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R

&RQVWLWXWLYHDFWLYLW\ZDVILUVWGHPRQVWUDWHGIRUWKHį-RSRLGDQGȕ 2 -AR receptors
R

R

and there is evidence that more than 60 GPCRs exhibit some level of basal activity in
vitro. Depending on the receptor and the cell type, the levels of constitutive activity
varies, and in some cases constitutive activity can be reversed by inverse agonists (Seifert
and Wenzel-Seifert, 2002). It is not clear if a majority of these receptors also exhibit
constitutive activity in vivo, because constitutive activity is often identified using in vitro
overexpression systems when the GPCR is expressed at significantly higher levels than
what is physiological (Arvanitakis et al., 1998). Constitutive activity of endogenous
GPCRs are kept low because a high level of activity can have deleterious effects on cells
(Seifert and Wenzel-Seifert, 2002). In addition, several viral GPCRs are constitutively
active and high activity of these receptors contributes to viral infection (Sherrill and
Miller, 2008). There are very few native constitutively active GPCRs for which high
activity has been observed in normal physiology (Hanf et al., 1993; Mehlmann et al.,
2004; Mewes et al., 1993; Morisset et al., 2000; Varma, 1999). GPR3 is a leading
example of a GPCR in which high constitutive activity is important for physiological
processes.
It is unknown if native constitutively active GPCRs are regulated. Our
knowledge of how constitutively active receptors are regulated is limited to studies on
wild type, inactive receptors that are either mutated experimentally or that acquire
activating mutations during pathogenesis. Thus, the mechanism regulating native
constitutively active GPCRs is an area of research that has been largely unexplored.
Currently, there is little known about how GPR3 activity and cAMP levels are regulated
in the oocyte and nervous system. Understanding GPR3 signaling and activity could
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have important implications for not only understanding constitutively active receptors in
general, but also therapeutically for treating reproductive and neurological disorders.

III.

G Protein-Coupled Receptor Signaling and Regulation by GRK and
Arrestin
GPCRs represent the largest family of integral membrane proteins and the most

versatile group of signaling proteins (Bockaert and Pin, 1999). GPCRs respond to a
diverse range of extracellular messengers and are fundamentally important in many
physiological processes such as sensory perception, cognition, muscle contraction,
endocrine and exocrine secretion, metabolism, inflammation and immunity. As a result,
GPCRs have a huge impact in medicine and approximately 30% of current therapeutics
target GPCRs (Brink et al., 2004). GPCRs are classified into five main families of
receptors: rhodopsin, secretin, glutamate, adhesion, and frizzled-taste-2 (Fredriksson et
al., 2003). Despite the diversity of the GPCR super family, they share a common
structure of seven-transmembrane domains linked by extracellular and intracellular loops,
an extracellular amino-terminus (N-terminus) and an intracellular carboxyl-terminal (Cterminus or C-tail) domain.
GPCRs receive extracellular stimuli and transmit signals to the interior of the cell
by way of second messengers. For many GPCRs, agonist binding to the extracellular
domains of the receptor causes the receptor to adopt an active conformation, an event that
involves a series of conformational changes within the transmembrane and intracellular
domains. This conformational change exposes intracellular binding sites for
heterotrimeric GTP-binding proteins (G proteins). The GPCR acts as a guanine exchange
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factor for G proteins and catalyzes the exchange of GDP for GTP on the G Į subunit. As
R

R

a result, the G-protein complex dissociates, producing a G Į -GTP subunit and a G ȕȖ
R

R

R

R

heterodimer (Reiter and Lefkowitz, 2006). Both of these active subunits can positively or
negatively regulate the activity of downstream effectors (eg. adenylate cyclase,
phospholipases, and ion channels) to generate second messenger molecules (eg. cAMP,
inositol trisphosphate, and Ca 2+ ) that produce a variety of physiological responses (Neer,
P

P

1995). GPCRs can also signal independently of G-proteins. The best characterized G
protein-LQGHSHQGHQWPHFKDQLVPLVPHGLDWHGE\ȕ-arrestins from endosomal
compartments (Lefkowitz and Shenoy, 2005).
A majority of GPCRs become activated and signal at the cell surface where the
receptor interacts with its agonist. Therefore, the level of receptor present at the plasma
membrane is thought to dictate the magnitude of GPCR signaling. Expression levesl of
GPCRs at the plasma membrane is the result of a balance of three highly regulated and
dynamic intracellular trafficking processes: export, internalization, and degradation
(Duvernay et al., 2005). GPCRs are synthesized, folded, and assembled in the ER.
Properly folded GPCRs migrate from the ER to the ERGIC (ER-golgi intermediate
complex), to the Golgi, and to the TGN (transgolgi network). Mature GPCRs bud off the
TGN and migrate to the plasma membrane, at which point they can interact with their
ligand and transduce a physiological response. Once at the cell surface, GPCRs undergo
internalization, which can be tonic or agonist-induced, and leads to either recycling or
downregulation of the signaling response (Duvernay et al., 2005).
During trafficking to and from the plasma membrane, GPCRs associate with a
myriad of proteins (referred to as GPCR interacting proteins; GIPs) that influence GPCR
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function and signal transduction (Magalhaes, Dunn & Ferguson, 2011). These proteins
can be either transmembrane or cytosolic and are involved in signaling, receptor ligand
specificity, receptor endocytosis, expression at the cell surface, receptor recycling,
processing in the ER, and compartmentalization. Of the many GPCR interacting
proteins, G-protein receptor kinases (GRK) and arrestins will be the focus of this
dissertation as they are the only two protein families that are able to specifically interact
with the activated conformation of GPCRs and are involved in regulating GPCR activity
at the cell surface (Lefkowitz and Shenoy, 2005). There are 7 subtypes of GRKs and 4
subtypes of arrestins. GRKs 1 and 7 are limited to retinal rods and cones, respectively.
GRK4 is expressed in the cerebellum, testis, and kidney whereas GRKs 2, 3, 5, and 6 are
ubiquitously expressed (Reiter and Lefkowitz, 2006). Arrestins 1 and 2 are specific to
the visual system and arrestin- ȕ-arrestin- DQGDUUHVWLQ ȕ-arrestin-2) are widely
expressed (Reiter and Lefkowitz, 2006). GRKs and arrestins coordinate GPCR activities
in three ways: (1) silencing of G protein signaling by desensitization; (2) receptor
internalization and trafficking; and (3) signaling independent of G proteins. GPCR
GHVHQVLWL]DWLRQE\*5.DQGȕ-arrestin as a mechanism to regulate GPR3 activity will be
the focus of this dissertation.

*5.VDQGȕ-arrestins in GPCR Desensitization
Most cells have developed ways of limiting and regulating GPCR activity. The
most understood mechanism is receptor desensitization that silences GPCR signaling in
response to acute or chronic receptor stimulation. Despite their diversity, most GPCRs
undergo desensitization that involves a universal mechanism orchestrated by GRKs and
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arrestins. As mentioned previously, the GPCR undergoes a conformational change
following ligand binding. This conformational change not only allows for G protein
activation, but it also unmasks sites for phosphorylation by GRKs. GRKs phosphorylate
serine and threonine residues at the C-terminus and/or the third intracellular loop.
Phosphorylation of the activated receptor recruits arrestin with high affinity and arrestin
acts through steric hindrance to uncouple G proteins from the receptor and to prevent
further GPCR signaling (Kohout and Lefkowitz, 2003). Studies have shown that arrestin
binding can diminish receptor signaling by as much as 80% (Attramadal et al., 1992;
Lohse et al., 1992)$QDGGHGOHYHORIFRPSOH[LW\WRWKLVV\VWHPLVWKDWȕ-arrestins can
also interact with cAMP phosphodiesterases of the 4D family (Perry et al., 2002) to
simultaneously prevent cAMP generation while enhancing cAMP degradation. Thus,
many GPCRs undergo desensitization following activation as a mechanism to regulate G
protein activation and production of second messengers. Whether there is a functional
desensitization pathway in the oocyte and whether it regulates GPR3 activity is currently
unknown.
Although phosphorylation of GPCRs by GRKs is an important event for arrestin
recruitment and attenuation of G-protein activation, GRKs can also regulate GPCR
signaling independently of phosphorylation. Studies using kinase inactive GRK mutants
demonstrate that phosphorylation is not absolutely required for desensitization. GRK2
and GRK3 possess a Regulator of G protein signaling (RGS)-like domain in the Nterminus that can sequester activated G Į subunits to prevent coupling to downstream
R

R

effectors (Ferguson, 2007a). There is also evidence that GRK2 and GRK3 can diminish
G protein signaling by simply interacting with the GPCR (Dhami et al., 2002). For
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example, the expression of only the N-terminal domain that contains elements for GPCR
binding is sufficient to desensitize some GPCRs (Ferguson, 2007a). GRK2 mediated
phosphorylation-LQGHSHQGHQWDWWHQXDWLRQRIVLJQDOLQJKDVEHHQREVHUYHGIRU*Į s -*Į i R

R

R

R

DQG*Į q -coupled receptors (Dicker et al., 1999; Lembo et al., 1999; Reiter et al., 2001).
R

R

The GRK/arrestin regulatory system is versatile and can be tailored to regulate
physiological processes in a tissue-specific manner. The extent of desensitization and the
signaling outcome depend on the cell type, the receptor, the contribution of each
individual GRK and arrestin subtype, the affinity to which arrestin binds, and the pattern
of GPCR phosphorylation (Reiter and Lefkowitz, 2006). It should also be mentioned that
GPCR desensitization is a complex situation that extends beyond the traditional role of
*5.VDQGȕ-arrestin. Kinases other than GRK, such as protein kinase C (PKC), PKA,
protein kinase B (AKT/PKB), and casein kinases have all been found to phosphorylate
GPCRs and modulate their activity, with PKC and PKA more commonly contributing to
desensitization. Additional GIPs including calmodulin, RGS proteins, and optineurin can
also regulate GPCR activity and act independently of phosphorylation by disrupting the
interaction between GPCRs and G proteins (Tobin, 2008).
As mentioned previously, little is known about how constitutively active GPCRs
are regulated, if they are regulated at all. It is possible that constitutively active GPCRs
are in an active state and in the appropriate conformation to be continuously
phosphorylated and transiently desensitized (Leurs et al., 1998). There is an example of
at least one constitutively active GPCR, the human cytomegalovirus chemokine receptor
46T

(US28), that signals from the cell surface and is constitutively phosphorylated by GRK2
and transiently desensitized. GRKDQGȕ-arrestin overexpression induces US28
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46T

internalization and attenuates G q -mediated phospholipase signaling (Casarosa et al.,
R

R

2001; Fraile-Ramos et al., 2001; Miller et al., 2003b; Mokros et al., 2002). Because the
constitutive activity of US28 appears to be regulated by GRKs, ȕ-arrestin, and membrane
trafficking, it is possible that there are common mechanisms that regulate both ligandactivated GPCRs and constitutively active GPCRs. GPR3 contains multiple serine and
threonine residues in the C-terminus and intracellular loops that could be sites for
phosphorylation by GRKs or other kinases in the desensitization pathway.

*5.VDQGȕ-arrestins in GPCR Trafficking
In addition to GPCR desensitizDWLRQ*5.VDQGȕ-arrestins have important roles
in GPCR trafficking. Although receptor internalization may not be necessary for
desensitization, it can influence the signaling response and result in: (1)
dephosphorylation and resensitization of the receptor, (2) targeting of the receptor to
lysosomes for degradation, or (3) activation of additional intracellular pathways (Reiter
and Lefkowitz, 2006). Clathrin-mediated endocytosis is the most common and
understood mechanism by which GPCRs are internalized and it usually requires GPCR
SKRVSKRU\ODWLRQE\*5.DQGVXEVHTXHQWȕ-arrestin recruitment (Moore et al., 2007;
Shenoy and Lefkowitz, 2003). However, GPCR internalization via caveolae and other
uncoated vesicles has also been described (Claing et al., 2002). Clathrin-mediated
endocytosis will be the only pathway of GPCR internalization that will be discussed in
this dissertation. Not only is there little known about desensitization of GPCRs in the
oocyte, but there is also little known about receptor-mediated endocytosis in the oocyte
and the proteins that might be involved.
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ȕ-arrestin facilitates internalization by targeting GPCRs to clathrin coated pits
WKURXJKGLUHFWLQWHUDFWLRQVZLWKWKHFODWKULQKHDY\FKDLQDQGWKHȕVXEXQLWRIWKHFODWKULQ
adaptor AP-2 (Goodman et al., 1996; Laporte et al., 1999)ȕ-arrestin can also interact
with other proteins involved in clathrin-mediated endocytosis such as E3 ubiquitin
ligases, the small G protein ADP-ribosylation factor 6 and its guanine nucleotide
exchange factor ADP ribosylation factor nucleotide site opener, phosphatidylinositol 4,5bisphosphate (PIP 2 ), phosphatidylinositol (3,4,5)-trisphosphate (PIP 3 ), and N R

15T46T

R

R

R

15T

15T46T

ethylmaleimide-sensitive fusion protein (Claing et al., 2001; Goodman et al., 1996). In
15T

addition to ȕ-arrestin, GRKs may also promote GPCR internalization by interacting with
endocytic proteins (eg. GTI1, PI3K, and ezrin) or by binding to clathrin heavy chain
(Ferguson, 2001; Shiina et al., 2001). Once the receptor is targeted to clathrin-coated
pits, the vesicles pinch off from the membrane in a dynamin-dependent or -independent
manner and are trafficked to early endosomes. At this point, GPCRs can either be sorted
to recycling endosomes and transported back to the plasma membrane or to late
endosomes that target receptors to lysosomes for degradation (Moore et al., 2007). The
stability and affinity with ZKLFKȕ-arrestin binds to the GPCR can also influence postendocytic sorting and the kinetics of receptor recycling (Oakley et al., 2001; Reiter and
Lefkowitz, 2006; Zhang et al., 1999).
Although GPCRs most commonly use arrestin as an adaptor for clathrin coated pit
targeting, in some cases GPCRs contain specific internalization motifs within the Cterminus (Bonifacino and Traub, 2003) that can bind to AP-2 (Honing et al., 2005; Ohno
et al., 1995). The two most common and understood internalization motifs that bind to
AP-2 complexes are dileucine- and tyrosine-EDVHGPRWLIV <;;ĭZKHUHĭLQGLFDWHVDQ
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amino acid with a bulky hydrophobic side chain). Some GPCRs need both ȕ-arrestin and
an internalization motif, but how these two mechanisms cooperate is currently unknown
(Moore et al., 2007). GPR3 contains a NPXY tyrosine-based internalization motif within
the seventh transmembrane domain proximal to the C-terminus. It is therefore possible
WKLVLVDVSHFLILFLQWHUQDOL]DWLRQPRWLIWKDWPHGLDWHV*35HQGRF\WRVLV:KHWKHUȕarrestins are also required for GPR3 internalization is unknown.

Signaling by Internalized GPCRs
It has been assumed that G protein dependent cascades are activated exclusively
at the cell surface and that receptor internalization terminates GPCR signaling and the
production of second messengers. However, several GPCRs remain intact and continue
to signal or initiate new signaling pathways from endosomal membranes. For example,
the thyroid stimulating hormone receptor ( TSH) and parathyroid hormone receptor
46T

46T

46T

( PTH) continue to signal following internalization. These receptors remain associated
46T

with G proteins and adenylate cyclase at endosomal compartments where signaling is
associated with a prolonged cAMP response following hormone treatment (Calebiro et
al., 2009; Ferrandon et al., 2009; Calebiro et al., 2010). These studies also found that
signaling from internalized receptors elicits a different cellular response than signaling
from receptors at the cell surface. In addition to the TSH and PTH receptors, there is
evidence that G i -dependent signaling from the S1P receptor may occur intracellularly
R

R

(Mullershausen et al., 2009) and GPR6, a closely related constitutively active receptor to
GPR3 (Kostenis, 2004b), is localized intracellularly rather than on the cell surface,
suggesting that it signals from endosomes (Padmanabhan et al., 2009). Intracellular
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signaling seems to contradict the well-established process of desensitization; therefore,
further studies are needed to reconcile these two concepts. It is not known if intracellular
cAMP signaling is a general feature of G s /G i coupled receptors or if it is a characteristic
R

R

R

R

of only a few receptors. Additional studies are also needed to determine if other GPCRs
exhibit intracellular signaling, in what cell types, and what are the consequences of
intracellular signaling. It is not known where in the oocyte GPR3 signals. An attractive
idea is that endosomal signaling of GPR3 contributes to prolonged cAMP production and
relay of the signal to the interior of the oocyte.

Dissertation Aims
It is clear that most cells have developed ways to limit and regulate GPCR
signaling. Because meiotic arrest is dependent upon constitutive GPR3 signaling, it
raises the question of whether there is a functional desensitization pathway in the oocyte.
The level of cAMP in a follicle-enclosed oocyte remains constant, even though there is
continuous production of cAMP and low PDE3A activity (Norris et al., 2009). This
demonstrates that there is a balance between cAMP production and degradation. Perhaps
the cAMP signaling pathway is regulated in order to prevent excessive cAMP
accumulation and this regulation could occur at the level of GPR3. Excessive cAMP
may be problematic because it could affect oocyte quality or counteract LH-induced
maturation. In order to address this, the first question that needs to be answered is where
in the cell GPR3 signals. As mentioned previously, endosomal signaling is associated
with a prolonged signaling response for some receptors. It is therefore possible that
GPR3 signals intracellularly and is not desensitized. Alternatively, GPR3 could signal
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from the cell surface and be continuously desensitized and internalized, leading to either
recycling or degradation. It is also possible that GPR3 is not internalized or targeted for
desensitization, but rather GPR3 activity is regulated by its level of expression. For
example, in Pde3a-null mouse oocytes, Gpr3 mRNA is downregulated by more than 50%
(Hinckley et al., 2005).
In Xenopus oocytes, vesicular trafficking at the cell membrane is important for
maintaining meiotic arrest. Blocking exocytosis promotes meiotic resumption
independently of progesterone while inhibiting clathrin-mediated endocytosis prevents
meiotic resumption stimulated by progesterone (El-Jouni et al., 2007). Furthermore,
effects of overexpressed *5.DQGȕ-arrestin on stimulating progesterone-independent
maturation in Xenopus oocytes have also been reported (Wang and Liu, 2003). These
findings support the argument that a cAMP-producing GPCR is regulated by a
desensitization pathway and is actively recycled, although the role of the GPCR was not
examined in this study. Membrane trafficking is also important for meiotic arrest in
Caenorhabditis elegans (Cheng et al., 2008). In C. elegans oocytes, major sperm protein
(MSP) is released from sperm in the oviduct where it directly binds to a transmembrane
protein, VAB-1, on the oocyte and stimulates meiosis (Miller et al., 2003a). A study by
Cheng, et al., 2008 demonstrated that VAB-1 receptor trafficking may regulate the MSP
signal, although, it is unclear how the localization of VAB-1 is related to its activity.
Thus, receptor trafficking may be important for meiotic arrest in species other than
Xenopus and C. elegans.
The following chapters examine the localization and membrane trafficking of
GPR3 as a possible mechanism by which its constitutive activity is regulated. Chapter
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two of this dissertation addresses the question of where GPR3 signals in the mouse
oocyte. We present evidence that GPR3 signaling at the plasma membrane is sufficient
for meiotic arrest. We use a FRET-based technique to measure the amount of cAMP in
single oocytes treated with an endocytic inhibitor. Chapter three further investigates the
localization and constitutive activity of GPR3 in HEK293 cells. GPR3 localization and
activity in response to endocytic inhibition and overexpression of GRK2 DQGȕ-arrestin-2
is also examined as well as specific residues that may be involved in GPR3 activity and
surface localization.
In the appendix of this dissertation, we examine whether nuclear and cytoplasmic
changes are preserved in oocytes that are cryopreserved and matured in vitro.
Cytoplasmic maturation is assessed by microinjection of DiI to label the ER and the
ability to release calcium is evaluated by microinjection of Calcium green and IP 3 . We
R

R

found that vitrification of GV-stage oocytes does not affect nuclear maturation, continuity
of the ER, or the ability to release calcium. However, reorganization of the ER is
disrupted in vitrified oocytes matured in vitro. We also found that the culture medium
greatly influenced the ability of the ER to reorganize into distinct clusters during IVM of
unfrozen oocytes. Thus, before this technique can become a reliable method for treating
infertility, further studies are needed to improve the process of IVM.

The overall goal of this dissertation is to understand where GPR3 signals in mouse
oocytes and HEK293 cells and whether the constitutive activity of GPR3 is regulated
by a *5.ȕ-arrestin-mediated mechanism.
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CHAPTER TWO
U

Endocytosis in the Mouse Oocyte and its Contribution to cAMP Signaling During
Meiotic Arrest

Abstract
Mammalian oocytes are arrested at prophase I of meiosis until a preovulatory
surge of LH stimulates them to resume meiosis. Prior to the LH surge, high levels of
cAMP within the oocyte maintain meiotic arrest; this cAMP is generated in the oocyte
through the activity of the constitutively active, G s -coupled receptor, G-protein-coupled
R

R

receptor 3 (GPR3) or GPR12. Activated GPRs are typically targeted for desensitization
through receptor-mediated endocytosis, but a continuously high level of cAMP is needed
for meiotic arrest. The aim of this study was to examine whether receptor-mediated
endocytosis occurs in the mouse oocyte and whether this could affect the maintenance of
meiotic arrest. We found that constitutive endocytosis occurs in the mouse oocyte.
Inhibitors of receptor-mediated endocytosis, monodansylcadaverine and dynasore,
inhibited the formation of early endosomes and completely inhibited spontaneous meiotic
resumption. A red fluorescent protein-tagged GPR3 localized in the plasma membrane
and within early endosomes in the oocyte, demonstrating that GPR3 is endocytosed.
However, overexpression of G-SURWHLQUHFHSWRUNLQDVHDQGȕ-arrestin-2 had only a
modest effect on stimulating meiotic resumption, suggesting that these proteins do not
play a major role in GPR3 endocytosis. Inhibition of endocytosis elevated cAMP levels
within oocytes, suggesting that there is an accumulation of GPR3 at the plasma
membrane. These results show that endocytosis occurs in the oocyte, leading to a
decrease in cAMP production, and suggest that there is a balance between cAMP
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production and degradation in the arrested oocyte that maintains cAMP levels at an
appropriate level during the maintenance of meiotic arrest.

Introduction
Mammalian oocytes become arrested at prophase I of meiosis during embryonic
development. Oocytes remain in prophase I until a preovulatory surge of LH from the
pituitary signals to the oocyte, via the surrounding follicle cells, to resume meiosis and
progress to metaphase II, where they undergo a second arrest. It is at the MII stage that
fertilization occurs. Meiotic resumption is coordinated with the LH surge, such that by
the time ovulation occurs the oocyte has undergone nuclear maturation as well as changes
in intracellular organization (cytoplasmic maturation) that prepare the mature, MII-stage
oocyte to be fertilized and initiate embryonic development.
It is well established that maintenance of meiotic arrest prior to the LH surge
depends on high levels of cAMP in the oocyte (Conti et al., 2002; Mehlmann, 2005b). In
rodents, cAMP is produced in the oocyte by the activity of a constitutively active Gprotein-coupled receptor 3 (GPR3; mouse) or GPR12 (rat; (Hinckley et al., 2005; Ledent
et al., 2005; Mehlmann et al., 2004; Vaccari et al., 2008), both of which stimulate a G ĮV
R

R

G-protein to activate adenylate cyclase and thereby produce cAMP (Freudzon et al.,
2005; Hinckley et al., 2005; Horner et al., 2003; Mehlmann, 2005a). The removal or
inactivation of any of the components of this signaling pathway causes the oocyte to
undergo meiotic resumption in the absence of the LH surge (DiLuigi et al., 2008; Horner
et al., 2003; Ledent et al., 2005; Mehlmann, 2005a; Mehlmann et al., 2002; Mehlmann et
al., 2004; Vaccari et al., 2008).
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Most GPCRs are inactive until they are stimulated by a ligand. Ligand binding
triggers a conformational change in the receptor and allows the phosphorylation by GproWHLQUHFHSWRUNLQDVHV *5.V DQGVXEVHTXHQWO\WKHUHFUXLWPHQWRIȕ-arrestins, which
cause receptor internalization through clathrin-coated pits. The receptor can then be
degraded or recycled back to the membrane (Moore et al., 2007; Reiter and Lefkowitz,
2006). GPR3 is unusual, as it is constitutively active and is likely to signal in the absence
of a ligand (Freudzon et al., 2005; Yin et al., 2009). As a constitutively active receptor, it
is unclear whether GPR3 is internalized in a similar fashion and whether the receptor
continues to signal internally to provide a constant level of cAMP to the interior of the
oocyte. Recently, the TSH and PTH receptors, both of which act through the G s
R

R

signaling pathway, have been shown to continue to signal following endocytosis, within
early endosomes (Calebiro et al., 2009; Calebiro et al., 2010b; Ferrandon et al., 2009). In
addition, GPR6, a constitutively active receptor closely related to GPR3 (Kostenis,
2004a), is localized within cells rather than on the cell surface, suggesting that it signals
within endosomes (Padmanabhan et al., 2009). Signaling within endosomes has been
associated with the ability of the cell to maintain a prolonged response to hormone
following receptor internalization. Because prolonged cAMP signaling is crucial for the
maintenance of meiotic arrest, it is possible that endosomal signaling is required for
sustained cAMP production. Alternatively, it is possible that GPR3 must continuously
remain in the oocyte plasma membrane in order to be active, so that it would either not
recycle or be endocytosed and rapidly recycled back to the membrane. Depletion of
GPR3 in the follicle-enclosed mouse oocyte by RNAi causes oocytes to undergo
spontaneous maturation in the absence of LH (Mehlmann, 2005a), indicating that GPR3
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endocytosis and degradation occur in the oocyte, concomitant with synthesis of new
GPR3 and insertion into the plasma membrane.
Receptor-mediated endocytosis is a critical process utilized by oocytes of nonmammalian species, such as insects and frogs, to import yolk protein precursors (Opresko
and Wiley, 1987). Import of vitellogenin occurs during oocyte growth through clathrinmediated endocytosis following binding to a receptor. Although mammalian oocytes do
not produce yolk, it is possible that endocytosis could be important during oocyte growth.
In addition, endocytosis of cell surface receptors could be important for the regulation of
meiosis. Indeed, receptor trafficking is critical for the regulation of meiotic maturation in
oocytes of Caenorhabditis elegans (Cheng et al., 2008).
Previous studies have shown that vesicular trafficking at the plasma membrane
has an important role in maintaining meiotic arrest in Xenopus oocytes (El-Jouni et al.,
2007). Inhibiting exocytosis stimulated meiotic resumption in the absence of
progesterone, whereas inhibiting endocytosis interfered with the ability of progesterone
to stimulate meiotic resumption, indicating that some component that maintains meiotic
arrest must be present in the plasma membrane. It was hypothesized that this component
could be a constitutively active receptor, although the role of the receptor was not
investigated. In this study, we examined whether active endocytosis occurs in the mouse
oocyte and whether endocytosis impacts the maintenance of meiotic arrest. Our results
demonstrate that trafficking at the membrane occurs and suggest that GPR3 signaling at
the plasma membrane, rather than intracellularly, is necessary for the maintenance of
meiotic arrest.
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Materials and Methods
U

Media and reagents
Except where noted, all chemicals were obtained from Sigma Chemical Co. The

medium used to collect isolated oocytes was 0(0Į ,Qvitrogen), supplemented with 20
P0+(3(6ȝJPOSHQLFLOOLQ*ȝJPOVWUHSWRP\FLQSRO\YLQ\ODOFRKRODQG
ȝ0PLOULQRQHWRLQKLELWVSRQWDQHRXVPHLRWLFUHVXPSWLRQ For extended culture,
oocytes were placed in bicarbonate-EXIIHUHG0(0ĮDs above, in which the HEPES was
UHSODFHGZLWKP0VRGLXPELFDUERQDWH The medium used to collect and culture
follicle-HQFORVHGRRF\WHVZDV0(0ĮVXSSOHPHQWHGZLWKȝJPOSHQLFLOOLQ*ȝJPO
streptomycin, and 5% fetal bovine serum (#12000-022, Invitrogen).
Mouse GPR3-RFP was provided by Y Saeki (Ohio State University) in pHGCY
and was linearized with PacI prior to in vitro transcription using the mMESSAGE
mMACHINE T7 ultra kit from Invitrogen. GRK2 was provided by R Lefkowitz (Duke
University Medical Center) in pRK5 and was subcloned into the EcoRI and BamHI sites
of pBSSK + vector. RNA was linearized with BamHI prior to in vitro transcription. ǺetaP

P

arrestin-2-GFP was obtained from M Caron (Duke University Medical Center) in pS65T
and was subcloned into pSP64.5 and was linearized with SalI prior to in vitro
transcription. 5DWȕ 2 AR was obtained from N Ancellin (University of CT Health Center)
R

R

in pBSSK+ and was linearized with NotI prior to in vitro transcription. MDC was
SUHSDUHGDVDP0VWRFNLQ'062 Dynasore (Tocris Bioscience, Ellisville, MO,
86$ ZDVSUHSDUHGDVDP0VWRFNLQHWKDQRO FM 1-43 (Invitrogen) was prepared as a
P0VWRFNLQZDWHU
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U

Mouse oocyte and follicle isolation and culture
All experiments were done with prior approval of the Animal Care and Use

Committee at the University of Connecticut Health Center.
Fully grown, GV-stage mouse oocytes were obtained from the ovaries of 6- to 12week old CF-1 mice (Harlan Sprague–Dawley, Indianapolis, IN, USA) that had been
SULPHGZLWK,8H&* 6LJPDRU&DOELRFKHP –KSULRUWRFROOHFWLRQ Cumulus
cells were removed by repeated pipetting through a small-bore pipette. Oocytes were
cultured in ȝOGURSVRIPHGLXPXQGHUOLJKWPLQHUDORLORQDZDUPLQJWUD\VHWWR&
(when in HEPES-EXIIHUHGPHGLXP RULQDKXPLGLILHGDWPRVSKHUHDW&ZLWK&2 2
R

and 95% air (when in bicarbonate-buffered medium). In some cases, the zonae
pellucidae were rePRYHGXVLQJȝJPOĮ-chymotrypsin (type II).
$QWUDOIROOLFOHV ȝPLQGLDPHWHU ZHUHGLVVHFWHGIURPWKHRYDULHVRI- to
25-day old B6SJL/F1 mice (Jackson Laboratories) as described previously (Jaffe et al.,
2009). Following isolation, follicles were placed on Millicell culture plate inserts
(PICMORG50, Millipore, Billerica, MA, USA) and cultured in a humidified atmosphere
DW&ZLWK&2 2 and 95% air. $IWHUDKFXOWXUHSHULRGIROOLFOH-enclosed oocytes
R

R

were examined under an upright microscope for the presence of a GV. Only follicles
containing oocytes with readily visible GVs were selected for use in these experiments.

U

Microinjection
Microinjection of isolated and follicle-enclosed oocytes was carried out as

described previously (Jaffe et al., 2009; Kline, 2009). For isolated oocytes, oocytes were
placed in HEPES-EXIIHUHG0(0ĮIRUPLFURLQMHFWLRQ For overnight culture, oocytes
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R

were incubated in bicarbonate-EXIIHUHG0(0ĮFRQWDLQLQJPLOULQRQH Follicles were
loaded into an injection chamber between two cover slips spaced ȝPDSDUW
Following microinjection, follicles were placed on Millicell membranes and incubated
for 17–KWKHRRF\WHVZHUHUHPRYHGDQGH[DPLQHGIRUWKHLUPHLRWLFVWDWXVE\WKH
presence or absence of a GV, assessed using a stereoscope. Quantitative microinjection
was carried out using pipettes backfilled with mercury and concentrations of injected
VXEVWDQFHVZHUHFDOFXODWHGEDVHGRQDQRRF\WHYROXPHRISO

U

Immunoblotting and immunofluorescence
For Western blots, oocyte samples were made by washing oocytes in PBS

containing 0.1% polyvinyl alcohol (PVA) to remove serum. Oocytes were transferred to
microcentrifuge tubes, gently pelleted, and excess culture medium was removed.
2RF\WHVZHUHIUR]HQLQOLTXLGQLWURJHQDQGVWRUHGDWí&XQWLOXVH Western blotting
was performed as described previously (Mehlmann et al., 1998). Except for anti-EEA1,
which was obtained from Cell Signaling Technology (Danvers, MA, USA), primary and
secondary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Blots were developed using ECL Plus reagents (Amersham).
)RULPPXQRIOXRUHVFHQFHRRF\WHVZHUHIL[HGIRUKLQIRUPDOGHK\GHLQ
P0+(3(6P0(*7$P00J62 4 , and 0.2% Triton X-DW& After
R

R

fixation, oocytes were incubated in blocking buffer (PBS containing 0.01% Triton X-100,
0.1% PVA, and 3% BSA), then in primary antibody overnight, diluted 1:100 in blocking
buffer, at room temperature. Oocytes were then washed in blocking buffer and were
incubated in secondary antibody and finally in PBS containing 0.1% PVA. The
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secondary antibody was Alexa Fluor 488-conjugated anti-rabbit (Invitrogen). Oocytes
were observed with a 40×, 1.2 NA lens (C-Apochromat; Carl Zeiss MicroImaging, Inc.,
Thornwood, NY, USA) on either a Zeiss 510 or a Zeiss Pascal confocal microscope.

U

RT-PCR
RNA was extracted from oocytes or mouse brain using TRIzol reagent

(Invitrogen), according to the manufacturer's instructions. cDNA was produced using the
Superscript III Reverse Transcriptase kit (Invitrogen) using oligo-dT as the primer. A
WRWDORIVHYHQRRF\WHHTXLYDOHQWVRUQJEUDLQF'1$ZDVXVHGIRUHDFK3&5UHDFWLRQ
The cycling parameters were an initial denaturation RIPLQ&IROORZHGE\
F\FOHVRI&IRUV&IRUV&IRUVDQGDILQDOH[WHQVLRQDW&IRU
PLQ3&5SURGXFWVZHUHHOHFWURSKRUHVHGRQDJDURVHJHOVYLVXDOL]HGE\VWDLQLQJ
the gel with SYBRGold (Invitrogen), and photographed with a digital camera (Canon
Power Shot A650). The primer sets used for each experiment are shown in Table 2.1.

U

FM 1-43 membrane labeling
To examine endocytosis, zona-IUHHRRF\WHVZHUHLQFXEDWHGLQȝ0)0-43

(Invitrogen). FM 1-43 was diluted in Ca 2+ /Mg 2+ -free Hank's buffered salt solution
P

P

P

P

(HBSS; Gibco) containing 0.1% PVA and oocytes were examined with a Zeiss LSM 510
confocal microscope after 1–K )OXRUHVFHQFHZDVH[FLWHGDWQPDQGZDVGHWHFWHG
DWQP,PDJHVZHUHFROOHFWHGXVLQJDî1$ 1.2 water immersion objective. The
method for quantifying plasma membrane and membrane to cytoplasmic ratios has
previously been described in detail (supplemental material in (Freudzon et al., 2005)),
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using MetaMorph Software (Molecular Devices Corp., Downington, PA, USA) and
Microsoft Excel.

U

cAMP measurements
cAMP measurements were made using a cAMP sensor (Epac2-camps300) that

has previously been described (Nikolaev et al., 2004; Norris et al., 2009). The sensor is
FRET based and consists of YFP and CFP linked by the cAMP-binding domain of
EPAC2. Epac2-FDPSVSURWHLQ ȝ0ILQDOFRQFHQWUDWLRQLQWKHRRF\WH ZDVLQMHFWHG
into isolated oocytes cultured in the presence of milrinone. Fluorescence was excited at
QPDQGZDVGHWHFWHGDWQP <)3 DQGDWQP &)3 ,PDJHVZHUH
collected using a 40× NA 1.2 water immersion objective on a Zeiss Pascal confocal
microscope. YFP and CFP intensities were quantified within a circular region of interest
that was slightly smaller than the oocyte diameter using the Zeiss Pascal program. Data
are reported as the ratio of YFP to CFP fluorescence after subtracting the background
value from an uninjected oocyte and correcting for spectral bleed-through of CFP into the
YFP channel (Norris et al., 2009).

U

Statistical analysis
Student's t-tests or one-way ANOVA followed by Tukey's multiple comparison

post-test were performed to determine statistical significance; P<0.05 was considered to
be significant.
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Results
U

Components of endocytosis are expressed in mouse oocytes
Endocytosis of receptors in somatic cells occurs predominantly through the

clustering and internalization of an activated receptor into clathrin-coated pits (Moore et
al., 2007; Wolfe and Trejo, 2007). However, little is known about the identity and
function of recycling components in mammalian oocytes. Therefore, we first examined
whether two of the most common proteins responsible for receptor endocytosis in
somatic cells were expressed in mouse oocytes. Clathrin is a protein that plays an
important role in the formation of coated pits in which receptors accumulate (Doherty
and McMahon, 2009). The heavy chain of clathrin is present in mouse oocytes, as
determined by Western blotting. Indeed, we were able to detect clathrin in as few as ten
oocytes (Figure 2.1A), indicating that it is abundant. Receptor endocytosis also requires
the activity of dynamin, a GTPase that is necessary for excising clathrin-coated pits from
the plasma membrane (Moore et al., 2007). We detected the expression of the
ubiquitously expressed dynamin 2 in the oocyte. In contrast, neither dynamin 1, which is
restricted to the nervous system, nor the more ubiquitously expressed dynamin 3, was
detectable by RT-PCR using our cycling parameters (Figure 2.1B). Western blot analysis
of oocyte lysate detected two bands at the expected size of N'DVKRZLQJWKDWWKH
protein is expressed. The signal was not strong, even using lysate from 500+ oocytes,
suggesting that the amount of dynamin in the oocyte is low. It is unclear why the protein
was expressed as a doublet; it is possible that the two bands could represent different
splice variants of dynamin 2 (Liu et al., 2008).

35

In addition to clathrin and dynamin, other major components of receptor recycling
include the adaptor proteins AP-2 and amphiphysin, as well as the mediators of
HQGRF\WRVLVȕ-arrestins and GRKs. We examined the expression of mRNAs encoding
these proteins using RT-PCR. mRNA for one of the major AP-VXEXQLWVȝ Ap2m1)
subunit of AP-2, and Amphiphysin were expressed (Figure 2.1C). In addition, ȕ-arrestin2 and Grk2 and Grk5 were present (Figure 2.1D and 2.1E), whereas ȕ-arrestin-1 and
Grk3 and Grk6 RNAs were not detectable in oocytes. The visual GRK1 and GRK7, and
the testis-specific GRK4, were not examined.

U

Monodansylcadaverine and dynasore inhibit endocytosis in mouse oocytes
As a prelude to examining whether endocytosis could have a role in meiotic

regulation, we first determined that inhibitors of receptor-mediated endocytosis could
prevent endocytosis in mouse oocytes using the inhibitors monodansylcadaverine (MDC)
and dynasore (Macia et al., 2006). We used pharmacological inhibitors because in initial
experiments we found that we were unable to deplete the amount of clathrin protein using
RNAi, nor were we able to significantly deplete the amount of dynamin 2 RNA within
our culture period of 4 days using follicle-enclosed oocytes (not shown). We chose
compounds that inhibit endocytosis through two different mechanisms: MDC inhibits the
protein cross-linker, tissue transglutaminase (Davies et al., 1980), and is thought to
inhibit the clustering and internalization of clathrin (Schlegel et al., 1982) whereas
dynasore inhibits the GTPase activity of dynamin without affecting the activity of other
small GTPases (Macia et al., 2006).
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To confirm that MDC blocked endocytosis in oocytes, we treated oocytes with
FM 1-43, a dye that becomes fluorescent when it incorporates into membranes and
retains its fluorescence when membrane is endocytosed. )ROORZLQJDKFXOWXUHSHULRGLQ
WKHSUHVHQFHRIȝ00'&DQGȝ0PLOULQRQH WRSUHYHQWVSRQWDQHRXVRRF\WH
maturation), we incubated zona-free oocytes in FM 1-43 and examined them with a
confocal microscope 1–KODWHU Zona-free oocytes were used because the FM 1-43
labeled transzonal processes in the zona pellucida, making plasma membrane
fluorescence difficult to quantify. Untreated oocytes were fluorescent in the plasma
membrane and throughout the cytoplasm, often in punctate clusters (Figure 2.2A). In
contrast, oocytes preincubated in MDC were mainly fluorescent in the plasma membrane.
The plasma membrane labeling was more intense than that in controls, suggesting that the
treated oocytes had more membrane area due to the absence of endocytosis (Figure
2.2A). The total plasma membrane to cytoplasmic fluorescence ratio was significantly
higher in oocytes treated with MDC than in controls (P<0.0001; Figure 2.2B),
demonstrating an inhibition of endocytosis. We also attempted to examine whether
dynasore inhibits endocytosis in oocytes using FM 1-43. However, plasma membrane
labeling in the presence of dynasore was very faint, indicating that dynasore might
interfere with the incorporation of FM 1-43 into the membrane.
Endocytosed proteins enter early endosomes, after which they can be sorted into
late endosomes and lysosomes, or can be recycled back to the membrane. We
hypothesized that inhibiting endocytosis with MDC and dynasore would block the
formation of early endosomes. For these experiments, we labeled early endosomes by
immunofluorescence using a specific antibody against the early endosome marker, early
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endosome antigen 1 (EEA1; Figure 2.2C). In control oocytes, early endosomes were
abundantly present in both the cortex and throughout the cytoplasm, excluding the
germinal vesicle (GV; Figure 2.2C). The diameter of the fluorescent spots was generally
much larger than the 50–QPGLDPHWHUWKDWFKDUDFWHUL]HVHQGRVRPHVLQPRVWVRPDWLF
cells (Jovic et al., 2010), reaching sizes of up to ȝP Figure 2.2C). MDC dose
dependently decreased the number of endosRPHVSUHVHQWLQWKHRRF\WHIROORZLQJDK
LQFXEDWLRQVXFKWKDWDWDFRQFHQWUDWLRQRIȝ0HDUO\HQGRVRPHVZHUHFRPSOHWHO\
absent (Figure 2.2C). A similar reduction in earO\HQGRVRPHVZDVVHHQXVLQJȝ0
dynasore, a concentration commonly used to inhibit endocytosis in somatic cells (Barrias
et al., 2010; de Beco et al., 2009; Macia et al., 2006; Newton et al., 2006) Figure 2.2C).
These results show that there is rapid endocytosis at the plasma membrane in mouse
oocytes and that both MDC and dynasore effectively inhibit endocytosis.

U

Inhibiting endocytosis prevents spontaneous meiotic resumption in mouse oocytes
To examine the effect of inhibiting endocytosis on spontaneous meiotic

UHVXPSWLRQRRF\WHVZHUHSUHWUHDWHGZLWK0'&RUG\QDVRUHIRUKLQWKHSUHVHQFHRI
milrinone, then were washed out of milrinone while maintained in MDC or dynasore, and
were periodically scored for the presence of a GV. MDC dose dependently inhibited
VSRQWDQHRXVPHLRWLFUHVXPSWLRQIRUDWOHDVWKDIWHURRF\WHVZHUHZDVKHGRXWRI
milrinone (Figure 2.3A). Oocytes became unhealthy during overnight incubation in
MDC, so later time points were not examined. 6LPLODUWR0'&ȝ0G\QDVRUHGRVH
dependently inhibited spontaneous maturation in the absence of milrinone (Figure 2.3B).
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The effects of MDC and dynasore were reversible, as oocytes treated with MDC
DQGG\QDVRUHIRUKXQGHUZHQWVSRQWDQHRXVPDWXUDWLRQfollowing the removal of MDC,
dynasore, and milrinone (Figure 2.3C). There was a slight delay between the time the
control oocytes underwent GVBD and those treated with MDC or dynasore. Although
DOPRVWKDOIRIWKHFRQWURORRF\WHVXQGHUZHQW*9%'ZLWKLQKIROORZLQJPLOULQRQH
UHPRYDO*9%'ZDVRQO\REVHUYHGDIWHUKLQRRF\WHVWUHDWHGZLWK0'&RUG\QDVRUH
The overall rate of GVBD was slower in the group treated with dynasore than in the
group treated with MDC. The reason for this delay is unclear. However, almost 100% of
WKHRRF\WHVLQERWKWUHDWHGJURXSVXQGHUZHQW*9%'ZLWKLQKDIWHULQKLELWRUZDVKRXW
and 84% of the matured oocytes from the MDC group and 90% of matured oocytes from
the dynasore group formed first polar bodies (n=25 and 30 oocytes respectively).
To further characterize MDC and dynasore as reversible endocytosis inhibitors,
we examined whether early endosomes reappear following MDC or dynasore washout.
2RF\WHVZHUHLQFXEDWHGLQȝ00'&RUȝ0G\QDVRUHIRUKLQWKHSUHVHQFHRI
milrinone and then were washed into medium without MDC or dynasore. We kept
milrinone in the culture medium for this experiment to rule out an effect of falling cAMP
levels (caused by activation of phosphodiesterase (Norris et al., 2009) on the localization
of endosomes. Early endosomes were completely absent in oocytes treated with MDC or
dynasore (Figures 2.2D and 2.3D) and EHJDQWRUHDSSHDUZLWKLQKIROORZLQJ0'&RU
dynasore washout (Figure 2.3D). Endosomes were generally smaller than those seen in
controls and were often concentrated around the cortex, where early endosomes are
formed. The formation of early endosomes preceded GVBD in oocytes treated with
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MDC or dynasore, indicating that cAMP levels are higher in the oocyte when endocytosis
is blocked and then fall when endocytosis resumes.
To examine the possibility that falling cAMP levels due to removal of milrinone
from medium that did not contain endocytosis inhibitors affects endosome localization,
ZHFROOHFWHGRRF\WHVLQWKHSUHVHQFHRIPLOULQRQHDQGODEHOHGHDUO\HQGRVRPHVDQGK
following milrinone washout. Localization of endosomes was indistinguishable from
those observed in the presence of milrinone (not shown), demonstrating that endosome
formation is independent of cAMP levels in the oocyte.

U

GPR3 undergoes endocytosis in the oocyte
Meiotic arrest depends on high levels of cAMP in the oocyte (Mehlmann, 2005b).

Because GPR3 is responsible for maintaining meiotic arrest prior to the LH surge, we
were interested in knowing whether its localization is important for the regulation of
meiotic arrest. Most GPCRs are internalized following agonist stimulation. However, as
a constitutively active receptor, it is possible that GPR3 does not get internalized but
remains at the plasma membrane and continuously signals. We examined GPR3
internalization in the oocyte by expressing GPR3 fused to red fluorescent protein (GPR3RFP). Overexpressed GPR3-RFP localized both in the plasma membrane and in clusters
throughout the cytoplasm of the oocyte (Figure 2.4) when incubated in the presence of
milrinone. Double labeling with EEA1 showed that GPR3-RFP co-localized within early
endosomes. These results demonstrate that GPR3 is internalized in the mouse oocyte.
We attempted to examine the localization of GPR3-RFP in response to treatment
of MDC and dynasore. However, there was no noticeable accumulation of GPR3-RFP in
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the plasma membrane in response to inhibitor treatment (not shown). This could be due
to the large surface area of the oocyte and the high level of membrane labeling of
overexpressed GPR3-RFP that would not permit the detection of small changes in plasma
membrane fluorescence.

U

2YHUH[SUHVVLRQRIȕ-arrestin-2 and GRK2 into follicle-enclosed oocytes has a partial

effect on stimulating GVBD
If GPR3 signaling at the plasma membrane is necessary to maintain meiotic
arrest, then the removal of GPR3 from the membrane would be expected to cause GVBD.
Receptor-mediated endocytosis generally occurs by phosphorylation of an activated
receptor by GRKs, follRZHGE\ELQGLQJWRȕ-arrestins that remove the receptor from the
membrane and sort it into clathrin-coated pits (Moore et al., 2007; Reiter and Lefkowitz,
2006). :HH[DPLQHGZKHWKHU*5.Vȕ-arrestins are involved in GPR3 endocytosis by
determLQLQJWKHHIIHFWRQ*9%'RIRYHUH[SUHVVLQJȕ-arrestin-2 and GRK2 in follicleenclosed oocytes. 2YHUH[SUHVVLRQRIȕ-arrestins/GRKs hyperphosphorylates and
enhances endocytosis of a constitutively active viral receptor, US28, in somatic cells and
decreases its activity (Miller et al., 2003b). We used follicle-enclosed oocytes for these
experiments because unlike the above pharmacological inhibitors, which are cell
SHUPHDEOHWKH*5.DQGȕ-arrestin-2-GFP proteins were not permeable, thereby
allowing us to discern an effect of the proteins on the oocyte as opposed to the follicle.
In addition, use of follicle-enclosed oocytes simulates the native environment of the
oocyte, rather than using oocytes incubated in inhibitors that artificially raise cAMP
levels.
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We microinjected RNA HQFRGLQJDIOXRUHVFHQWO\WDJJHGȕ-arrestin- ȕ-arrestin2-*)3 DQG*5.LQWRRRF\WHVIURPIROOLFOHVȝPLQGLDPHWHUVXFKIROOLFOHVFRQWDLQ
oocytes that are competent to resume meiosis. After a 17–KLQFXEDWLRQWRDOORZWLPH
for the proteins to be expressed, oocytes were removed from their follicles and the
meiotic status evaluated. By the end of the culture period, 13% of the injected oocytes
had undergone GV breakdown (GVBD) compared with 0% of control oocytes (n=24 and
n=23 respectively; Figure 2.5A), despite the proteins being robustly expressed as
determined by Western blot for GRK2 (Figure 2.5% DQGIOXRUHVFHQFHPLFURVFRS\IRUȕarrestin-2-GFP (not shown).
7RFRQILUPWKDWRXUȕ-arrestin-2 and/or GRK2 proteins were active, we examined
WKHDELOLW\RIȕ-arrestin-2-GFP to translocate from the cytoplasm to the plasma membrane
following stimulation of an exogenously expressed G s -coupled receptor. To do this, we
R

R

co-LQMHFWHGLVRODWHGRRF\WHVZLWK51$HQFRGLQJWKHȕDGUHQHUJLFUHFHSWRU ȕ$5 
*5.DQGȕ-arrestin-2-GFP. Following an overnight culture to allow time for the
oocytes to synthesize the proteins, we examined the oocytes before and after stimulating
WKHUHFHSWRUZLWKȝ0LVRSURWHUHQRO Before adding the isoproterenol, oocytes were
fluorescent throughout the cytoplasm, excluding the GV (Figure 2.5B). :LWKLQPLQRI
DGGLQJLVRSURWHUHQROWKHȕ-arrestin-2-GFP translocated to the plasma membrane (Figure
2.5C). The localization to the membrane was transient, and fluorescence began to be lost
IURPWKHPHPEUDQHDQGEHFRPHSXQFWDWHZLWKLQPLQDIWHUDGGLQJDJRQLVW Figure
2.5C), indicating that the receptor was rapidly removed from the membrane. These
UHVXOWVVKRZWKDWPRXVHRRF\WHVDUHFDSDEOHRIXQGHUJRLQJ*5.ȕ-arrestin-dependent
UHFHSWRUUHF\FOLQJEXWVXJJHVWWKDWLI*5.Vȕ-arrestins have a role in clathrin-mediated
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receptor endocytosis of GPR3, it is not likely to be the primary mechanism by which this
occurs in the oocyte.

U

Inhibiting endocytosis raises cAMP levels in the oocyte
If GPR3 signaling at the cell membrane is necessary for maintaining meiotic

arrest, we would expect to see an increase in cAMP concentration in oocytes in which
endocytosis is inhibited. To examine the possibility that GPR3 activity at the plasma
membrane increases cAMP levels, we measured cAMP levels in oocytes treated with
dynasore. We used dynasore for this experiment because we found in preliminary
experiments that MDC interfered with the cAMP sensor, whereas dynasore did not (not
shown). To measure cAMP levels, we used a fluorescence resonance energy transfer
(FRET)-based assay that has previously been described (Nikolaev et al., 2004; Norris et
al., 2009). This assay uses an indicator consisting of yellow fluorescent protein (YFP)
and cyan fluorescent protein (CFP) fused to the cAMP-binding domain of EPAC2
(Epac2-camps300). cAMP levels are inversely proportional to FRET when CFP is
excited with a laser (see Materials and Methods).
We microinjected the cAMP indicator protein, Epac2-camps300, into oocytes and
measured the YFP/CFP ratio following excitation of CFP, after treatment with dynasore.
We found that oocytes held in the presence of milrinone throughout the course of the
experiment maintained a constant fluorescence ratio (Figure 2.6). When oocytes were
washed out of milrinone, the YFP/CFP ratio increased by 20%, demonstrating that
cAMP levels decreased. The baseline ratios that we observed, and the increase in FRET
seen following removal of milrinone, are very similar to those reported previously in
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follicle-enclosed oocytes, in which cAMP levels corresponded to Q0prior to
adding LH and dropped to Q0IROORZLQJ/+WUHDWPHQW(Norris et al., 2009).
Oocytes treated with dynasore displayed a gradual decrease in FRET that was statistically
signLILFDQWDIWHUKRIWUHDWPHQW Figure 2.6). The YFP/CFP ratio continued to decrease
even after oocytes were washed out of milrinone but maintained in dynasore. These
results show that inhibiting endocytosis increases cAMP levels and suggest that signaling
at the plasma membrane is needed to maintain meiotic arrest prior to the LH surge.

Discussion
Endocytosis is a ubiquitous process in somatic cells and is critically important for
yolk production in the oocytes of non-mammalian species. However, endocytosis in
mammalian germ cells and its possible contribution to their unique physiology is poorly
understood. The aim of this study was to examine whether endocytosis occurs in the
mouse oocyte and whether this affects the signaling properties of GPR3. We found that
active, robust endocytosis occurs in the isolated mouse oocyte. Inhibiting endocytosis
had an effect on the oocyte's meiotic status, inhibiting spontaneous meiotic resumption in
the absence of PDE inhibitors. We also found that GPR3 localizes in the oocyte plasma
membrane as well as in early endosomes, indicating that it is actively endocytosed in the
oocyte. Inhibiting endocytosis stimulated an increase in oocyte cAMP, suggesting that
signaling at the plasma membrane, possibly through an accumulation of GPR3, is
responsible for maintaining meiotic arrest.
Mouse oocytes express several of the major proteins involved in receptor
endocytosis, including clathrin, dynamin 2, AP-DPSKLSK\VLQȕ-arrestin-2, and GRK2
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and GRK5. The well-characterized inhibitors of receptor-mediated endocytosis, MDC
and dynasore, effectively prevented endocytosis in oocytes. These inhibitors blocked the
formation of both endocytic vesicles and early endosomes, as well as spontaneous
meiotic resumption. The effect of MDC is likely to be related to inhibition of the protein
cross-linker, tissue transglutaminase (Davies et al., 1980) and is thought to inhibit the
clustering and internalization of clathrin (Schlegel et al., 1982). Indeed, MDC does not
inhibit endocytosis in cells lacking transglutaminase (Davies et al., 1984). A previous
study in mouse oocytes showed the presence of active tissue transglutaminase that was
inhibited by MDC (Kim et al., 2001), and in that study, MDC inhibited GVBD in a dosedependent manner. However, endocytosis itself was not examined. As a second method
of blocking endocytosis in oocytes, we used dynasore. In contrast to MDC, dynasore
specifically inhibits dynamin by inhibiting its GTPase activity without affecting the
activity of other small GTPases (Macia et al., 2006). Dynasore may therefore be the
more specific inhibitor of endocytosis. The results showing that dynasore inhibits
endocytosis in oocytes support the data using MDC, confirming that endocytosis was
prevented using both inhibitors.
Dynasore caused an increase in cytoplasmic cAMP levels in oocytes, suggesting
that GPR3 signaling at the plasma membrane could be responsible for this increase.
Recently, it has been shown that some GPRs are able to signal within endosomes
(Calebiro et al., 2009; Calebiro et al., 2010b; Ferrandon et al., 2009; Mullershausen et al.,
2009) and that this signaling is necessary for prolonged cAMP signaling initiated by
various hormones. Therefore, it is possible that GPR3 likewise signals within
endosomes, perhaps to provide cAMP to the interior of the oocyte, which has a relatively
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large volume. Although our results do not exclude the possibility that endosomal
signaling occurs within arrested oocytes, they support the hypothesis that signaling at the
plasma membrane and not within endosomes is sufficient and necessary to maintain
meiotic arrest.
If signaling at the plasma membrane alone is needed to maintain meiotic arrest,
how is cAMP able to transmit its signal to the interior of the oocyte, which has a large
volume? Cyclic AMP is a freely diffusible molecule (Bacskai et al., 1993; Chen et al.,
1999), but its diffusion is restricted in many cases by the localized pools of PDEs and
protein kinase A (PKA) tethered to the plasma membrane and various intracellular
membranes by the A kinase anchoring proteins (AKAPs; (Dodge et al., 2001). It is
thought that PDE activity stimulated by PKA is necessary for establishing cAMP
microdomains (Fischmeister et al., 2006; Houslay et al., 2007). For example, stimulation
RIWKHȕ-AR in neonatal cardiac myocytes generates microdomains of high concentrations
of cAMP that act within a range as small as ȝPZKLOHF$03GLIIXVHVIUHHO\LQFHOOV
that have been treated with PDE inhibitors (Zaccolo and Pozzan, 2002). On the other
KDQGȕ 1 -$5VJHQHUDWHF$03VLJQDOVFDSDEOHRIGLIIXVLQJRYHUȝPWKURXJKRXWODUJH
R

R

adult ventricular cardiomyocytes even in the absence of PDE inhibitors (Nikolaev et al.,
2006). AKAPs have been identified in mouse oocytes (Brown et al., 2002; Kovo et al.,
2006; Newhall et al., 2006) and the RI- and RII-type PKAs are tethered in the plasma
membrane and the cytoplasm respectively (Brown et al., 2002; Newhall et al., 2006;
Webb et al., 2008). However, PDE activity is kept low in oocytes by cGMP that is
produced in the somatic cells and diffuses into the oocyte through gap junctions (Norris
et al., 2009). It is not until the surge of LH that cGMP levels in the oocyte fall, allowing

46

the activation of PDE3A (Norris et al., 2009; Vaccari et al., 2009). Therefore, it is
possible that cAMP is able to readily diffuse throughout the oocyte cytoplasm prior to LH
stimulation to activate intracellular PKAs. In support of this, the catalytic subunit of
PKA is present both in the plasma membrane and throughout the cytoplasm (Brown et
al., 2002).
If signaling at the plasma membrane is needed for maintenance of meiotic arrest,
it is not clear why GPR3 might be targeted for endocytosis, or the mechanism(s) by
which endocytosis occurs. Many GPCRs undergo a conformational change upon
stimulation that allows the phosphorylation by GRKs and subsequent binding and
LQWHUQDOL]DWLRQE\ȕ-arrestins. ,QWKLVVWXG\ZHIRXQGWKDWRYHUH[SUHVVLRQRIȕ-arrestin-2
with GRK2 caused GVBD in a small percentage of oocytes within our culture period,
VXJJHVWLQJWKDW*5.VDQGȕ-arrestins could interact with GPR3. However, because the
percentage of oocytes that underwent GVBD was not significantly different from
controls, it is not likely to be the primary mechanism by which endocytosis occurs. Other
GPCRs (e.g. the PAR1 and M 2 muscarinic receptors; (Paing et al., 2002; PalsR

R

Rylaarsdam et al., 1997) are HQGRF\WRVHGWKURXJKȕ-arrestin/GRK-independent
mechanisms; it is possible that GPR3 endocytosis occurs through similar mechanisms. It
is also possible that GPR3 signals intracellularly either from endosomes or prior to
membrane insertion.
Another constitutively active receptor, the herpes virus chemokine receptor US28,
signals in the absence of an agonist (Fraile-Ramos et al., 2001) and could perhaps serve
as a model for the regulation of the signaling of constitutively active receptors, including
GPR3. US28 is constitutively phosphorylated when overexpressed in cultured cells
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(Mokros et al., 2002)DQGWKLVSKRVSKRU\ODWLRQOHDGVWRDQLQFUHDVHLQ*5.ȕ-arrestininduced receptor internalization (Miller et al., 2003b). In addition, overexpressing GRKs
DQGRUȕ-arrestins causes a decrease in US28 activity (Miller et al., 2003b). Furthermore,
mutation of serines at the C-terminus impairs phosphorylation and receptor
internalization, leading to an increase in surface expression and consequently to an
increase in activity (Miller et al., 2003b; Mokros et al., 2002). Taken together, these
results show that surface expression of a constitutively active GPCR is necessary for
intracellular signaling. Interestingly, the internalization of US28 is enhanced by, but not
GHSHQGHQWRQȕ-arrestins, although it is dependent on a clathrin-mediated pathway
(Droese et al., 2004; Fraile-Ramos et al., 2003). It will be interesting to determine
whether GPR3 activity is regulated by similar mechanisms.
In summary, our results show that vesicular trafficking actively occurs at the
mouse oocyte plasma membrane and that trafficking is a regulator of meiotic arrest.
Although we were unable to observe an accumulation of overexpressed GPR3 at the
plasma membrane following inhibition of endocytosis, our results showing an increase in
cAMP concentration following inhibition of endocytosis are consistent with this
possibility. In addition, our results suggest that even if GPR3 normally signals within
endosomes, that signaling at the plasma membrane is sufficient for the maintenance of
meiotic arrest prior to the LH surge, as cAMP levels increased following endocytosis
inhibition, when endosomes were absent. It should be noted that due to the nature of the
chemical inhibitors we used, which were membrane permeable, we were limited to
examining isolated, rather than follicle-enclosed, oocytes. It would be interesting to
determine whether inhibiting endocytosis affects LH-induced meiotic resumption in
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follicle-enclosed oocytes. Future experiments will be needed to examine the mechanisms
by which endocytosis occurs in oocytes and how GPR3 might be regulated in order to
maintain the proper concentration of cAMP that is necessary to maintain meiotic arrest in
the oocyte.
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Figure 2.1.

Figure 2.1. Components of receptor-mediated endocytosis are expressed in mouse
oocytes. (A) Expression of clathrin protein, as assessed by western blot using lysate from
ten oocytes. (B) Expression of dynamin in mouse oocytes, as assessed by RT-PCR. O,
oocyte; B, brain, used as a positive control. (C) Western blot showing two bands at
N'DLQO\VDWHIURPRRF\WHVGHPRQVWUDWLQJWKDWG\QDPLQSURWHLQLVSUHVHQWLQ
mouse oocytes. (C, D and E) RT-PCRs showing expression of other components of
endocytosis in mouse oocytes. Ap2m1 , AP-ȝVXEXQLW Amph DPSKLSK\VLQȕ- arr ȕarrestin.
15T
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Figure 2.2.

Figure 2.2. Inhibitors of clathrin-mediated endocytosis inhibit endocytosis in mouse
oocytes. (A 0'&LQKLELWVHQGRF\WRVLV,VRODWHGRRF\WHVZHUHWUHDWHGZLWKȝ00'&
WKH]RQDHZHUHUHPRYHGDQGRRF\WHVZHUHLQFXEDWHGLQȝ0)0-43 and imaged 1–K
later with a confocal microscope. (B) Quantification of membrane to cytoplasmic
fluorescence in control and MDC-treated oocytes. The membrane to cytoplasm ratio was
significantly higher in MDC-treated than in control oocytes (***P<0.0001; error bars =
mean ± S.E.M.). The number of oocytes is indicated in parentheses. (C) MDC and
dynasore block the formation of early endosomes. (Left) Antibody against EEA1 that was
used for these experiments specifically recognizes a single band from mouse oocyte
lysate. (Right) Early endosomes are present throughout the oocyte excluding the GV in
FRQWURORRF\WHVZKHUHDVLQRRF\WHVWUHDWHGZLWKȝ00'&RUȝ0G\QDVRUHHDUO\
endosomes were completely absent. Bars = ȝP
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Figure 2.3.

Figure 2.3. MDC and dynasore inhibit spontaneous meiotic resumption in oocytes.
Isolated oocytes were treated with the indicated concentrations of MDC (A) or dynasore
(B $IWHUDKLQFXEDWLRQSHULRGWKHRRF\WHVZHUHZDVKHGRXWRIPLOULQRQHDQG
periodically scored for the presence or absence of a GV. (C) The effects on of MDC and
dynasore on inhibiting GVBD are reversible. Oocytes were treated with MDC or
G\QDVRUHIRUKLQWKHSUHVHQFHRIPLOULQRQHDQGZHUHZDVKHGRXWRIDOOLQKLELWRUV D)
Early endosomes were DEVHQWIROORZLQJDK treatment with MDC or dynasore and reIRUPZLWKLQKDIWHU0'&RUG\QDVRUHDUHUHPRYHGIURPWKHFXOWXUHPHGLXP%DU =
ȝP
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Figure 2.4.

Figure 2.4. GPR3-RFP localizes in the plasma membrane in oocytes and co-localizes
with early endosomes. Isolated oocytes were injected with RNA encoding GPR3-RFP
and cultured overnight prior to fixation. Early endosomes were labeled using
immunofluorescence. GPR3-RFP (left). Early endosomes (middle). Merge (right). Bar =
ȝP
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Figure 2.5.

Figure 2.5. (IIHFWRI*5.DQGȕ-arrestin 2 on meiotic resumption. (A) Follicleenclosed oocytes were injected with Grk2/ȕ-arrestin-2-GFP mRNA. Follicles were
cultured for 17–KDQGWKHRRF\WHVZHUHLVRODWHGWRH[DPLQHPHLRWLFVWDWXV7KH
number above each bar is the total number of follicles per group. The experiment was
repeated three times. (B) Immunoblot showing expression of GRK2 in follicle-enclosed
oocytes. (C) *5.DQGȕ-arrestin-2-GFP are active in mouse oocytes. Isolated oocytes
were co-LQMHFWHGZLWK*5.ȕ-arrestin-2-*)3DQGWKHȕ 2 -adrenergic receptor. After an
overnight culture, oocytes were imaged with a confocal microscope before and after
DGGLQJȝ0LVRSURWHUHQRO LVR %DU ȝP
R
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Figure 2.6.

Figure 2.6. Inhibiting endocytosis with dynasore increases cAMP levels in oocytes.
Measurement of cAMP levels in oocytes using the FRET-based cAMP sensor, Epac2FDPSV,VRODWHGRRF\WHVZHUHLQMHFWHGZLWKȝ0(SDF-camps300 protein, cells were
visualized with a confocal microscope at hourly intervals, and the YFP/CFP ratio was
PHDVXUHG7KHKWLPHSRLQWFRUUHVSRQGVWRDKWUHDWPHQWZLWKG\QDVRUH&RQWURO
oocytes were maintained in milrinone throughout the course of the recordings. The arrow
shows the point at which milrinone was washed out of the culture medium in the
milrinone washout and dynasore-treated groups. Each point represents mean ± S.D.
Statistical significance relative to controls is indicated by asterisks (*P<0.05;
***P<0.0001).
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Table 2.1 Primer Sets used for RT-PCR
Dynamin 1
Dynamin 2
Dynamin 3
AP-2
Amphiphysin
ȕ-arrestin-1
ȕ-arrestin-2
GRK2
GRK3
GRK5
GRK6

5’-ATCTGAAGCTGCGTGATGTG-3’
5’-GCCGATTCTTCCATCAGTGT-3’
5’-GACCTCCCAGGCATCACTAA-3’
5’-ACTCTCGGATGTGGTTGGTC-3’
5’-GCTTGTGTGCTGTGCTTTGT-3’
5’-ATCGCTGATGGATCACCTTC-3’
5’-CTTCAAGCCCTCACTTCTGG-3’5’- TACTTGGACCTGTGGGAAGG-3’
5’-GGATTCTCAGGCAACTCTGC-3’
5’-TGCTCTTTCCCCTCTTCGTA-3’
5’-CCCATGTGTGAAGGGCTAGT-3’
5’-AATGACTTCACGGGACAAGG-3’
5’-CAACGTCCATGTCACCAACAA-3’
5’-ACCACCAGCTTCACCTTGA-3’
5’-ACCAGGGAACTGTACCGCAAC-3’
5’-TGCGTTCCTTGATCTGTGTC-3’
5’-AAGCTGGACAACGAAGAGGA-3’
5’-GTGTGGAAGGCGTAGGTCAT-3’
5’-GGTGCTGGAGACTGAGGAAG-3’
5’-CCGTTAGGTCCGAACACATT-3’
5’-ACTCTTCAGTCGCCAAAGGA-3’
5’-GCCCTAGAAGCCTGGAGTTT-3’
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CHAPTER THREE
U

Regulation of Constitutive GPR3 Signaling and Surface Localization by Residues in the
Third Intracellular Loop and C-terminus

Abstract
G protein-coupled receptor 3 (GPR3) is a constitutively active receptor that
maintains high cAMP levels required for meiotic arrest in oocytes and CNS function.
Ligand-activated GPCRs signal at the cell surface and are silenced by phosphorylation
DQGȕ-arrestin recruitment upon endocytosis. Some GPCRs can signal from the
endosome. Little is known about the localization, signaling, and regulation of
constitutively active GPCRs. We demonstrate herein that exogenously-expressed GPR3
localizes to the cell membrane and undergoes internalization in HEK293 cells. Inhibition
of endocytosis increased cell surface-localized GPR3 and cAMP levels while
overexpression of GPCR-.LQDVH *5. DQGȕ-arrestin-2 decreased cell surfacelocalized GPR3 and cAMP levels. To identify the residues that are targeted for
desensitization, we mutated the serine and threonine residues in the third intracellular
loop and C-terminus. Mutation of residues in the third intracellular loop dramatically
increased cAMP levels. Mutation of residues in the C-terminus decreased the surface
localization of GPR3 but did not change cAMP production. These results demonstrate
WKDW*35VLJQDOLQJDWWKHSODVPDPHPEUDQHFDQEHVLOHQFHGE\*5.ȕ-arrestin.
However, localization at the plasma membrane is not required for cAMP signaling and
GPR3 may signal from other membranes. These results also strongly implicate the serine
and/or threonine residues in the third intracellular loop in the regulation of GPR3 activity.
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Introduction
G protein-coupled receptors (GPCRs) represent the largest family of integral
membrane proteins and regulate a wide variety of physiological processes. GPCRs
typically bind to an extracellular agonist and causes the receptor to adopt an active
conformation. However, some receptors exhibit constitutive activity in the absence of a
ligand. The level of constitutive activity varies among receptors and also seems to
depend on the cell type (Seifert and Wenzel-Seifert, 2002). Constitutive activity can be a
property of the receptor itself or the result of chronic stimulation by a ligand, as in the
case of the dog adenosine A2a receptor (Maenhaut et al., 1990).
GPR3, GPR6, and GPR12 constitute a family of constitutively active G s -coupled
R

R

GPCRs (Song et al., 1994). The magnitude of constitutive activity of these receptors is
reported to be the highest among all GPCRs and is similar in amplitude to a ligandstimulated GPCR (Eggerickx et al., 1995; Seifert and Wenzel-Seifert, 2002). GPR3 is
classified as an orphan receptor and it is thought to mediate sustained cAMP production
in the absence of a ligand (Eggerickx et al., 1995; Freudzon et al., 2005; Yin et al., 2009),
although a membrane bound ligand cannot be ruled out completely. In the mouse, GPR3
is expressed highly in the brain, with lower amounts in the ovary, testis and eye
(Eggerickx et al., 1995). GPR3 is essential for maintaining prophase I meiotic arrest in
mouse and pig oocytes (Hinckley et al., 2005; Ledent et al., 2005; Mehlmann et al., 2004;
Yang et al., 2012) and may play a role in meiotic arrest in human and Xenopus oocytes
(Deng et al., 2008; DiLuigi et al., 2008; Rios-Cardona et al., 2008). GPR3 is also
important for several neurological processes including neurite outgrowth, postnatal
cerebellar development (Tanaka et al., 2007; Tanaka et al., 2009), emotional-like
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responses, Alzheimer’s disease, early phases of cocaine reinforcement, and neuropathic
pain therapy (Ruiz-Medina et al., 2011; Thathiah et al., 2009; Tourino et al., 2012;
Valverde et al., 2009). Although the constitutive activity of GPR3/6 and 12 has long
been recognized, little is known about the molecular details by which the signaling
activity and subcellular localization of these receptors is controlled. Understanding
GPR3 regulation may not only be important for understanding other constitutively active
receptors, but it may also be important for treating reproductive and neurological
disorders.
An important mechanism that regulates GPCR signaling is desensitization. This
process involves the G protein-coupled receptor kinases (GRKs) and the arrestins
(Lefkowitz and Shenoy, 2005; Shenoy and Lefkowitz, 2003). GRKs selectively
phosphorylate active GPCRs at serine and threonine residues within the C-terminus and
third intracellular loop. This leads to the recruitment of arrestins that prevent subsequent
interactions with the receptor and G proteins and terminate G protein-mediated signaling
(Kohout and Lefkowitz, 2003; Perry et al., 2002). Arrestin binding can also promote
internalization of the receptor through a clathrin-dependent pathway. Following
internalization, the receptor is either dephosphorylated and recycled back to the
membrane or it is targeted to lysosomes for degradation. Although it is assumed that
receptor internalization terminates GPCR signaling, there are recent reports of cAMP
signaling by internalized GPCRs. The thyroid-stimulating hormone (TSH) and
parathyroid hormone (PTH) receptors continue to signal following internalization where
they remain associated with G proteins and adenylate cyclase at endosomal
compartments. Signaling from internalized receptors is associated with a prolonged
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cAMP response following hormone treatment, whereas signaling at the cell surface is
more transient (Calebiro et al., 2009; Calebiro et al., 2010a; Ferrandon et al., 2009). In
addition to G s -dependent signaling, there is evidence that G i -dependent signaling
R

R

R

R

stimulated by the S1P receptor may occur internally as well (Mullershausen et al., 2009).
Intracellular signaling seems to contradict the well-established process of desensitization;
therefore, further studies are needed to reconcile these two concepts. It is not known
whether intracellular signaling to cAMP is a general feature of G s /G i coupled receptors
R

R

R

R

or whether it is a characteristic of only a few receptors.
GPR3 behaves like agonist-occupied receptors in that it uses traditional GPCR
pathways to transmit signals and is internalized by an endocytic pathway (Fraile-Ramos
et al., 2003; Freudzon et al., 2005; Lowther et al., 2011). However, it is unknown
whether the activity and localization of GPR3 and other constitutively active GPCRs are
regulated by GRKs and arrestins. Since the constitutive activity of GPR3 is required to
maintain high cAMP levels for meiotic arrest, it could signal following internalization in
order to prolong cAMP signaling. Our previous findings show that GPR3 is internalized
in the oocyte and inhibition of endocytosis increases cAMP and delays oocyte maturation
(Lowther et al., 2011). This finding is consistent with signaling at the cell surface rather
than continued signaling following internalization. It is possible that GPR3 might not
signal from intracellular sites and would need to be regulated in a manner similar to
ligand-activated GPCRs in order to prevent excessive intracellular levels of cAMP. Here,
we investigated the localization and possible regulation of GPR3-cAMP signaling in
cultured HEK293 cells. GPCRs, in general, are difficult to study because native
expression levels are very low. Also, biochemical experiments with mouse oocytes are
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unfeasible due to the limited amount of sample that can be obtained. Therefore, we used
an overexpression system in HEK293 cells, which have been commonly used to study
signaling and regulation of a variety of GPCRs, to study GPR3 localization and signaling.
We found that GPR3 signals at the cell surface, is internalized by a dynamin-dependent
PHFKDQLVPDQGLVVXVFHSWLEOHWRGHVHQVLWL]DWLRQE\*5.DQGȕ-arrestin-2
overexpression. Mutations of the serine and threonine residues in the third intracellular
loop markedly increased cAMP levels and are not involved in desensitization by GRK2
DQGȕ-arrestin-2. Mutations of serines in the C-terminus decreased cell surface
localization of GPR3 but did not affect cAMP production. We also provide evidence that
GPR3 is regulated by one or more protein kinase C isoforms.

47T

U

Experimental Procedures

Cell culture and Transfection
HEK293 cells were cultured in Dulbecco's modified Eagle's (DMEM)/F-12

medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum
(Invitrogen), 100 U/mL penicillin and 100 μg/mL streptomycin (Invitrogen) at 37 ͼ C in a
P

P

humidified 5% CO 2 /95% air incubator. Cells in 6-well dishes were transfected with
R

R

plasmid DNA using Lipofectamine 2000 (Invitrogen) following the manufacturer's
recommendations. Experiments were performed 24 hr after transfection.
Bisindolylmaleimide I (Bis I) and Phorbol 12-myristate 13-acetate (PMA) were
purchased from Calbiochem (La Jolla, CA) and Tocris Bioscience (Minneapolis, MN),
respectively. Methyl-ȕ-cyclodextrin was purchased from Sigma (St. Louis, MO).
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Plasmids
Mouse GPR3-RFP was provided by Y. Saeki (Ohio State University) in pHGCY.

Human GPR3 in pCMV6-AC-HA-His (GPR3-HA) was purchased from Origene
(Rockville, MD). Dynamin 1 WT and K44A in pcDNA3.1 were purchased from ATCC
(Manassas, VA). GRK2 was provided by R. Lefkowitz (Duke University Medical
Center) in pRKȕ-arrestin-2-GFP was obtained from M. Caron (Duke University
Medical Center) in pS65T and was subcloned into pSP64.5. pcDNA3.1 empty vector
was purchased from Invitrogen. CFP-(SDF į'(3-CD)-YFP was provided by K. Jalink
(The Netherlands Cancer Institute).

U

Transferrin Assay
Cells were washed in RPMI-1640 without bicarbonate (Invitrogen) + 0.2% BSA

(Sigma), pH 7.4, for 30 min at 37°C. Cells were incubated with 50 μg/mL Alexa Fluor
488-labelled transferrin (Invitrogen) for 2 min at 37°C, placed on ice for 10 min, and
washed with cold PBS. Cells were fixed in 2% formaldehyde (Sigma) for 30 min at
room temperature, washed twice with PBS, and transferrin internalization was examined
with a Zeiss LSM 510 confocal microscope (Carl Zeiss Microimaging, Inc.).
47T

47T

Fluorescence was excited at 488 nm and detected at 530 nm. Images were collected
using a 40X NA 1.2 water immersion objective (C-Apochromat; Carl Zeiss
MicroImaging, Inc., Thornwood, NY).

U

Biotinylation

62

Biotinylation was performed on cells in suspension according to the
manufacturer’s recommendation. Briefly, cells were trypsinized using 0.025% TrypsinEDTA, resuspended in growth medium, washed three times with ice cold PBS (pH 8.0),
incubated in 0.5 mg/mL sulfo-NHS-LC-Biotin (Pierce Biotechnology, Rockford, IL) for
30 min at 4°C, and washed with ice cold PBS (pH 8.0) + 100 mM glycine to remove
unbound biotin. For internalization assays, cell surface proteins were biotinylated with
cleavable sulfo-NHS-SS-biotin (Pierce) as indicated above. Cells were then incubated in
regular medium at 37°C for 30 min or 1 hr to allow internalization. Cleavage of surface
biotin was performed as previously described (Cao et al., 1998). Briefly, cells were
incubated at 4°C with 3 washes of glutathione strip buffer (50 mM glutathione, 75 mM
NaCl, 75mM NaOH, 10% FBS in H 2 0) for 15 min each. Glutathione was quenched by 3
R

R

washes of iodoacetamide buffer (50 mM iodoacetamide, 1% BSA in PBS, pH 7.4) for 15
min each at 4°C.
Protein samples were prepared in RIPA buffer (Teknova, Hollister, CA)
containing protease inhibitor cocktail (Pierce Biotechnology), sonicated, and rotated at
4°C for 30 min. Supernatants were collected following centrifugation at 14,000 x g for
20 min at 4°C.

Protein concentrations were determined by BCA assay (Pierce

Biotechnology).

U

Antigen Precipitation
Cell surface biotinylated proteins were precipitated from cell lysates using

streptavidin agarose resin (Pierce). Sixty μg of protein was added to 30 μl of agarose
beads in a total volume of 200 μl with RIPA buffer. Samples were rotated for 2 hr at

63

4°C, spun at 1150xg for 5 min at 4°C, and washed four times with 500 μl RIPA buffer.
After the final wash, the beads were resuspended in Laemmli sample buffer with 5% 2Mercaptoethanol and boiled for 5 min. Five μl of the sample was analyzed by Western
%ORW'HWHFWLRQRI*$3'+RUȕ-actin in 0.5 μg of total lysate was used as a loading
control.

U

Western Blot Analysis
Western blot analysis was performed as described previously (Mehlmann et al.,

1998). Proteins were resolved on a 4-15% Tris-HCl ready gel (Biorad, Hercules, CA),
transferred onto a nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ),
and blocked in 5% milk for 30 min. The membrane was incubated in primary antibody
overnight at room temperature, washed, incubated in horseradish peroxidase-conjugated
secondary antibody for 1 hr, and washed. Primary antibodies were anti-HA high affinity
5RFKH$SSOLHG6FLHQFH,QGLDQDSROLV,1 *$3'+DQGȕ-actin (Abcam, Cambridge,
MA) and were diluted 1:1000 in blocking buffer. Anti-dynamin 1/2 (Santa Cruz
Biotechnology, Santa Cruz, CA) was diluted 1:200 in blocking buffer. Secondary
antibodies were obtained from Santa Cruz and diluted 1:5000 in blocking buffer.
Immunoreactive protein bands were detected using ECL Prime or ECL plus Western
blotting detection system and visualized with GE Hyperfilm (Amersham Biosciences).
Films were scanned and band intensities were analyzed by densitometry using Image J
software (National Institutes of Health). Densitometry values for surface and total GPR3
H[SUHVVLRQZHUHQRUPDOL]HGWR*$3'+RUȕ-actin. The normalized value for surface
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GPR3 was divided by the normalized value for total GPR3 to examine the ratio of surface
vs. total GPR3.

15TU

EIA cAMP Measurement
HEK293 cells were transfected with the indicated plasmid DNA using

Lipofectamine 2000. Twenty-four hr after transfection, cells were trypsinized as
described above and 400,000 cells were washed with PBS, lysed in 225 μl of 0.1 M HCl
for 10 min at room temperature, sonicated, and stored at -80°C until the assay was
performed. Levels of intracellular cAMP were measured using the cAMP enzyme
immunoassay (EIA) kit, Direct (Sigma, or Enzo Life Sciences, Plymouth Meeting, PA),
using the nonacetylation EIA procedure. Similar results were obtained using both EIA
kits. Results are presented as pmol/mL cAMP.

U

Fluorescence resonance energy transfer (FRET) measurement of cAMP
To study changes in intracellular cAMP by FRET, HEK293 cells were plated on

round glass cover slides and transfected 24 h later with the CFP-(SDF į'(3-CD)-YFP
(Ponsioen et al., 2004) sensor plasmid and, when indicated, with GPR3-RFP, Dynamin
:7RU.$*5.DQGȕ-arrestin-2 plasmids. 24-36 h after transfection, cells were
washed once and maintained in a physiological buffer containing 144 mM NaCl, 5.4 mM
KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , and 20 mM HEPES, pH 7.4 at room temperature, and
R

R

R

R

placed on a Zeiss Axio Observer A1 microscope equipped with Plan-Apochromat 63x/1.4
oil immersion objective, Polychrome V light source, DV2 DualView beam splitter and
CoolSNAP-HQ2 CCD-camera (Visitron Systems, Pullheim, Germany). The YFP/CFP
emission ratio upon 436 nm excitation (filters YFP 535 ± 15 nm, CFP 480 ± 20 nm) was
65

measured before and after saturation of the sensor with isoproterenol plus
46T

44T

46T

isobutylmethyl-xanthine (IBMX) or forskolin plus IBMX. Measurements were
44T

monitored online and recorded by the VisiView software (Visitron). After each
measurement, emission values were corrected for bleedthrough of CFP into YFP channel
and for photobleaching as described (Borner et al., 2011). The data were analyzed with
Excel and Origin 8.5 (OriginLab) packages to calculate percent change in YFP/CFP ratio.
To convert FRET ratio data into absolute cAMP concentrations, the maximal response of
the sensor in each cell stimulated with isoproterenol plus IBMX or with forskolin plus
,%0; ǻ)5(7 ZDVPHDVXUHG1H[WWKHGHJUHHRIVHQVRUDFWLYDWLRQDWEDVDOVWDWHZDV
calculated as (55.4 -ǻ)5(7  ZKHUH PHDQ6(0 LVWKH
PD[LPDOǻ)5(7PHDVXUHG in empty vector-transfected cells. The degree of sensor
activation (y) was used to calculate cAMP concentrations (x) based on the published
concentration-response-dependence measured in vitro (Ponsioen et al., 2004) according
to the equation x=13.21*y/(100-y) which describes the published curve. Values are
presented as mean ± SEM.

U

Mutagenesis
GPR3-HA mutants, in which serine and threonine residues in the third

intracellular loop and C-terminus were mutated to alanine, were generated using the
QuikChange II site-directed mutagenesis Kit (Agilent, Cedar Creek, TX) according to the
manufacturer’s protocol. Amino acids at 237 and 242 in the third intracellular loop (S,T)
and amino acids at 316, 317, 318, 324, 326, 328 in the C-terminus (1-6) were mutated to
alanine. HPLC purified primers for mutagenesis were purchased from Sigma (Table 1)
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and mutations were made in the order the primers are presented. Three mutants were
generated: GPR3-HA ST/A, GPR3-HA S1-6A, GPR3-HA ST/A, S1-6-A. A GRK2K220R catalytically inactive mutant where the lysine at position 220 was mutated to
arginine was made using the QuikChange II site-directed mutagenesis kit and the
primers: 5’CAAGATGTACGCCA-TGAGGTGTCTGGACAAGAAGC 3’ and 5’
GCTTCTTGTCCAGACACCTCATGGC-GTACATCTTG 3’.

U

Statistical Analysis
Data are representative of at least three independent experiments, unless

otherwise specified. Values were analyzed by One-way ANOVA, Repeated Measures
ANOVA, or Student’s t test as described in each figure legend. Statistical analysis was
performed using Graph Pad Prism software and significance was assessed at P<0.05.

Results and Discussion
U

Inhibition of endocytosis in HEK293 cells by overexpressing a dominant negative form

of dynamin (Dyn K44A) increases cell surface localization of GPR3
To confirm that GPR3 is endocytosed in HEK293 cells, cell surface proteins were
biotinylated with cleavable sulfo-NHS-SS-biotin. Following internalization, remaining
biotinylated cell surface proteins were stripped and detected by streptavidin precipitation
and Western blot. Biotinylated GPR3 was detected at the cell surface (Lane 1 of Figure
3.1) and in internalized samples at 30 min and 60 min (Lane 3 and 4 of Figure 3.1). The
internalized sample did not contain cell surface GPR3 because efficient stripping of
biotinylated cell surface proteins was observed (Lane 2 of Figure 3.1).
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In order to examine whether GPR3 signals from the cell membrane and/or
endosomes, we used Dyn K44A to inhibit endocytosis (van der Bliek et al., 1993). Dyn
K44A is mutated in the GTP binding domain, which blocks early events of endocytosis.
To confirm that Dyn K44A effectively inhibits endocytosis in HEK293 cells, Dyn WT
and K44A were expressed by transient transfection and 24 hr later, the cells were labeled
with Alexa Fluor 488-labeled transferrin to evaluate receptor-mediated internalization.
Confocal images show that cells transfected with Dyn K44A have lower levels of
transferrin internalization with more accumulation at the cell surface compared to cells
transfected with Dyn WT (Figure 3.2 A and B). These results are consistent with
previous findings that Dyn K44A inhibits receptor-mediated endocytosis (van der Bliek
et al., 1993).
Localization of GPR3 in response to endocytic inhibition was evaluated using two
methods. First, HEK293 cells were co-transfected with GPR3-RFP and Dyn WT or Dyn
K44A, and imaged by confocal microscopy. In cells co-transfected with Dyn WT,
GPR3-RFP is localized in the plasma membrane and also within intracellular clusters
(Figure 3.2 C), similar to its localization in mouse oocytes (Lowther et al., 2011) and
transfected Neuro2a cells (Tanaka et al., 2007). Co-transfection of GPR3-RFP with Dyn
K44A increased GPR3 fluorescence at the plasma membrane (Figure 3.2 D). Western
analysis confirmed that Dyn WT and Dyn K44A were expressed at equivalent levels
(Figure 3.2 E). Second, GPR3-HA localization at the plasma membrane was evaluated
by biotinylation and precipitation of cell surface proteins and Western blot. Total GPR3HA expression normalized to GAPDH was similar in cells co-transfected with DynWT
and DynK44A based on densitometry (Figure 3.2 F-G). In support of the results from
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confocal microscopy, there is a ~2 fold increase in surface GPR3 precipitated from
biotinylated cell lysates co-transfected with Dyn K44A compared to Dyn WT (Figure 3.2
H). Similar results were obtained using methyl-ȕ-F\FORGH[WULQ 0ȕ&' DGUXJWKDW
selectively extracts cholesterol from the plasma membrane and inhibits receptor-mediated
endocytosis by preventing invagination of caveolae and clathrin-coated pits (Rodal et al.,
1999) (Data not shown). These results demonstrate that GPR3 is constitutively
internalized by a dynamin-dependent mechanism and inhibition of endocytosis increased
GPR3 surface expression.

U

Inhibition of endocytosis in cells transfected with GPR3-HA increases intracellular

cAMP levels
GPCR internalization usually leads to signal termination. However, recent studies
have shown that several receptors including TSH and PTH receptors continue to signal
following internalization (Calebiro et al., 2009; Calebiro et al., 2010a; Ferrandon et al.,
2009). In these previous studies, cAMP levels returned to basal levels following ligand
treatment and endocytic inhibition. Because constitutively active GPCRs signal in the
absence of an agonist, it is possible that placement at the plasma membrane is not
required for G s activation and that they may be able to signal internally. To determine
R

R

whether GPR3 signals following endocytosis, we measured cAMP using an EIA assay in
cells co-transfected with GPR3-HA and Dyn WT or K44A. Transient transfection of
HEK293 cells with GPR3-HA caused cAMP levels to increase significantly compared to
empty vector-transfected cells, confirming the constitutive activity of GPR3. When cotransfected with Dyn K44A, cAMP levels significantly increased compared to cells co-
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transfected with empty vector or Dyn WT (Figure 3.3 A). These results demonstrate that
an increase in GPR3 at the cell surface corresponds to an increase in cAMP levels,
suggesting that GPR3 signals at the cell surface and not from endosomes. Transfection
of Dyn WT or K44A in the absence of GPR3-HA did not alter cAMP levels (data not
shown). Treatment of GPR3-HA trDQVIHFWHGFHOOVZLWK0ȕ&', which prevents
endocytosis and increases surface GPR3, also significantly increased cAMP levels (data
not shown).
In order to corroborate the cAMP data obtained by EIA assay, we performed a
FRET-based assay using a low affinity (K d = ~14 μM) Epac-based cAMP sensor (CFPR

R

(SDF į'(3-CD)-YFP (Ponsioen et al., 2004)) that is not saturated in cells transfected
with GPR3-RFP. This method is advantageous over standard EIA methods because only
transfected cells are used for cAMP measurements. Cells were co-transfected with
GPR3-RFP, Epac sensor, and empty vector or Dyn WT or Dyn K44A. GPR3-positive
red cells of similar intensity were selected for all recordings. The YFP/CFP emissions
were recorded before and after isoproterenol/IBMX treatment and cAMP concentrations
were calculated. As expected, cells transfected with GPR3-RFP have a higher level of
cAMP (~19μM) compared to empty vector (~0.1μM), demonstrating high constitutive
activity of GPR3. Cells co-transfected with GPR3-RFP and Dyn K44A have higher
cAMP levels (~64 μM) compared to GPR3-RFP with Dyn WT (~9 μM) or empty vector
(Figure 3.3 B), confirming that cAMP levels significantly increase when endocytosis is
inhibited. Together, these results demonstrate that GPR3 signals at the cell surface and
does not signal from endosomal compartments. This finding is in contrast to GPR6, a
closely related receptor to GPR3, that is thought to signal internally because it is
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primarily localized in intracellular compartments (Padmanabhan et al., 2009). GPR3
seems to be largely localized on the cell surface in oocytes (Lowther et al., 2011),
Neuro2a cells (Tanaka et al., 2007), and HEK293 cells (Zhang et al., 2012) and this
difference in localization between GPR3 and GPR6 may explain why they may signal
from different membrane compartments.

U

2YHUH[SUHVVLRQRI*5.DQGȕ-arrestin-2 decreases surface localization of GPR3 and

cAMP production
It is unknown whether GPR3 and other constitutively active GPCRs are regulated
by similar mechanisms as ligand-activated GPCRs. It is thought that constitutively active
GPCRs are in the appropriate conformation to be continuously phosphorylated by GRKs
and signaling is transiently silenced (Leurs et al., 1998). To determine whether GPR3
FDQEHUHJXODWHGE\*5.VRUȕ-arrestins, these proteins were co-expressed with GPR3
and localization was evaluated by the same methods described above. Overexpression of
*5.DQGȕ-arrestin-2 appears to decrease GPR3-RFP cell surface localization as
assessed by confocal microscopy (Figure 3.4 A and B). The decrease in cell surface
GPR3 is more obvious when detected by biotinylation and precipitation and Western
analysis (Figure 3.4 C). Using densitometry, total GPR3 expression was not significantly
different (Figure 3.4 D). However, surface expression of GPR3 as compared to total
GPR3 expression was lower in cells co-WUDQVIHFWHGZLWK*5.DQGȕ-arrestin-2 (Figure
3.4 E), suggesting that these proteins induce GPR3 internalization. Measurements of
cAMP using EIA and FRET showed that cAMP levels decreased by more than 50% as a
result of GPR3-HA co-H[SUHVVLRQZLWK*5.DQGȕ-arrestin-2 (Figure 3.5 A and B).
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These results demonstrate that GPR3 is susceptible to desensitization by a
GRK2- DQGȕ-arrestin2-dependent mechanism. There is an example of at least one
constitutively active GPCR, the human cytomegalovirus (HCMV)-encoded receptor
US28, that signals at the cell surface and is constitutively phosphorylated by GRKs.
Following phosphorylation, US28 is rapidly internalized through a clathrin-mediated
mechanism and PD\QRWEHGHSHQGHQWRQȕ-arrestins (Droese et al., 2004; Miller et al.,
2003b; Mokros et al., 2002), and internalization attenuates US28-induced G q -mediated
R

R

phospholipase signaling (Casarosa et al., 2001; Fraile-Ramos et al., 2001; Miller et al.,
2003b; Mokros et al., 2002). Deletion or mutation of the C-terminus of US28 so that it
can no longer be phosphorylated results in an increase in phospholipase signaling and an
increase in surface expression (Miller et al., 2003b; Mokros et al., 2002; Waldhoer et al.,
2003). It has been speculated that this behavior allows HCMV entry into the cells and
contributes to viral infection. Whether all constitutively active GPCRs are regulated in a
similar manner or whether it is unique to US28 is not understood. GPR3 seems to be
VLPLODUWR86LQWKDWLQWHUQDOL]DWLRQLQGXFHGE\*5.DQGȕ-arrestin overexpression
attenuates cAMP signaling. Whether GPR3 is regulated by this pathway under
physiological conditions remains unknown.

U

The serine and threonine residues in the third intracellular loop and C-terminus have

different functions in regulating GPR3 activity and surface localization
GPR3 contains two potential sites for phosphorylation by protein kinase C (PKC)
as well as several serine residues that could be targets for GRKs. To determine whether
GPR3 activity is regulated by any of these sites, we mutated all six serines in the C-
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terminus and the serine and threonine residues in the third intracellular loop to alanine
(Figure 3.6 A). If GPR3 is desensitized due to the phosphorylation of these residues, then
it is expected that mutations of these sites would prevent desensitization and increase
cAMP levels. Mutation of the six serines in the C-terminus (S1-6A) produced cAMP
levels comparable to GPR3 WT. In contrast, mutation of the serine and threonine
residues in the third intracellular loop (ST/A) led to significantly higher cAMP levels
compared to GPR3 WT (Figure 3.6 B), suggesting that these residues are important for
phosphorylation and desensitization of GPR3. It is expected that if the ST/A mutant is
resistant to desensitization, internalization would be impaired, and surface localization
would increase. However, we found that surface localization of the ST/A mutant
compared to total expression was lower, but not significantly different from GPR3 WT
(Figure 3.6 D).
Interestingly, the S1-6A mutant exhibited significantly lower surface expression
compared to GPR3 WT but cAMP levels were unaffected (Figure 3.6 D). It is possible
that reduced membrane expression of the S1-6A mutant is because the mutated receptor
does not make it to the membrane. Because decreased cell surface expression of the S16A mutant does not prevent the receptor from activating cAMP, it suggests that surface
localization is not a requirement for cAMP production and that GPR3 may be able to
signal from other membranes. This possibility is supported by the double mutant, ST/A,
S1-6A, that has increased activity but lower cell surface localization compared to GPR3
WT. Because some GPCRs can signal from endosomal compartments, it is conceivable
that some GPCRs may also be able to signal internally prior to plasma membrane
insertion, especially those that are constitutively active. The ȕ 2 -adrenergic receptor
30T
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R

30 T

ȕ 2 AR) forms a complex with G s and adenylate cyclase soon after leaving the ER in
R

R

R

R

transit to the Golgi (Dupre et al., 2007; Dupre et al., 2006)+RZHYHUȕ 2 AR does not
R

R

activate G s at this compartment because it does not interact with its ligand until it reaches
R

R

the cell surface. Because GPR3 is thought to signal in the absence of a ligand, it is
possible that it could signal internally prior to membrane insertion; however, this has not
been directly examined. It has been shown that inhibition of exocytosis in Xenopus
oocytes results in premature meiotic resumption (El-Jouni et al., 2007), supporting the
idea that GPR3 is actively trafficked to the cell surface but does not signal during
exocytosis. In HEK293 cells, GPR3 may be able to signal internally from other
membranes because S1-6A mutant produces similar levels of cAMP compared to GPR3
WT, even though surface expression is lower.
Together, these results demonstrate that the ST/A and S1-6A mutations have
different effects on GPR3 localization and signaling. The ST/A mutation produces a
hyperactive receptor whereas the S1-6 residues in the C-terminus are important for
surface localization but not cAMP production. It is not understood why mutation of the
serine and threonine residue in the third intracellular loop increases GPR3 activity. One
possibility is that these sites are involved in regulating GPR3 activity by phosphorylation.
The total expression of the GPR3 WT and mutants varied but were not significantly
different (Figure 3.6 C). Therefore, it is unlikely that differences in cAMP production are
due to differences in receptor expression because the ST/A and ST/A, S1-6A mutants are
expressed at slightly lower levels but produce more cAMP than GPR3 WT and S1-6A
mutant. Further studies with fluorescently-tagged mutant receptors are needed in order to
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understand how these residues regulate surface localization of GPR3 and what
membranes GPR3 can signal from.

U

The serine and/or threonine in the third intracellular loop are not targeted by GRK2 and

ȕ-arrestin-2
One possibility that may explain why the ST/A mutant is hyperactive is that it is
resistant to desensitization. To determine whether the serine and threonine residues in the
WKLUGLQWUDFHOOXODUORRSDUHUHTXLUHGIRUVLOHQFLQJRI*35VLJQDOLQJE\*5.DQGȕarrestin-2, cAMP levels were measured in cells co-transfected with the GPR3 ST/A
PXWDQWDQG*5.DQGȕ-arrestin-2. We found that cAMP levels produced by the GPR3
67$VWLOOGHFUHDVHGLQUHVSRQVHWR*5.DQGȕ-arrestin-2 overexpression. cAMP levels
decreased by ~76% and ~73% for GPR3 WT and ST/A, respectively (Figure 3.7 A and
B). Contrary to our expectations, these data demonstrate that mutation of potential
phosphorylation sites in the third intracellular loop did not result in loss of regulation by
*5.DQGȕ-arrestin-2 and these residues are not involved in desensitization by this
pathway. We also found that surface expression of GPR3 ST/A decreased in response to
*5.DQGȕ-arrestin-2 overexpression but it was not as dramatic as what is observed
with GPR3 WT (Figure 3.7 C). Further studies are required to determine the role of the
third intracellular loop in the regulation of GPR3 activity. In addition to GRK
phosphorylation, the third intracellular loop can regulate GPCR signaling by influencing
G protein activation and binding of GPCR-interacting proteins such as 14-3-3,
sphinophilin, RGS2, and arrestin (Damaj et al., 1996; Prezeau et al., 1999; Richman et
al., 2001; Wade et al., 1999; Wu et al., 1997). The third intracellular loop is also thought
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to be involved in stabilizing the neuropeptide Y1 receptor in the inactive state and confers
structural properties for regulating receptor activation (Chee et al., 2008).
Because the GPR3 ST/A mutant was susceptible to desensitization by GRK2 and
ȕ-arrestin overexpression, it is possible that other sites within GPR3 are phosphorylated
by GRK or that GRK mediates desensitization independently of phosphorylation. We
constructed a catalytically inactive GRK2 mutant (GRK2-K220R), in which the lysine at
residue 220 was mutated to arginine. This mutation in the ATP binding domain inhibits
the kinase activity of GRK2 (Casarosa et al., 2001; Miller et al., 2003b). HEK293 cells
were co-transfected with GPR3 WT or ST/A and GRK2-.5DQGȕ-arrestin-2-GFP.
GRK2-K220R significantly decreased cAMP for GPR3 WT and ST/A, although the
decrease was not to the same extent as GRK2 WT (Figure 3.7 A and B). This effect is
not dXHWRȕ-arrestin because transfection of GRK2-K220R alone is sufficient to decrease
cAMP. This result suggests that GRK2 desensitizes GPR3 activity independently of its
kinase activity, which has been observed for other GPCRs including the metabotropic
glutamate receptor, parathyroid hormone receptor, and type 1A angiotensin II (Dhami et
al., 2002; Dicker et al., 1999; Oppermann et al., 1996). The amino terminus of GRK2
contains a regulator of G-protein signaling (RGS) homology (RH) domain that can
regulate G protein activation by binding to and sequestering G proteins in the cytoplasm
R

R

to prevent further interactions with GPCRs (reviewed in (Ferguson, 2007b). Indeed,
expression of the amino-terminal domain of GRK that contains the RH domain is
sufficient to diminish cAMP activity without phosphorylation of several GPCRs (Carman
et al., 1999; Damaj et al., 1996; Fernandez et al., 2011). Based on our studies, it is
unclear whether GPR3 phosphorylation by GRKs is important for GPR3 signaling, since
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both wild-type and kinase-inactive GRK2 inhibited cAMP production. Future studies are
needed to determine whether GPR3 is phosphorylated, whether this phosphorylation is
diminished with the ST/A mutant, and whether the RH domain of GRK2 can reduce
GPR3 activity. Further studies are also required to understand whether ȕ-arrestin is
required for GPR3 internalization.

U

PKC inhibition increases GPR3-cAMP signaling and PKC activation decreases GPR3-

cAMP signaling
As mentioned above, it is possible that other kinases are involved in regulating
GPR3 activity. In addition to GRK, second messenger-dependent kinases including PKA
and PKC can also phosphorylate GPCRs (Tobin, 2008). Signal termination in this
manner involves a feedback loop in which second messengers produced by GPCR
signaling activate PKA or PKC that then phosphorylate the receptor and lead to
desensitization. Unlike GRKs, these kinases do not discriminate between agonist-bound
and agonist-free GPCRs (Kohout and Lefkowitz, 2003). PKA is not likely to be involved
in regulating GPR3 because GPR3 does not contain a PKA consensus site; however,
GPR3 has two predicted PKC sites within the third intracellular loop and the C-terminus
(Eggerickx et al., 1995; Saeki et al., 1993). The threonine in the third intracellular loop is
of particular interest because when mutated, intracellular cAMP levels increase more than
2-fold over WT. To test whether GPR3-cAMP signaling can be mediated by PKC, we
treated HEK293 cells transfected with GPR3-HA WT with a PKC inhibitor (Bis I) or a
PKC activator (PMA). In response to Bis I treatment, cAMP levels significantly
increased compared to DMSO-treated cells (Figure 3.8 A). In contrast, treatment with
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PMA significantly decreased cAMP levels compared to DMSO treatment, suggesting that
PKC regulates GPR3 signaling (Figure 3.8 B). Because the threonine in the third
intracellular loop is a potential PKC site, it is possible that this mutant will not respond to
Bis I or PMA treatment. However, we found that Bis I treatment increased cAMP levels
and PMA decreased cAMP levels for the ST/A mutant (Figure 3.8 C and D). Together,
these results demonstrate the potential for GPR3 regulation by PKC but the threonine
residue in the third intracellular loop does not appear to be involved in this regulation.
Further studies are needed to examine whether other PKC isoforms, not targeted by Bis I
or PMA, can regulate GPR3 activity. In addition, PKC is activated by G q -coupled
R

R

receptors or by G ȕȖ and there is currently no evidence that GPR3 can signal through these
R

R

pathways.
In summary, GPR3 is a constitutively active receptor that is an important
regulator of meiosis in oocytes (Hinckley et al., 2005; Ledent et al., 2005; Mehlmann et
al., 2004) and has a variety of functions in the brain (Ruiz-Medina et al., 2011; Tanaka et
al., 2007; Tanaka et al., 2009; Thathiah et al., 2009; Tourino et al., 2012; Valverde et al.,
2009). In oocytes, GPR3 is localized in the plasma membrane and early endosomes and
inhibiting endocytosis increases cAMP levels (Lowther et al., 2011). However, the
mechanisms controlling GPR3 activity and subcellular localization, if any, have not yet
been characterized. In the present study, we found that inhibition of endocytosis results
in increased GPR3 at the cell surface and increased cAMP levels. Conversely,
RYHUH[SUHVVLRQRI*5.DQGȕ-arrestin-2 decreased both cell surface GPR3 and
intracellular cAMP levels. Together, these results are consistent with the hypothesis that
GPR3 signals at the cell surface and is susceptible to desensitization by a GRK2- DQGȕ-
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arrestin-2-dependent mechanism. Although it appears that GPR3 signals from the cell
membrane and does not continue to signal following internalization, surface localization
is not required for cAMP production. Mutation of the serine residues in the C-terminus
diminished surface localization but did not affect cAMP production. Therefore, GPR3
can potentially activate cAMP prior to membrane insertion. We also provide evidence
that GRK2 and PKC regulate cAMP production by GPR3 but it is not via the
phosphorylation of the serine or threonine residues in the third intracellular loop. Future
studies are needed to determine how GRK2, PKC, and the serine and threonine residues
in the third intracellular loop regulate GPR3 activity and whether additional regulatory
proteins interact with GPR3. It will also be interesting to examine whether GPR3 is
regulated by similar mechanisms in oocytes and whether GPR3 localization and
trafficking is perturbed in women with reproductive problems such as fertility or primary
ovarian insufficiency. Several studies have examined whether mutations in GPR3 are
present in women with primary ovarian insufficiency; however, no perturbations were
found in the coding region of GPR3 in the populations included in these studies (Kovanci
et al., 2008; Zhou et al., 2009). Whether GPR3 localization or activity in the ovary is
abnormally regulated in these women remains to be explored.
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Figure 3.1.

Figure 3.1. GPR3 is localized at the cell surface and undergoes internalization.
HEK293 cells were transfected with GPR3-HA. Twenty-four hr later, surface proteins
were biotinylated (lane 1), allowed to internalize for 30 min (lane 3) or 60 min (lane 4) at
37϶C, and biotinylated proteins remaining at the cell surface were removed using a
glutathione strip buffer. Biotinylated proteins were precipitated from the total lysate and
5μl of the sample was analyzed by Western blotting. Lane 2 represents biotinylated
GPR3 stripped from the cell surface. Detection of GAPDH in 0.5μg of total lysate was
run on the same gel and served as a loading control to confirm that an equivalent amount
of protein was used for precipitations.
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Figure 3.2.

Figure 3.2. Inhibition of endocytosis increases cell surface GPR3. (A and B)
HEK293 cells were transfected with Dyn WT (A) or Dyn K44A (B) and 24 hr later, the
cells were incubated with Alexa Fluor 488-labelled transferrin and imaged with a
confocal microscope. (C and D) Cells were co-transfected with GPR3-RFP and Dyn WT
(C) or Dyn K44A (D) and imaged using a confocal microscope 24 hr later. Bar = 10 μm.
(E) One μg of HEK293 lysate was used to detect Dyn WT and Dyn K44A
overexpression by Western blot analysis. (F) HEK293 cells were co-transfected with
GPR3-HA and Dyn WT or Dyn K44A and 24 hr after transfection cell surface proteins
were biotinylated, precipitated, and surface expression of GPR3-HA was detected by
Western blot analysis. 0.5 μg of total lysate was used to detect total GPR3 and GAPDH
expression. Blot is representative of 4 separate experiments. (G-H) Bands
corresponding to surface GPR3 and total GPR3 expression were analyzed using
densitometry and normalized to GAPDH. G) Total GPR3 expression in cell lysates cotransfected with Dyn WT or Dyn K44A. H) Normalized surface GPR3 was divided by
normalized total GPR3 expression to compare the amount of GPR3 at the surface
compared to total GPR3. Results are presented as mean ± S.E.M from 3 separate
experiments.
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Figure 3.3.

Figure 3.3. Inhibition of endocytosis increases intracellular cAMP. A) HEK293
cells were co-transfected with GPR3-HA and pcDNA (empty vector) or with Dyn WT or
Dyn K44A. Twenty-four hr after transfection, cells were harvested for cAMP EIA. The
results are presented as mean ± S.E.M from 4 separate experiments. (a) indicates a
significant increase in cAMP compared to “pcDNA” and (b) indicates a significant
increase in cAMP compared to “GPR3 + pcDNA” and “GPR3 + Dyn WT”. Significance
was determined by One-way ANOVA followed by Newman-Keuls multiple comparison
test (p<0.01). B) FRET measurements of red positive HEK293 cells co-transfected with
GPR3-RFP and CFP-(SDF į'(3-CD)-YFP and pcDNA, or Dyn WT or Dyn K44A
following isoproterenol and IBMX treatment. FRET measurements were converted to
cAMP levels (μM) as described in the experimental protocol. (a) indicates a significant
increase in cAMP compared to “pcDNA”, (b) indicates a significant change in cAMP
compared to “GPR3 + pcDNA”, and (c) indicates a significant increase in cAMP
compared to “GPR3 + Dyn WT”. Significance was determined by One-way ANOVA
followed by Newman-Keuls Multiple Comparison Test (p<0.01). Results were obtained
from 15 different GPR3-RFP expressing cells per group.
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Figure 3.4.

Figure 3.4. Overexpression of GRK2 and ȕ-arrestin-2 decreases cell surface GPR3
expression. A-B) HEK293 cells were co-transfected with GPR3-RFP and pcDNA (A)
or GPR3-RFP and *5.DQGȕ-arrestin-2 (B) and imaged using a confocal microscope
24 hr after transfection. Bar = 10 μm. C) HEK293 cells were co-transfected with
GPR3-HA and pcDNA (-) or GPR3-+$DQG*5.DQGȕ-arrestin-2 (+). 24 hr after
transfection, cell surface proteins were biotinylated, precipitated, and cell surface
expression of GPR3-HA was detected by Western blotting. 0.5 μg of total lysate was
used to detect total GPR3 and GAPDH expression. Blot is representative of 4 separate
experiments. D-E) Bands corresponding to surface GPR3 and total GPR3 expression
were analyzed using densitometry and normalized to GAPDH. D) Total GPR3
expression in cell lysates co-WUDQVIHFWHGZLWK*5.DQGȕ-arrestin-2. E) Normalized
surface GPR3 was divided by normalized total GPR3 expression to compare the amount
of GPR3 at the surface compared to total GPR3. Results are presented as mean ± S.E.M.
from 3 separate experiments.
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Figure 3.5.

Figure 3.5. Overexpression of GRK2 and ȕ-arrestin-2 decreases intracellular cAMP
levels. A) HEK293 cells were co-transfected with GPR3-HA and pcDNA or GPR3-HA
DQG*5.DQGȕ-arrestin-2. Twenty-four hr after transfection, cells were harvested for
cAMP EIA. The results are presented as mean ± S.E.M from 3 separate experiments. (a)
indicates a significant increase in cAMP level compared to “pcDNA” and (b) indicates a
significant decrease in cAMP level compared to “GPR3 + pcDNA”. Significance was
measured by One-way ANOVA followed by Newman-Keuls Multiple Comparison Test
(p<0.05). B) FRET measurements of red positive HEK293 cells co-transfected with
GPR3-RFP, CFP-(SDF į'(3-CD)-YFP, and pcDNA or GPR3-RFP, CFP-(SDF į'(3CD)-YFP, DQG*5.DQGȕ-arrestin-2 following forskolin and IBMX treatment. FRET
measurements were converted to cAMP levels (μM) as described in the experimental
protocol. (*) indicates a significant decrease in cAMP levels compared to “GPR3-RFP”.
Significance was determined by two-tailed unpaired T test (p<0.05). Results were
obtained from 13-18 different GPR3-RFP expressing cells per group.
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Figure 3.6

Figure 3.6. Mutation of S and T residues in the third intracellular loop increases
intracellular cAMP while mutation of S residues in the C-terminus decreases cell
surface expression of GPR3. A) Schematic identifying potential serine and threonine
residues in the third intracellular loop and C-terminus that could be targeted for
regulation by phosphorylation. These residues were mutated to alanine to create 3
mutants: ST/A, S1-6A, and ST/A, S1-6A. B) GPR3-HA WT and mutants were
transfected into HEK293 cells and harvested 24 hr later for cAMP EIA. Results are
presented as mean ± S.E.M. from 6 separate experiments. (a) indicates a significant
increase in cAMP level compared to “WT”, (b) indicates a significant difference in
cAMP compared to “ST/A”, and (c) indicates a significant difference in cAMP compared
to “S1-6A” as determined by Repeated Measures ANOVA followed by Newman-Keuls
Multiple Comparison Test (p<0.01). C-D) 24 hr after transfection, cell surface proteins
were biotinylated, precipitated, and surface expression of GPR3-HA was detected by
Western blotting. 0.5 μg of total lysate was used to detect total GPR3 and actin
expression. Bands corresponding to surface GPR3 and total GPR3 expression were
analyzed using densitometry and normalized to Actin. C) Total GPR3 WT and mutant
expression in cell lysates. D) Normalized surface GPR3 was divided by normalized total
GPR3 expression to compare the amount of GPR3 at the surface compared to total GPR3.
Results are presented as mean ± S.E.M from 3 separate experiments. (*) indicates a
significant difference in cell surface vs. total expression as compared to “WT”.
Significance was determined by One-way ANOVA followed by Newman-Keuls Multiple
Comparison Test (p<0.05).
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Figure 3.7.

Figure 3.7. S and T residues in the third intracellular loop are not involved in
GRK2/ȕ-arrestin-2- mediated desensitization. A-B) GPR3-HA WT and ST/A were
co-WUDQVIHFWHGZLWKSF'1$RU*5.DQGȕ-arrestin-2, or GRK2-K220R, or GRK2.5DQGȕ-arr-2. Twenty-four hr after transfection, cells were harvested for cAMP
EIA. Results are presented as mean ± S.E.M from 3-5 separate experiments. (*) indicates
a significant decrease in cAMP compared to “pcDNA”. Significance was determined by
One-way ANOVA followed by Dunnett’s Multiple Comparison Test (p<0.05). (C)
GPR3-HA WT and ST/A were co-WUDQVIHFWHGZLWKSF'1$RU*5.DQGȕ-arrestin-2.
Twenty-four hr after transfection, cell surface proteins were biotinylated, precipitated
from cell lysates, and analyzed by Western blotting. Normalized surface GPR3 was
divided by normalized total GPR3 expression to compare the amount of GPR3 at the
surface compared to total GPR3. Results are presented as mean ± S.E.M from 3 separate
experiments.
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Figure 3.8.

Figure 3.8. PKC inhibition increases intracellular cAMP and PKC activation
decreases intracellular cAMP levels. A-B). HEK293 cells were transfected with
GPR3-HA WT and 4 hr later treated with 5μM Bis I (A) or 10 nM PMA (B). Following
18 to 24 hr treatment, cells were harvested for cAMP EIA. C-D) HEK293 cells were
transfected with GPR3-HA ST/A and 4 hr later treated with 5μM Bis I (C) or 10 nM
PMA (D). Following 18 to 24 hr treatment, cells were harvested for cAMP EIA. Results
are presented as mean ± S.E.M from 3-4 separate experiments. (*) indicates a significant
difference in cAMP levels from “-” DMSO treated cells as determined by two-tailed
paired Student’s t test (p<0.05). ~170,000 cells lysed in 0.1M HCl were used in the EIA
assay, except for the GPR3-HA ST/A treated with Bis I and DMSO where ~90,000 cells
were used.
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Table 3.1 Primer Sets used for GPR3-HA Mutagenesis
GPR3 S1-3A
GPR3 S6A

5’-GGGCTGTCTGCTGCTGCTGATCCTCTTCCAAGATCCCCTTCC-3’
5’-GGAAGGGGATCTTGGAAGAGGATCAGCAGCAGCAGACAGCCC-3’
5’-GATCCCGCTCCCCCAGTGATGTCACGCGTT-3’
5’- AACGCGTGACATCACTGGGGGAGCGGGATC -3’
5’-GATCCCCTTCCGAGCCCGCGCCCCCGCTGATG-3’
5’- CATCAGCGGGGGCGCGGGCTCGGAAGGGGATC -3’
5’-CACTATGTGGCCGCACGCAAGGGCATT-3’
5’- AATGCCCTTGCGTGCGGCCACATAGTG -3’
5’-CCTGCTGCCTGCCGCCCACTATGTG-3’
5’- CACATAGTGGGCGGCAGGCAGCAGG -3’
33T

GPR3 S4,5A

33T

33T

GPR3 T/A

33T

33T

GPR3 S/A

33T

33T

33T
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CHAPTER FOUR
U

Concluding Remarks and Future Directions

The projects described in this dissertation have begun our understanding of how
the constitutively active receptor, GPR3, is regulated in mouse oocytes and HEK293
cells. Similar to Xenopus and C. elegans oocytes (Cheng et al., 2008; El-Jouni et al.,
2007), membrane trafficking is important for meiotic arrest in mouse oocytes. The
mouse oocyte undergoes active endocytosis and signaling at the cell surface is important
for cAMP production and meiotic arrest. In HEK293 cells, GPR3 signals at the cell
surface and does not continue to signal following internalization. GPR3-mediated cAMP
production can be regulated by overexpressed GRKDQGȕ-arrestin in a manner that does
not depend on the kinase activity of GRK2. In addition, residues in the third intracellular
loop may be sites for regulation by either phosphorylation or interaction with other G
protein-coupled receptor interacting proteins (GIPs) and residues in the C-terminus are
important for membrane expression. In this chapter, I will provide a short summary of
the conclusions from these studies, and introduce some avenues for further research. I
will also describe some preliminary data that explore these avenues.

U

Endocytosis in the mouse oocyte and its contribution to cAMP signaling during meiotic

arrest
The goal of this study was to examine whether receptor-mediated endocytosis
occurs in the mouse oocyte and whether this could affect the maintenance of meiotic
arrest due to GPR3 signaling. We hypothesized that if GPR3 signals at the cell surface,
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then inhibition of endocytosis would delay or inhibit oocyte maturation due to an increase
in GPR3 at the cell surface and an increase in cAMP signaling. Because little is known
about endocytosis in mammalian oocytes, we confirmed that oocytes express important
components required for receptor-mediated endocytosis and that constitutive endocytosis
occurs in the mouse oocyte. To determine whether endocytosis contributes to cAMP
signaling, we treated oocytes with inhibitors of receptor-mediated endocytosis, MDC and
dynasore. These endocytic inhibitors dose-dependently delayed spontaneous meiotic
resumption for at least 7 hours following milrinone washout. Dynasore treatment also
significantly increased cAMP levels in the absence of milrinone, confirming that the
delay or complete block in oocyte maturation in response to endocytic inhibition is
attributed to elevated levels of cAMP. We conclude from these experiments that cAMP
signaling occurs at the plasma membrane and is sufficient for meiotic arrest. If cAMP is
generated from endosomal compartments in the oocyte, it would be expected that cAMP
levels would decrease in response to dynasore treatment, as it does in thyroid follicles
treated with dynasore and TSH (Calebiro et al., 2009). Thus, endosomal signaling does
not appear to contribute to cAMP production needed for meiotic arrest in the oocyte.
Our original hypothesis was that endocytic inhibition would cause GPR3 to
accumulate at the plasma membrane and therefore increase cAMP production. We
examined GPR3 localization in mouse oocytes by microinjection of mRNA encoding
GPR3-RFP. GPR3-RFP localized in the plasma membrane and in clusters throughout the
cytoplasm of the oocyte. Fixation and labeling with EEA1 showed that GPR3-RFP colocalized within early endosomes, demonstrating that it is internalized in the mouse
oocyte. In an attempt to determine whether GPR3 accumulates at the cell surface as a
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result of endocytic inhibition, we expressed GPR3-RFP in the oocyte and treated with
MDC or dynasore. We did not see any noticeable accumulation of GPR3 at the cell
surface; therefore, we cannot correlate the increase in cAMP production in response to
dynasore to increased GPR3 at the cell surface.
Next, we examined whether GPR3 activity and internalization can be regulated by
components of the desensitization pathway, GRKDQGȕ-arrestin-2. We found that
GRKDQGȕ-arrestin-2 overexpression stimulated meiotic resumption in a small number
of oocytes, suggesting that these proteins can interact with GPR3 but likely do not play a
major role in regulating GPR3 activity and endocytosis. However, in this experiment the
level of cAMP was not measured. It is possible that GRKDQGȕ-arrestin-2
overexpression decreases cAMP levels in the oocyte, but not to the extent where it would
cause maturation. Because cAMP levels need to remain high for meiotic arrest, it is
probable that whatever mechanism is regulating GPR3 activity acts to prevent excessive
cAMP accumulation rather than to completely abolish cAMP production. Otherwise, the
oocyte would resume meiosis. In summary, from these studies we conclude that
endocytosis is an active process in mouse oocytes and is a regulator of meiotic arrest.
These results are consistent with the hypothesis that GPR3-cAMP signaling at the cell
surface, and not from endosomes, is necessary for maintaining meiotic arrest.

U

Future Studies
There are still many unanswered questions about GPR3 signaling as well as

general questions about membrane trafficking in the mouse oocyte. We present evidence
that GPR3 does not signal from endosomes, at least not to the extent required for meiotic
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DUUHVWEXWDUHWKHUHDQ\RWKHUPHPEUDQHVWKDW*35FDQVLJQDOIURP"%HFDXVHȕ 2 -AR
R

R

receptor has been shown to preassemble with G s and adenylate cyclase on the ER/Golgi
R

R

(Dupre et al., 2007; Dupre et al., 2006), it presents the possibility that GPCRs can signal
during the biosynthetic pathway prior to plasma membrane insertion and does not need to
be present at the cell surface to mediate cAMP production. The general mechanisms of
endocytosis and exocytosis in the mouse oocyte are also poorly understood and warrant
further investigation.

When is GPR3 expressed during meiosis?
Little is known about when GPR3 expression is turned on during follicle
development and how this occurs. We know that GPR3 needs to be expressed prior to
the acquisition of meiotic competence, which occurs around the time of antrum
IRUPDWLRQ%DVHGRQ*Į s localization, GPR3 is fully active in preantral follicles (120R

R

190 μm diameter) (Freudzon et al., 2005). Using in situ hybridization, it was also
demonstrated that Gpr3 is expressed in the oocyte during different stages of
development; however, the stages were not defined in this study (Hinckley et al., 2005).
Thus, it is not known if GPR3 is expressed and active in earlier stage follicles. As
mentioned previously, Gpr3-deficient mice displayed increased rates of oocyte
degeneration and reduced litter size (Ledent et al., 2005; Vaccari et al., 2008). This
phenotype could be the result of premature maturation. However, this phenotype could
also be the result of decreased developmental and meiotic competence of oocytes.
Interestingly, cAMP has been shown to be important for the acquisition of meiotic
competence (Chesnel et al., 1994; Eppig et al., 2004b), presenting the possibility that
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GPR3 and cAMP production are important during earlier stages of folliculogenesis. It is
also not known if GPR3 is active following GVBD and if it is needed for early
development. Gpr3 mRNA is present in eggs and early embryos at the one and two cell
stage, but whether the protein is expressed is unknown. Trace amounts of Gpr3 mRNA
is detected in morulae and it is absent in blastocysts (Ledent et al., 2005), suggesting that
GPR3 is not needed following the 8-cell stage. Thus, further studies are needed to
determine whether GPR3 is expressed before and after prophase I arrest and how this
expression might be regulated.

Does GPR3 signal during exocytosis?
The colocalization of GPR3 with early endosomes demonstrates that GPR3 is
actively endocytosed in the oocyte and is not stably present at the cell surface. Delivery
of GPCRs to the cell surface occurs by exocytosis regardless of whether GPCRs are
recycled following internalization or newly synthesized. Based on the original
hypothesis, if GPR3 signals from the cell surface, then preventing exocytosis should
decrease the amount of receptor at the cell surface, decrease cAMP levels, and stimulate
meiotic resumption. Alternatively, it is possible that GPR3 can signal from vesicles prior
to exocytosis because it is constitutively active and may not need to be at the plasma
membrane to activate G s . To test whether GPR3 can signal prior to membrane insertion,
R

R

we injected antral follicle-enclosed oocytes with mRNA encoding dominant negative
61$3 61$3ǻ WRSUHYHQWH[RF\WRVLV7KHIROOLFOH-enclosed oocytes injected
ZLWKWKH61$3ǻXQGHUZHQW*9%'GXULQJWKHFXOWXUHSHULRGZKHUHDVthe
uninjected or the SNAP25 WT-injected follicle-enclosed oocytes remained GV intact
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(Figure 4.1). Whether the effect on stimulating maturation is due to decreased GPR3 at
the cell surface and decreased cAMP levels is not currently understood. It is likely that
inhibiting exocytosis would prevent other proteins required for meiotic arrest from
inserting into the membrane, such as adenylate cyclase or gap junction proteins.
Nevertheless, this finding demonstrates the importance of membrane trafficking in
maintaining meiotic arrest in the mouse oocyte. Additional studies could examine
whether GPR3 can signal during exocytosis prior to membrane insertion using
mutagenesis to create a GPR3 mutant that exhibits impaired cell surface trafficking and
increased ER retention. Using EIA or FRET assays, the effect of this mutant on cAMP
levels can be measured.

What proteins are involved in exocytosis?
Although our interest in this project is to understand GPR3 signaling, during the
course of these experiments we realized that there is a lack of understanding about the
mechanism of exocytosis in the oocyte. The mammalian oocyte, like all cells, requires
constitutive exocytosis to maintain appropriate proteins and lipids at the cell surface. In
addition, the oocyte secretes specific paracrine factors such as growth differentiation
factor 9 (GDF9), bone morphogenetic protein 15 (BMP15), and fibroblast growth factor
8B (FGF8B) that are essential for follicle development, cumulus cell metabolism,
expansion, and ovulation (Dong et al., 1996; Elvin et al., 1999; Sugiura et al., 2007; Yan
et al., 2001). These paracrine factors are also important for the oocyte because they
promote the expression of genes in cumulus cells that compensate for processes deficient
in oocytes including the ability to transport certain amino acids, glycolysis, and
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cholesterol synthesis (Su et al., 2009). During maturation, the oocyte transitions to a cell
primed to undergo regulated, Ca 2+ -dependent exocytosis of cortical granules. Cortical
P

P

granules are located in the cortex of mature eggs of many species and are released in
response to a rise in intracellular Ca 2+ upon fertilization (Kline, 1988; Kline and Kline,
P

P

1992; Zucker and Steinhardt, 1978). Cortical granules contain proteoglycans and
enzymes that permanently modify the extracellular surface of the egg to prevent
polyspermy (Wessel et al., 2001). In sea urchin eggs, cortical granule exocytosis is
associated with components of exocytic machinery including SNARE proteins, munc18,
rab3, and synaptotagmin 1 (Conner et al., 1997; Conner and Wessel, 1998; Leguia et al.,
2006; Leguia and Wessel, 2004). Similar studies in mammalian oocytes are currently
lacking.
In preliminary experiments, SNARE proteins in the mouse oocyte were identified
by RT-PCR. The oocyte expresses syntaxin1, syntaxin4, vamp3, vamp4, snap23, snap25,
synaptotagmin5, synaptotagmin9, and low amounts of synaptotagmin1. Although
SNAP25 is involved in Ca 2+ dependent exocytosis, we did not detect protein expression
P

P

in oocytes or eggs. We did find that the oocyte abundantly expresses SNAP23 protein
(unpublished data), a non-neuronal isoform of SNAP25 that is involved in both
constitutive and regulated exocytosis (Hepp et al., 2005; Ravichandran et al., 1996; Suh
et al., 2010; Suh et al., 2011). The finding that SNAP25 is not expressed is in contrast to
a published report of SNAP25 being essential for cortical granule exocytosis in the
mouse egg (Ikebuchi et al., 1998).
It is also possible that the oocyte utilizes a novel SNARE protein that has yet to be
identified. To identify novel SNARES, we performed RT-PCR using degenerate primers
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designed against a coiled coil domain, a characteristic motif of SNARE proteins. This
PCR amplified a product identified as TXLNG (taxilin gamma) from oocyte cDNA
(unpublished data). Taxilin has been shown to interact with syntaxin and be involved in
Ca 2+ dependent exocytosis in neuroendocrine cells (Nogami et al., 2003). In addition to
P

P

taxilin, SNAP23 and SNAP25 were identified from this PCR. Further studies are needed
to determine the functional consequence of inhibiting SNAP23 and taxilin on follicle
development, meiosis, ovulation, and cortical granule exocytosis.

Membrane transport ceases after meiotic resumption. Is this process regulated and what
is its importance?
Using EEA1 immunofluorescence, we found that early endosomes disappear
following milrinone washout and GVBD. The number of early endosomes appears to be
lower in MII-arrested eggs than in oocytes and they are less concentrated in the cortex
(Figure 4.2A). Also, it appears that exocytosis stops during maturation. When GPR3RFP mRNA is microinjected into oocytes undergoing meiotic resumption, it does not
localize to the plasma membrane as it does in prophase I-arrested oocytes, indicating that
insertion of plasma membrane proteins is inhibited (Figure 4.2B). It is not surprising that
membrane transport stops during oocyte maturation because there is dramatic
reorganization of the ER and other cytoplasmic structures. In Xenopus oocytes,
membrane traffic to the surface is blocked during transition to MII and is associated with
the disappearance of the Golgi apparatus (Colman et al., 1985). Also, because
endocytosis and exocytosis are indirectly coupled processes, it is expected that if one
process stops, so does the other.
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It has been hypothesized that membrane trafficking stops during maturation in
order to stock membranes for rapid cleavages that occur during early development
(Gilbert, 1988; Singal and Sanders, 1974). Two other thoughts that may explain why
membrane transport stops are (1) all secretory vesicles are directed into a calciumdependent regulated pathway in preparation for cortical granule exocytosis at fertilization
(Roberts et al., 1992); and (2) membrane transport ceases in preparation for the large
retrieval of membrane (compensatory endocytosis) that occurs following cortical granule
exocytosis. In support of this idea, the SNARE complex (VAMP1, Syntaxin 2, SNAP23,
and complexin) and clathrin relocalize under the oocyte plasma membrane during
maturation in porcine oocytes (Tsai et al., 2010). Following fertilization, the proteins are
released into the cytoplasm and there is compensatory endocytosis of VAMP1. The
docking of this complex during maturation inhibits membrane trafficking until
fertilization in order to prevent premature cortical granule exocytosis. Proteins involved
in other endocytic pathways do not relocalize during maturation, suggesting that clathrinmediated endocytosis is important for compensatory endocytosis (Tsai et al., 2010).
Further studies are needed to examine why membrane trafficking stops in mammalian
oocytes and how this process is regulated.

U

Regulation of Constitutive GPR3 Signaling and Surface Localization by Residues in the

Third Intracellular Loop and C-terminus
Because we were not able to correlate inhibition of endocytosis and an increase in
cAMP with GPR3 localization in the oocyte, we extended our studies to cultured
HEK293 cells. Using confocal microscopy and biotinylation of cell surface proteins, we
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found that inhibiting endocytosis using Dyn1 K44A increased the amount of GPR3 at the
plasma membrane. Inhibition of endocytosis also significantly increased cAMP levels as
measured by EIA and FRET. The next question that we addressed was whether GPR3
activity and internalization is regulated by a GRKDQGȕ-arrestin-dependent mechanism.
Using the same methods stated above, we found that overexpression of GRKDQGȕarrestin-2 decreased the amount of GPR3 at the cell surface as well as cAMP levels.
From these results, we conclude that GPR3 signals at the plasma membrane and is
actively internalized but does not continue to produce cAMP following internalization.
Whether GPR3 is targeted for desensitization by GRKDQGȕ-arrestin 2 under
physiological conditions and whether it is internalized by other pathways remains
unknown. In addition, studies on the TSH receptor in thyroid follicles demonstrate that
endosomal signaling and membrane signaling have different consequences on the cell.
Thus, it is possible that GPR3 signals from endosomal compartments, but it may be
required for a different signaling outcome other than cAMP production.
We also examined whether potential phosphorylation sites in the third
intracellular loop and C-terminus regulate GPR3 activity. GPR3 contains two potential
sites for phosphorylation by protein kinase C (PKC) and several serine residues that
could be targets for GRKs. We mutated all six serines in the C-terminus and the serine
and threonine residues in the third intracellular loop to alanine. We found that mutation
of the serine and threonine residues in the third intracellular loop (ST/A) led to
significantly higher cAMP levels compared to GPR3 WT. This result indicates that these
residues are important for GPR3 regulation, although this regulation is independent of
GRKDQGȕ-arrestin or PKC. Mutation of serines in the C-terminus did not have an
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effect on cAMP levels. However, the S1-6A mutant exhibited lower levels of cell surface
expression, suggesting that these residues are involved in GPR3 trafficking and that
GPR3 localization at the plasma membrane is not a requirement for cAMP production. It
is possible that that GPR3 can signal from other membranes prior to membrane insertion,
as mentioned above. Interestingly, we also found that the kinase activity of GRK2 is not
required to diminish cAMP signaling. This raises the question of whether GPR3 is
SKRVSKRU\ODWHGDQGZKDWPHGLDWHVȕ-arrestin recruitment, if at all.

U

Future Studies
Many unanswered questions remain regarding the regulation of GPR3 activity.

We know that the serine residues in the C-terminus are not involved in GPR3 activity,
whereas the serine and/or threonine residues in the third intracellular loop are. Whether
these residues in the third intracellular loop are targeted by some pathway to regulate
GPR3 activity is unknown. It is possible that these residues are sites for phosphorylation
by other GRK isoforms or kinases. It is also possible that they interact with a GIP or are
involved in maintaining structural properties of GPR3. Additionally, we present
evidence that PKC can regulate cAMP production by GPR3, but how this occurs is not
understood. Further studies are needed to determine whether GPR3 is phosphorylated,
contains regulatory elements in the C-terminus that interact with GIPs, and what the role
RIȕ-arrestin is in regulating GPR3 activity and internalization. It should also be
mentioned that GPR3 may behave differently in HEK293 cells than in oocytes, although
it is our hope that understanding GPR3 activity in HEK293 cells will be important for
future experiments in oocytes.
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Is GPR3 phosphorylated?
Almost all GPCRs are regulated by phosphorylation, a key process in regulating
cellular distribution and signaling properties (Carman and Benovic, 1998; Lefkowitz and
Whalen, 2004). GPCRs can be phosphorylated by several types of kinases that recognize
distinct sites on the C-terminus and intracellular loops. We have shown that the serine
residues in the C-terminus do not change cAMP production when mutated and are
therefore not likely to be sites for phosphorylation-mediated desensitization, but they
appear to be involved in membrane expression of GPR3. Perhaps phosphorylation of
these sites is required for trafficking of GPR3 to the cell surface. The serine and
threonine residues in the third intracellular loop could be phosphorylation sites involved
in desensitization because mutation of these residues increases cAMP levels. The serine
and threonine residues in the second intracellular loop have not been examined. It is
likely that GPR3 is not phosphorylated by GRK2 because the kinase inactive GRK2
mutant is able to decrease cAMP production. However, it remains to be explored
whether GPR3 is phosphorylated by other GRK isoforms or by other kinases.
Phosphorylation of GPCRs can be detected using several methods, including ProQ
Diamond Phosphorylation Gel Stain (Invitrogen), metabolic labeling of cells with [ 32 P]
P

P

orthophosphate and autoradiography, or mass spectrometry. Mass spectrometry can also
be used to examine whether GPR3 undergoes other modifications such as glycosylation,
palmitoylation, acetylation, ubiquitinylation, and myristoylation, which have been shown
to regulate GPCR activity (Millar and Newton, 2010). GPR3 contains a potential Nlinked glycosylation site and a lysine residue in the C-terminus that could be targeted for
ubiquitinylation.
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How does PKC Regulate GPR3 Activity?
The finding that PKC can regulate GPR3 activity in HEK293 cells suggested that
the threonine residue in the third intracellular loop, a potential PKC site, could be
targeted by PKC for phosphorylation. Indeed, mutation of the threonine by itself is
sufficient to increase cAMP production compared to GPR3 WT (Figure 4.3). However,
we found that the activity of the ST/A mutant, which presumably cannot be
phosphorylated, can be modified by pharmacological manipulation of PKC similar to
GPR3 WT. Therefore, the threonine or the serine residues in the third intracellular loop
are not targeted by PKC. Further studies are required to determine whether PKC
regulates GPR3 activity in other cell types and how this regulation occurs. PKC could
directly phosphorylate GPR3 to silence cAMP production. Alternatively, PKC action
could be indirect and it could phosphorylate a GIP that would then modulate GPR3
activity. In addition, it remains unknown how PKC is activated in HEK293 cells
transfected with GPR3. PKC is activated by the phospholipase C (PLC) signaling
cascade in which PLC cleaves PIP 2 into IP 3 and diacylglycerol. Depending on the
R

R

R

R

isoform, PKC is activated by a combination of Ca 2+ and/or DAG, and phospholipid
P

P

phosphatidylserine, whereas atypical PKC isoforms require neither Ca 2+ or DAG (Webb
P

P

et al., 2000)3KRVSKROLSDVH&LVDFWLYDWHGPDLQO\WKURXJK*Į q/11 signaling but can also
R

R

be activated by G ȕȖ (Boyer et al., 1992). There is currently no evidence that GPR3
R

R

VLJQDOVWKURXJK*Į q/11 or activates atypical PKC isoforms. It is also not known if the G ȕȖ
R

R

R

subunit mediates downstream signaling events, such as PKC activation.

What is thHUROHRIȕ-arrestin in GPR3 regulation?
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R

ȕ-arrestin coordinates GPCR activity in several ways, including desensitization,
internalization and trafficking, and mediating G protein-independent signaling. It is not
clear if arrestin is involved in regulating any of these pathways for GPR3. For some
*3&5VRYHUH[SUHVVLRQRIȕ-arrestin can terminate G-protein signaling, but it is not
absolutely required for internalization (Fraile-Ramos et al., 2003; Paing et al., 2002).
7KXVWKHFRQWULEXWLRQRIȕ-arrestin to GPR3 activity and internalization warrants further
investigation. The serine-rich cluster in the C-terminus of GPR3 classifies it as a Class B
receptor (Class A and B are defined by the absence or presence of a Ser-Thr rich cluster,
respectively). Class A receptors are rapidly recycled followed internalization whereas
&ODVV%UHFHSWRUVJHQHUDOO\IRUPVWDEOHFRPSOH[HVZLWKȕ-arrestins and are internalized
together, at which point they are either slowly recycled or degraded (Oakley et al., 2001).
We found that mutation of these serines (S1-6A mutant) decreased surface expression of
the mutant. ,IWKHVHVLWHVDUHLPSRUWDQWIRULQWHUDFWLQJZLWKȕ-arrestin for slow recycling
or degradation, we would expect that the mutant would have increased expression at the
cell surface. Thus, further studies are needed to determine how the serine residues in the
C-terminus are involved in membrane expression of GPR3 and whether they are involved
in post-endocytic events mediated by ȕ-arrestin.
It should also be mentioned that phosphorylation is not an absolute requirement
IRUȕ-arrestin recruitment. ȕ-arrestin maintains multiple interactions with GPCRs such
that it can recognize the active state separately from the phosphorylated state. In the
DEVHQFHRISKRVSKRU\ODWLRQWKHDIILQLW\RIȕ-arrestin may be reduced, but perhaps not to
the extent where it would completely prevent binding (Tobin, 2008). The presence of
negatively charged residues can act as “phospho-PLPHWLFV´IRUȕ-arrestin recruitment
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(Galliera et al., 2004; Mukherjee et al., 2002). GPR3 does not contain any acidic amino
acid clusters in the C-terminus or intracellular loops, but does have two aspartic acid
residues in the C-terminus (amino acid #303 and #329) and a glutamic acid residue in the
second intracellular loop (amino acid #147). Even if GPR3 is not phosphorylated, it is
VWLOOSRVVLEOHWKDWȕ-arrestins are involved in regulating its activity and internalization. A
useful approach to determine whether WKHDEVHQFHRIȕ-arrestin changes GPR3 trafficking
or signaling is to use embryonic fibroblasts derived froPȕ-arrestin1/2 knockout mice.

Does GPR3 contain regulatory regions within its C-terminus?
In addition to sites for phosphorylation and arrestin binding, the C-termini of
many GPCRs contain motifs that mediate internalization and association with other
regulatory proteins. The most understood sorting signals for cargo-selective clathrin
adaptors are dileucine- and tyrosine-based motifs. GPR3 contains an NPXY tyrosinebased motif that is located in the seventh transmembrane domain next to the C-terminus.
,WLVQRWNQRZQLIWKLVPRWLILVLQYROYHGLQ*35LQWHUQDOL]DWLRQRULILWFRRSHUDWHVZLWKȕarrestin-mediated internalization (as described in Chapter 1). It would be interesting to
mutate this motif and examine the effect on GPR3 internalization and activity. Also,
several GIPs are known to associate with specific sequences in the C-terminus. Of the
consensus sequences established for GIPs, none are found in the C-terminus of GPR3;
however, GPR3 contains sequences that may correspond to potential PDZ ligands (named
after the first three proteins identified to share the domain; post synaptic density protein
(PSD95), Drosophila disc large tumor suppressor (Dlg1), and zonula occludens-1 protein
(zo-1) (Figure 4.4A). Many GPCRs express a PDZ ligand that corresponds to the last 3
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or 4 amino acids at the extreme end of the C-terminus and binds to proteins containing
PDZ domains. These proteins are involved in signaling specificity, spatial organization
and receptor trafficking and targeting (Bockaert et al., 2003). The C-terminus of GPR3
may also contain a sequence that either mediates internalization or interaction with a
regulatory protein that has yet to be identified.
To determine whether the C-terminus of GPR3 is important for localization
and/or activity, we constructed a truncated GPR3 mutant in which the last 15 amino acids
were deleted by insertion of a stop codon (Figure 4.4B). We found that the truncated
mutant produced significantly less cAMP compared to the full length wild-type receptor
(Figure 4.4C). This result suggests that this region of the C-terminus is important for
GPR3 activity. We know that the reduced cAMP level produced by truncated GPR3 is
not due to deletion of the serine residues. Additionally, if this sequence was important
for binding of a protein(s) involved in internalization or diminishing cAMP production, it
is expected that cAMP mediated by this mutant would increase, not decrease. There are
several explanations that could explain why truncated GPR3 produces less cAMP
compared to the WT. (1) GPR3 could bind to trafficking proteins such as NHERF, a
PDZ-domain-containing protein that accelerates rHF\FOLQJRIȕ-$5DQGț-opoid
receptors (Cao et al., 1999). If truncation of GPR3 prevents or slows recycling to the
membrane, it is expected that cAMP levels would decrease. (2) GPR3 could bind to a
protein that promotes G protein-mediated signaling, and in the absence of this interaction,
cAMP levels decrease. (3) An export motif required for proper membrane expression of
GPR3 could be present in this region of the C-terminus. Several reports have
demonstrated that a dibasic motif in the C-terminus is required for cell surface expression
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and function of the rat melanin-concentrating hormone receptor 1 and CCR5 (Tetsuka et
al., 2004; Venkatesan et al., 2001). GPR3 contains a “RSR” dibasic motif at amino acids
#323-325 that is deleted in the truncated mutant (underlined in Figure 4.4B).
Interestingly, the dibasic motif is conserved in many Class A (Rhodopsin family) GPCRs
and may have functional importance. It has also been reported that a cysteine cluster in
the C-terminus cooperates with the dibasic motif for optimal cell surface expression
(Venkatesan et al., 2001). GPR3 contains a cysteine cluster in the C-terminus at amino
acids #312-315 (underlined in Figure 4.4B). It would be interesting to examine whether
deleting both motifs has a more dramatic effect on lowering cAMP levels and surface
expression. Thus, further experiments are needed to determine whether truncating GPR3
reduces its membrane localization and interferes with intracellular trafficking. If we
found that truncated GPR3 has lower membrane localization, this finding would need to
be reconciled with the S1-6A mutant that has lower membrane expression but cAMP
production is unaffected. Perhaps the truncated mutant and the S1-6A mutant exhibit
impaired trafficking and are localized at different sites within the cell. Additionally, the
importance of other residues in the C-terminus cannot be excluded, as the truncated
GPR3 mutant only deleted the last 15 amino acids. It is possible that there are other
regions within the C-terminus that are also important for GPR3 activity and trafficking.
This could be determined by serial truncations of additional residues in the entire Cterminus.

Does GPR3 interact with other G-protein interacting proteins (GIPs)?
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The association of GIPs is emerging as a major mechanism contributing to the
functioning of GPCRs. There have been more than 50 GIPs identified that are membrane
or intracellular proteins and can regulate GPCR signaling, cytoskeletal and extracellular
matrix interactions, receptor internalization, and trafficking (reviewed in (Magalhaes et
al., 2012). For examples, proteins including ATRAP, phospholipase D2, Ral, NHERF,
Nm23-H2, Rab5, calcyon, Filamin-A, PSD-95 and GASP interact with GPCRs and
influence endocytosis and post-endocytic trafficking whereas proteins such as calmodulin
and RGS proteins interact with GPCRs to attenuate GPCR signaling independently of
phosphorylation (Ferguson, 2007a). Additionally, GPCRs can undergo homo- or heterooligomerization, a process that can modify signaling and activate other receptors (Ferre et
al., 2009; Millar and Newton, 2010). Thus, it is possible that GPR3 associates with
UHJXODWRU\SURWHLQVRWKHUWKDQ*5.VDQGȕ-arrestins. In preliminary experiments, RGS2
was identified as a potential regulatory protein for GPR3 because the oocyte abundantly
expresses RGS2 mRNA. However, over expression or RNAi-mediated knock down of
RGS2 did not affect oocyte maturation (unpublished data). Whether RGS2
overexpression or knockdown had any effect on cAMP levels was not examined. It is
also possible that GPR3 may interact with novel proteins that have yet to be
characterized. There are several approaches commonly used for identifying GPCRassociated proteins including yeast two-hybrid and co-immunoprecipitation followed by
mass spectrometry.
In summary, GPR3 is a constitutively active GPCR that mediates sustained cAMP
production required for meiotic arrest and neurological processes. How GPR3 and other
constitutively active GPCRs are regulated is an area of research that has been largely
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unexplored. The projects described in this dissertation have started our understanding of
where GPR3 signals in the oocyte and HEK293 cells as well as potential mechanisms that
could regulate its localization and activity. It is well established that GPCR signaling and
trafficking are highly flexible processes that depend on the cellular context. At the same
time, GPCR signaling is also very specific, such that the same GPCR can elicit different
signaling responses and that multiple GPCRs can activate the same G protein. It might
be surprising that GRKs DQGȕ-arrestins regulate such diverse processes; however, it
should be appreciated that the contribution of each individual GRK and arrestin subtype,
the affinity with which arrestin binds, and the pattern of GPCR phosphorylation can
contribute to differential regulation of GPCRs by these common proteins. Further fine
tuning of GPCR activity can be achieved by additional receptor-interacting proteins that
are expressed differentially across cell types and are emerging as a major mechanism
regulating GPCR activity. It will be interesting to see how GPR3 activity and regulation
may differ from other constitutively active receptors and how that might be
physiologically important. Additionally, the oocyte is a unique cell itself and may utilize
novel mechanisms for regulating GPCR activity.
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Figure 4.1

Figure 4.1. Inhibition of exocytosis stimulates spontaneous meiotic resumption. Antral
follicle-enclosed oocytes were microinjected with ~11 pg of mRNA encoding
SNAP25WT or 61$3ǻDQGFXOWXUHG for 18-20 hours on Millicell membranes. The
oocytes were removed from the follicle and assessed for meiotic status based on the
presence or absence of a GV. A) Confocal images of an uninjected oocyte and oocyte
injected with SNAP25WT mRNA which were GV-intact upon isolation. Oocytes
LQMHFWHGZLWK61$3ǻP51$XQGHUZHQW*9%'B) Percentage of oocytes that
underwent GVBD within the culture period. The total number of oocytes evaluated is
indicated by the number above each bar. C) Western blot using an anti-SNAP25
antiERG\FRQILUPLQJSURWHLQH[SUHVVLRQRI61$3:7DQGǻ
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Figure 4.2

Figure 4.2. Membrane trafficking stops during oocyte maturation. A) Oocytes and in
vitro matured eggs were fixed and labeled with an antibody specific for the early
endosome marker, EEA1. B) Oocytes arrested at prophase I and oocytes undergoing in
vitro maturation were microinjected with ~ 5 pg of GPR3-RFP mRNA and examined
with a confocal microscope the next day.
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Figure 4.3

Figure 4.3. Mutation of the threonine residue in the third intracellular loop of GPR3
increases cAMP production. HEK293 cells were transfected with GPR3 WT or with
mutated GPR3 and 24 hrs later the cells were harvested in 0.1 M HCl. cAMP levels were
measured by EIA. Results are presented as mean ± SEM of 7 different experiments. (*)
indicates a cAMP value that is significantly different compared to WT. Significance was
determined by a paired Student’s T-test (P<0.001).
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Figure 4.4

Figure 4.4. C-terminal truncation of GPR3 decreases cAMP production. A) Schematic
illustrating the amino acid sequence of the C-terminus of GPR3that may contain potential
PDZ ligands. Highlighted amino acids correspond to potential PDZ ligands and are
DUUDQJHGE\FODVVZKHUHĭDQGȌDUHK\GURSKRELFDQGDFLGLFUHVLGXHVUHVSHFWLYHO\B)
A truncated GPR3 mutant in which the last 15 amino acids are deleted was made by
mutating the serine at amino acid 316 (indicated by arrow) to a stop codon. Cysteine
cluster and dibasic amino acid motifs are underlined. C) HEK293 cells were transfected
with GPR3 WT or with the truncated GPR3 and 24 hrs later the cells were harvested in
0.1 M HCl. cAMP levels were measured by EIA. Results are presented as mean ± SEM
of 5 different experiments. (*) indicates a cAMP value that is significantly decreased
compared to WT. Significance was determined by a paired Student’s T-test (P<0.001).

112

APPENDIX
U

U

A.1. Methods for Chapter 4

Media and reagents
Except where noted, all chemicals were obtained from Sigma Chemical Co. The

PHGLXPXVHGWRFROOHFWLVRODWHGRRF\WHVZDV0(0Į ,QYLWURJHQ VXSSOHPHQWHGZLWK
P0+(3(6ȝJPOSHQLFLOOLQ*ȝJPOVWUHSWRP\FLQSRO\YLQ\ODOFRKRO
DQGȝ0PLOULQone to inhibit spontaneous meiotic resumption. For extended culture,
oocytes were placed in bicarbonate-EXIIHUHG0(0ĮDVDERYHLQZKLFKWKH+(3(6ZDV
UHSODFHGZLWKP0VRGLXPELFDUERQDWHDQGSRO\YLQ\ODOFRKROZDVUHSODFHGZLWK
fetal bovine serum (#12000-022, Invitrogen). The medium used to collect and culture
follicle-HQFORVHGRRF\WHVZDV0(0ĮVXSSOHPHQWHGZLWKȝJPOSHQLFLOOLQ*ȝJPO
streptomycin, and 5% fetal bovine serum.
Mouse GPR3-RFP was provided by Y Saeki (Ohio State University) in pHGCY.
61$3:7DQGǻZHUHSURYLGHGE\K Machaca (Weill Cornell Medical College) in
pcDNA3. mRNA was transcribed in vitro using the Superscript III kit from Invitrogen.
Human GPR3 in pCMV6-AC-HA-His (GPR3-HA) was purchased from Origene
(Rockville, MD).

U

Mouse oocyte and follicle isolation and culture
All experiments were done with prior approval of the Animal Care and Use

Committee at the University of Connecticut Health Center. Fully grown, GV-stage
mouse oocytes were obtained from the ovaries of 6- to 12-week old CF-1 mice (Harlan
Sprague–'DZOH\,QGLDQDSROLV,186$ WKDWKDGEHHQSULPHGZLWK,8H&* 6LJPD
or Calbiochem) 40–KSULRUWRFROOHFWLRQ&XPXOXVFHOOVZHUHUHPRYHGE\UHSHDWHG
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pipetting through a small-bore pipette. Oocytes were FXOWXUHGLQȝOGURSVRIPHGLXP
XQGHUOLJKWPLQHUDORLORQDZDUPLQJWUD\VHWWR& ZKHQLQ+(3(6-buffered
medium). Metaphase II-stage oocytes were collected from the ampullae of the oviduct
from mice that were superovulated with 10 IU eCG, followed by 10 IU human chorionic
gonadotropin 44–48 h later. Oocytes were collected in Hepes-EXIIHUHG0(0ĮDQG
cumulus cells were removed using 0.3 mg/ml hyaluronidase (type IV-S). Oocytes and
eggs were cultured overnight in bicarbonate-buffered medium in a humidified
DWPRVSKHUHDW&ZLWK&2 2 and 95% air.
R

R

$QWUDOIROOLFOHV ȝPLQGLDPHWHU ZHUHGLVVHFWHGIURPWKHRYDULHVRI- to
25-day old B6SJL/F1 mice (Jackson Laboratories) as described previously (Jaffe et al.,
2009). Following isolation, follicles were placed on Millicell culture plate inserts
(PICMORG50, Millipore, Billerica, MA, USA) and cultured in a humidified atmosphere
DW&ZLWK&2 2 DQGDLU$IWHUDKFXOWXUHSHULRGIROOLFOH-enclosed oocytes
R

R

were examined under an upright microscope for the presence of a GV. Only follicles
containing oocytes with readily visible GVs were selected for use in these experiments.

U

Microinjection
Microinjection of isolated and follicle-enclosed oocytes was carried out as

described previously (Jaffe et al., 2009; Kline, 2009). For isolated oocytes, oocytes were
placed in HEPES-EXIIHUHG0(0ĮIRUPLFURLQMHFWLRQ)RURYHUQLJKWFXOWXUHRRF\WHV
were incubated in bicarbonate-EXIIHUHG0(0ĮFRQWDLQLQJPLOULQRQH)ROOLFOHVZHUH
loaded into an injection chamber between two cover slips spaced ȝPDSDUW
Following microinjection, follicles were placed on Millicell membranes and incubated
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for 17–KWKHRRF\WHVZHUHUHPRYHGDQGH[DPLQHGIRUWKHLUPHLRWLFVWDWXVE\WKH
presence or absence of a GV, assessed using a stereoscope. Quantitative microinjection
was carried out using pipettes backfilled with mercury and concentrations of injected
VXEVWDQFHVZHUHFDOFXODWHGEDVHGRQDQRRF\WHYROXPHRISO,QH[SHULPHQWVZKHUH
oocytes were microinjected during maturation, the oocytes were washed out of milrinone
and injected 2-3 hours after GVBD.

U

Immunoblotting
For Western blots, oocyte samples were made by washing oocytes in PBS

containing 0.1% polyvinyl alcohol (PVA) to remove serum. Oocytes were transferred to
microcentrifuge tubes, gently pelleted, and excess culture medium was removed. Oocytes
ZHUHIUR]HQLQOLTXLGQLWURJHQDQGVWRUHGDWí&XQWLOXVH:HVWHUQEORWWLQJZDV
performed as described previously (Mehlmann et al., 1998). Primary and secondary
antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). AntiSNAP 25 was diluted 1:200 in blocking buffer and secondary anti-mouse antibody was
diluted 1:5000 in blocking buffer. Blots were developed using ECL Plus reagents
(Amersham).

U

EEA1 Immunofluorescence
2RF\WHVZHUHIL[HGIRUKLQIRUPDOGHK\GHLQP0+(3(6P0

(*7$P00J62 4 , and 0.2% Triton X-DW&$IWHUIL[DWLRQRRF\WHVZHUH
R

R

incubated in blocking buffer (PBS containing 0.01% Triton X-100, 0.1% PVA, and 3%
BSA), then in anti-EEA1 antibody (Cell Signaling Technology , Danvers, MA)
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overnight, diluted 1:100 in blocking buffer, at room temperature. Oocytes were then
washed in blocking buffer, incubated in secondary antibody for 1 hr at room temperature,
and finally washed in PBS containing 0.1% PVA. The secondary antibody was Alexa
Fluor 488-conjugated anti-rabbit (Invitrogen). Oocytes were observed with a 40x, 1.2 NA
lens (C-Apochromat; Carl Zeiss MicroImaging, Inc., Thornwood, NY, USA) on a Zeiss
510 confocal microscope.

U

Mutagenesis
The C-terminus of GPR3 is 31 amino acids long. To determine whether the C-

terminus contains residues important for GPR3 signaling, we constructed a mutant in
which the last 15 amino acids were deleted. Amino acid at residue 316 was mutated to a
stop codon by point mutation (TGTÆTGA) using the QuikChange II site-directed
mutagenesis Kit (Agilent, Cedar Creek, TX) according to the manufacturer’s protocol.
HPLC purified primers were purchased from Sigma. Primers were 5’GGGCTGTCTGCTGCTGCTGATCCTCTTCCAAGATCCCC-TTCC-3’ and 3’CCCGACAGACGACGACGACTAGGAGAAGGTTCTAGGGGAAGG-5’.
Mutation of the threonine residue in the third intracellular loop to alanine was achieved
using the primers: 5’-CACTATGTGGCCGCACGCAAGGGCATT-3’ and 5’33T

U

AATGCCCTTGCGTGCGGCCACATAGTG -3’
33T

HEK293 cell culture, Transfection and EIA cAMP Measurement
U15TU

U15T

HEK 293 cells were cultured in Dulbecco's modified Eagle's (DMEM)/F-12
medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum
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(Invitrogen), 100 U/mL penicillin and 100 μg/mL streptomycin (Invitrogen) at 37 ͼ C in a
P

P

humidified 5% CO 2 /95% air incubator. Cells were plated at 400,000 cells per well in 6R

R

well dishes and were transiently transfected the next day with 1 μg of plasmid DNA
using 2.5 μl of Lipofectamine 2000 (Invitrogen) following the manufacturer's
recommendations.
Twenty-four hr after transfection, cells were counted and 400,000 cells were
washed with PBS and lysed in 225 μl of 0.1 M HCl. The cells were incubated in 0.1 M
HCl for 10 min at room temperature, sonicated, and stored at -80°C until the assay was
performed. Levels of intracellular cAMP were measured using the cAMP enzyme
immunoassay (EIA) kit, Direct (Sigma), using the non-acetylation EIA procedure.
Results are presented as pmol/mL cAMP.

U

Statistical Analysis
Tests of statistical significance were performed using GraphPad Prism Software.

Differences between groups were determined by Student t-test and significance was
assessed at P < 0.05.
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A.2. Maturation, Fertilization, and the Structure and Function of the Endoplasmic
Reticulum in Cryopreserved Mouse Oocytes
Abstract
Oocyte cryopreservation is a promising technology that could benefit women
undergoing assisted reproduction. Most studies examining the effects of cryopreservation
on fertilization and developmental competence have been done using metaphase II-stage
oocytes, while fewer studies have focused on freezing oocytes at the germinal vesicle
(GV) stage, followed by in vitro maturation. Herein, we examined the effects of vitrifying
GV-stage mouse oocytes on cytoplasmic structure and on the ability to undergo
cytoplasmic changes necessary for proper fertilization and early embryonic development.
We examined the endoplasmic reticulum (ER) as one indicator of cytoplasmic structure,
as well as the ability of oocytes to develop Ca 2+ release mechanisms following
P

P

vitrification and in vitro maturation. Vitrified GV-stage oocytes matured in culture to
metaphase II at a rate comparable to that of controls. These oocytes had the capacity to
release Ca 2+ following injection of inositol 1,4,5-trisphosphate, demonstrating that Ca 2+
P

P

P

P

release mechanisms developed during meiotic maturation. The ER remained intact during
the vitrification procedure as assessed using the lipophilic fluorescent dye DiI. However,
the reorganization of the ER that occurs during in vivo maturation was impaired in
oocytes that were vitrified before oocyte maturation. These results show that vitrification
of GV-stage oocytes does not affect nuclear maturation or the continuity of the ER, but
normal cytoplasmic maturation as assessed by the reorganization of the ER is disrupted.
Deficiencies in factors that are responsible for proper ER reorganization during oocyte
maturation could contribute to the low developmental potential previously reported in
vitrified in vitro-matured oocytes.
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Introduction
Infertility is a widespread problem, affecting approximately 5%–15% of the
population (Boivin et al., 2007). The most common form of assisted reproductive
technology is in vitro fertilization (IVF), in which metaphase II (MII)-stage oocytes are
obtained from women following hormonally induced ovarian stimulation and are
fertilized with sperm. A few of the resulting embryos are usually implanted right away,
but in many cases leftover embryos are frozen for later use.
Cryopreservation of embryos is a well-established technique that has been used
successfully for many years (Borini et al., 2008). However, this method can introduce
some practical and ethical issues, and the production of embryos requires that a woman
have a partner's or donor's sperm. Therefore, it is not a viable option for all infertile
women. For these reasons, it would be preferable to cryopreserve unfertilized eggs or
immature oocytes.
To date, attempts to produce high-quality embryos that develop to term following
freezing and thawing of MII-stage oocytes have had limited success (Gardner et al.,
2007; Gomes et al., 2008; Huang et al., 2008). Reasons for this may include low
permeability of the oocyte membrane to cryoprotectants, susceptibility of the meiotic
spindle to cooling (Huang et al., 2008; Huang et al., 2007; Larman et al., 2007a;
Sathananthan et al., 1988; Zenzes et al., 2001), and toxic effects of cryoprotectants that
affect various aspects of the oocyte's physiology (Gardner et al., 2007; Lane and Gardner,
2001; Larman et al., 2007a; Larman et al., 2006). The two main methods that have been
used for cryopreservation are slow freezing/thawing and ultrarapid freezing
(vitrification). While both methods can yield high oocyte survival and fertilization rates
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following cryopreservation (Carroll et al., 1993; Coticchio et al., 2007; Endoh et al.,
2007; Gomes et al., 2008; Huang et al., 2007; Lane and Gardner, 2001), direct
comparisons between slow and rapid freezing procedures have shown that vitrification is
likely to be the more promising method (Huang et al., 2007; Ko et al., 2008; Lane and
Gardner, 2001; Larman et al., 2007a; Larman et al., 2007b). Although survival and
fertilization rates of vitrified eggs have improved over the past several years, this
procedure has resulted in only 300–500 live births to date (Gardner et al., 2007; Jurema
and Nogueira, 2006; Suikkari and Soderstrom-Anttila, 2007), suggesting that
cryopreserved oocytes are compromised in other ways that do not affect survival and
fertilizability.
Alternatively, the ability to cryopreserve immature oocytes that are at the
germinal vesicle (GV) stage and then to mature them in vitro would represent a
significant advance that could assist more groups of women. The process of in vitro
oocyte maturation (IVM) has many advantages over current standard IVF protocols,
which necessitate injecting women with large doses of hormones that can have unwanted
adverse effects. With IVM, immature oocytes could be retrieved from the ovaries of
women without prior hormone injection or with lower doses of hormones. In recent
years, this procedure has improved and shows promise as a treatment for infertility
(Holzer et al., 2007; Jurema and Nogueira, 2006; Le Du et al., 2005; Mikkelsen, 2005;
Soderstrom-Anttila et al., 2005). Because GV-stage oocytes have not yet formed meiotic
spindles and their chromatin is decondensed within the nuclear envelope, they may be
less susceptible to freezing damage that would otherwise disrupt the spindle in an MIIstage oocyte. Therefore, the cryopreservation of GV-stage oocytes is an attractive
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alternative for freezing female gametes. Although studies have shown that bovine
oocytes frozen at the GV stage have lower survival rates and developmental competence
than oocytes frozen at the MII stage (Abe et al., 2005; Diez et al., 2005; Kubota et al.,
1998; Men et al., 2002; Otoi et al., 1995; Suzuki et al., 1996; Vieira et al., 2008), live
births have been obtained using this procedure (Abe et al., 2005; Diez et al., 2005; Suzuki
et al., 1996; Vieira et al., 2008; Vieira et al., 2002). Because the developmental
competence of both cryopreserved GV-stage and MII-stage bovine oocytes is
significantly lower than that of unfrozen controls, a more accurate comparison between
freezing GV-stage vs. MII-stage bovine oocytes might be made after the overall
cryopreservation procedure is improved.
There have been fewer studies examining the developmental competence in
human and mouse oocytes following cryopreservation and IVM. In the limited studies
that have been done in the mouse, it has been shown that GV-stage oocytes can be
successfully frozen and thawed (Aono et al., 2005; Aono et al., 2003; Eroglu et al.,
1998a), that they can subsequently mature in culture and form morphologically normal
spindles (Eroglu et al., 1998a), and that they can develop after fertilization and produce
live births (Aono et al., 2005; Aono et al., 2003). However, as in bovine oocytes, the
developmental competence in terms of blastocyst formation and live births is
approximately 50% lower than that of unfrozen controls (Aono et al., 2005; Aono et al.,
2003). Therefore, more studies need to be done to examine the cause of this lower
developmental competence. In addition, it is important to investigate other aspects of
oocyte cryopreservation on oocyte physiology, particularly on components that are
necessary for IVM. Defects in cytoplasmic structures and meiotic competence that arise
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due to cryopreservation could contribute to the low success rates following oocyte
freezing.
During maturation, the oocyte undergoes many cytoplasmic changes that prepare
it for successful fertilization and early embryonic development. One of these changes
involves the development of the ability of the mature oocyte to release Ca 2+ in response
P

P

to sperm penetration (Fujiwara et al., 1993; Jones et al., 1995; Mehlmann and Kline,
1994; Mehlmann et al., 1996). Ca 2+ release at fertilization is responsible for preventing
P

P

polyspermy and for stimulating the oocyte to complete meiosis and to begin early
development (Ducibella et al., 2006). An important component of the Ca 2+ release
P

P

system is the endoplasmic reticulum (ER), which is a continuous membranous network
throughout the egg that is the major site of Ca 2+ storage (Han and Nuccitelli, 1990; Kline
P

P

et al., 1999; Mehlmann et al., 1995; Shiraishi et al., 1995; Terasaki and Sardet, 1991).
The ER undergoes a dramatic change during oocyte maturation, such that clusters of ER
form in the mature oocyte's cortex, and this reorganization is thought to be associated
with the ability of the oocyte to release Ca 2+ at fertilization (FitzHarris et al., 2007;
P

P

Mehlmann and Kline, 1994). The objectives of this study were to examine the meiotic
competence of vitrified oocytes, the ability of oocytes to develop to the MII stage
following IVM, and the ability of immature oocytes to develop Ca 2+ release mechanisms
P

P

during oocyte maturation. We also used the structure of the ER as a cytoplasmic
indicator to show the effects of vitrification on the ability of the ER to reorganize
following IVM.
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Materials and Methods
Preparation and Culture of Gametes
All experiments were performed in accord with the Center for Laboratory Animal
Care at the University of Connecticut Health Center. Except where noted, all chemicals
were purchased from Sigma (St. Louis, MO).
CF1 mice (Harlan Sprague-Dawley, Indianapolis, IN) were used for all
experiments, and oocytes and sperm were collected as previously described (Kline,
2009). In brief, fully grown GV-stage oocytes were obtained from the ovaries of 6- to
10-wk-old female mice that had been primed 40–46 h earlier with 10 IU equine chorionic
gonadotropin (eCG). Cumulus cells were removed by repeated pipetting through a smallbore pipette. Oocytes were cultured in 200-ȝOGURSVRIPHGLXPXQGHUOLJKWPLQHUDORLO
(Fisher Scientific, Pittsburgh, PA) at 37°C. The collection medium was modified Eagle
PHGLXP 0(0 Į 1R–022; Invitrogen, Carlsbad, CA) supplemented with 20
P0+HSHVȝJPOSHQLFLOOLQ*ȝJPOVWUHSWRP\FLQVXOIDWHSRO\YLQ\O
DOFRKRODQGȝ0GLEXW\U\O GE F$03WRSUHYHQWVSRQWDQHRXVRRF\te maturation. To
initiate meiotic maturation, oocytes were washed into medium without dbcAMP. For
overnight cultures, oocytes were incubated in bicarbonate-EXIIHUHG0(0ĮLQZKLFK
mM sodium bicarbonate was substituted for the Hepes and 5% fetal bovine serum (FBS)
(Invitrogen) was substituted for the polyvinyl alcohol. Oocytes were assessed for the
meiotic stage (MII, GV breakdown (GVBD), or GV intact) after 18–20 h.
Metaphase II-stage oocytes were collected from the ampullae of the oviduct from
mice that were superovulated with 10 IU eCG, followed by 10 IU human chorionic
gonadotropin 44–48 h later. Oocytes were collected in Hepes-EXIIHUHG0(0ĮDQG
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cumulus cells were removed using 0.3 mg/ml hyaluronidase (type IV-S). Oocytes were
used on the same day they were collected.
6SHUPZHUHFROOHFWHGIURPWKHFDXGDOHSLGLG\PLGHVDQGYDVGHIHUHQVRI-wkold CF1 mice in IVF medium (Mehlmann et al., 1998) containing 3% bovine serum
albumin (BSA) (fraction V; Calbiochem, La Jolla, CA). Sperm were capacitated for 1–2
h in a humidified atmosphere of 5% CO 2 /95% air before insemination. For insemination,
R

R

sperm were diluted to a final concentration of 2–5 × 10 5 sperm/ml. Sperm and oocytes
P

P

were incubated together for 1.5–2 h, and then the oocytes were washed out and incubated
further in bicarbonate-EXIIHUHG0(0ĮDW&LQDKXPLGLILHG&2 2 incubator.
R

R

Fertilized oocytes were observed periodically for the presence of second polar bodies and
pronuclei.

Oocyte Vitrification and Warming
For vitrification, isolated GV-stage oocytes were placed into IVF medium
supplemented with 20% FBS (holding medium) for 1 min. The oocytes were washed
into holding medium containing 1.0 M ethylene glycol and 1.0 M 1,2-propanediol for 5
min and were then transferred to vitrification medium composed of holding medium
containing 2.0 M ethylene glycol, 2.0 M 1,2-propanediol, and 0.5 M sucrose for 5 min.
Oocytes were loaded onto the center of a vapor-chilled polyethylene terephthalate plastic
strip (thickness, 100–ȝP FXWIURPWKHZDOORID-L Poland Spring Water bottle
(Wilkes Barre, PA). The initial volume of the drops containing the oocytes was 1–ȝO
then the oocytes were spread out on the slide, and the remaining medium was removed
using a small-ERUHSLSHWWHVXFKWKDWWKHILQDOYROXPHRQWKHVWULSZDVȝO7KHVWULSV
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were then plunged directly into liquid nitrogen and placed in cryovials for storage in
liquid nitrogen. All steps before vitrification were carried out at 37°C.
For warming, the strips containing the vitrified oocytes were removed from liquid
nitrogen and immediately immersed in holding medium containing 0.5 M sucrose for 1
min. Oocytes were transferred to holding medium containing 0.25 M sucrose for 3 min
and then were transferred to holding medium containing 0.125 M sucrose for 3 min. All
steps during warming were carried out at 37°C. Oocytes were washed twice in holding
medium and twice in culture medium. The oocytes were then cultured in a 37°C
incubator with 5% CO 2 /95% air.
R

R

Microinjection, Confocal Microscopy, and Ca 2+ Measurements
P

P

Quantitative microinjection was performed as previously described using
mercury-filled micropipettes (Kline, 2009)$VDWXUDWHGVROXWLRQRI'L, ƍdihexadecyl-ƍƍ-tetramethylindocarbocyanine perchlorate; Invitrogen) was prepared
in soybean oil (Wesson Oil; ConAgra Foods, Inc., Memphis, TN) and stored at 4°C. The
DiI solution was front-loaded into a beveled mercury-filled pipette connected to a
micrometer syringe system filled with Fluorinert FC-70 (Sigma). The same pipette was
used to inject several oocytes with 2.5–5 pl of solution, which formed an oil droplet
inside the oocytes. This 2-fold range in the amount of DiI did not affect the qualitative
results to be described. The volume injected was calculated based on the diameter of the
sphere that forms in the oocyte cytoplasm during microinjection. DiI-labeled GV-stage
and MII-stage oocytes were observed using a confocal microscope (Pascal; Carl Zeiss
Microimaging, Inc., Thornwood, NY) 30 min to 2 h after microinjection. Fluorescence
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was excited with the 543-nm line of a HeNe laser and was detected using a 560-nm
emission filter. Images were collected using a 40× NA 1.2 water immersion objective
(C-Apochromat; Carl Zeiss MicroImaging, Inc.). Cortical ER clusters were evaluated by
examining the pattern of DiI labeling at the bottom edge of the cortex, just beneath the
plasma membrane. The optical section thickness was ȝP7KHSUHVHQFHRIFRUWLFDO
FOXVWHUVDVGHILQHGE\GLVWLQFWDJJUHJDWLRQVRI(5WKDWZHUHȝPLQGLDPHWHr, was
evaluated blindly by two different people.
Injected concentrations of calcium green 10-kDa dextran (Invitrogen) and inositol
1,4,5-trisphosphate (IP 3 ; Calbiochem) were based on an oocyte volume of 200 pl. Ca 2+
R

R

P

P

measurements were performed as previously described (Mehlmann et al., 1998) using a
photodiode with a built-in amplifier (Oriel Instruments, Stratford, CT) mounted on an
inverted microscope and connected to a chart recorder. Figures were made using Adobe
Photoshop (Adobe Systems Inc., San Jose, CA) after scanning the chart records into a
computer.

Immunofluorescence
In vitro-matured oocytes were fixed for 1 h in 2% formaldehyde in 100 mM
Hepes, 50 mM ethyleneglycoltetracetic acid, 10 mM MgSO 4 , and 0.2% Triton X-100 at
R

R

37°C. After fixation, oocytes were washed into PBS containing 1% Triton X-100,
incubated for 5 h at 4°C, and then washed into blocking buffer (PBS containing 0.01%
Triton X-100, 0.1% polyvinyl alcohol, and 3% BSA) for 15 min. Oocytes were
incubated in primary antibody (anti-tubulin, YL1/2; Serotec Inc., Raleigh, NC) diluted
1:100 in blocking buffer overnight at room temperature. Following primary antibody
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incubation, oocytes were washed with blocking buffer and incubated for 2 h with
secondary antibody (Alexa Fluor 488-conjugated anti-rat IgG; Invitrogen) diluted 1:200
LQEORFNLQJEXIIHU2RF\WHVZHUHWKHQZDVKHGLQ3%6,QWKHILUVWZDVKȝJPO
Hoechst 33528 (Invitrogen) was included and incubated for 15 min. Labeled oocytes
were observed with the 40× NA 1.2 lens on a Zeiss 510 confocal microscope (Carl Zeiss
Microimaging, Inc.). Fluorescence was excited at 488 nm for tubulin and at 364 nm for
Hoechst and was detected at 505 nm and 435–485 nm for tubulin and Hoechst,
respectively.

Statistical Analysis
Tests of statistical significance were performed using InStat software (GraphPad
Software, Inc., San Diego, CA). Differences between groups were determined by
Student t-test or Fisher exact test. P < 0.05 was considered statistically significant.

Results
Vitrified GV-Stage Oocytes Are Morphologically Normal and Are Meiotically
Competent
Vitrified, warmed (hereafter referred to as vitrified) GV-stage oocytes (n = 265)
were morphologically indistinguishable from freshly isolated oocytes when examined
live by transmitted light microscopy (Figure A.1). After washing dbcAMP from the
culture medium, the vitrified oocytes resumed meiotic maturation, underwent GVBD,
and extruded a first polar body (Figure A.1). The time to GVBD in vitrified oocytes was
slightly slower than that in control fresh oocytes, with only 54% of vitrified oocytes
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undergoing GVBD within 2 h compared with 94% of controls (Figure A.2). However, by
6.5 h after removal of dbcAMP, similar numbers of oocytes in the vitrified (n = 89) and
control (n = 400) groups had undergone GVBD (97% and 95%, respectively) (Figure
A.2), demonstrating that almost all of the vitrified oocytes were meiotically competent.
Seventy-eight percent of those GV-stage oocytes (n = 253) that underwent GVBD went
on to extrude first polar bodies compared with 80% of fresh control oocytes (n = 221).
Vitrified oocytes (n = 12) that were matured in vitro to the MII stage formed MII spindles
that were morphologically identical to those of freshly isolated in vivo-matured MII-stage
oocytes (n = 21) (92% vs. 95%) (Figure A.3).

Vitrified Oocytes Develop the Ability to Release Ca 2+ in Response to IP 3 Following In
P

P

R

R

Vitro Maturation and Are Fertilizable
Release of intracellular Ca 2+ at fertilization is critical for polyspermy prevention,
P

P

meiotic resumption, and initiation of early embryonic development. The ability to release
Ca 2+ develops during oocyte maturation; immature GV-stage oocytes are unable to
P

P

release a comparable amount of Ca 2+ as mature oocytes at the MII stage (Jones et al.,
P

P

1995; Mehlmann and Kline, 1994). To examine if vitrified oocytes matured in vitro can
initiate a normal pattern of Ca 2+ release in response to a physiological stimulus, we
P

P

injected oocytes with the Ca 2+ -sensitive indicator dye calcium green dextran and
P

P

monitored intracellular Ca 2+ during injection of 100 nM IP 3 . This concentration of IP 3
P

P

R

R

R

R

has previously been shown to induce a transient Ca 2+ release in MII-stage oocytes that is
P

P

occasionally followed by a series of repetitive Ca 2+ oscillations lasting 10–15 min
P

P

(Mehlmann and Kline, 1994). Injection of IP 3 into freshly ovulated MII-stage oocytes
R

R
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stimulated the following two types of Ca 2+ release: (1) a single transient (Figure A.4A) or
P

P

(2) an initial Ca 2+ transient that was followed by one or more oscillations (Figure A.4B).
P

P

IP 3 injection into vitrified oocytes that were matured in vitro also stimulated Ca 2+
R

R

P

P

release, with an initial Ca 2+ transient that was followed by repetitive Ca 2+ oscillations
P

P

P

P

that were more prolonged than in fresh in vivo-matured MII-stage oocytes (Figure A.4C).
The mean ± SD duration of the first transients was not significantly different between the
freshly ovulated and vitrified in vitro-matured GV-stage oocytes (2.3 ± 0.5 and 1.6 ± 0.2
min, respectively; P > 0.05). However, the average number of transients was
significantly higher in the vitrified group, with an average of eight oscillations vs. two
oscillations in freshly ovulated MII-stage oocytes. The amplitude of the first transient
above baseline was variable but did not differ significantly between the two groups.
Although the number of oscillations differed between the fresh and vitrified groups, these
data show that vitrified in vitro-matured oocytes can produce a series of Ca 2+ transients
P

P

in response to IP 3 .
R

R

We also fertilized vitrified, in vitro-matured MII-stage oocytes and examined the
presence of second polar bodies and pronuclei (Table A.1). For these experiments, we
used zona-free oocytes because of previous evidence that the zona can harden in response
to vitrification (Carroll et al., 1990; Gardner et al., 2007; Ko et al., 2008; Lane and
Gardner, 2001; Larman et al., 2006). Consistent with these observations, we found that it
was necessary to remove the zonae before vitrification, as we were unable to remove
them with acid Tyrode or chymotrypsin following vitrification. Eighty-six percent of
control, freshly ovulated MII-stage oocytes (n = 35) formed second polar bodies within 2
h after insemination, and 87% of those oocytes with second polar bodies went on to form
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pronuclei (Table A.1). Similarly, 72% of control (unfrozen), in vitro-matured MII-stage
oocytes (n = 29) formed second polar bodies, and 67% of those went on to form
pronuclei. Vitrified oocytes (n = 43) that were matured in vitro had 67% polar body
formation, and 76% of those formed pronuclei (Table A.1). No statistical differences
were found among any of these groups. These results show that vitrified, in vitromatured oocytes are able to initiate the early events of egg activation following
fertilization and, by extension, suggest that the Ca 2+ releasing ability of vitrified oocytes
P

P

is functional because of this.

The Continuity of the ER Is Preserved Following Oocyte Vitrification
To examine the effects of cryopreservation on ER structure, we observed the
structure of the ER following vitrification. The ER was visualized using the lipophilic
fluorescent dye DiI and confocal microscopy (Carroll et al., 1990; FitzHarris et al., 2007;
Kline et al., 1999; Mehlmann et al., 1995; Shiraishi et al., 1995; Terasaki and Jaffe, 1993;
Terasaki and Jaffe, 2004; Terasaki and Sardet, 1991). To label the ER, DiI was prepared
as a saturated solution in soybean oil and microinjected into the oocyte, where it contacts
intracellular membranes. Because the ER is a continuous network, the dye will spread
throughout the entire ER if it is intact. As reported previously (Kline et al., 1999;
Terasaki and Jaffe, 1993), control, unfrozen GV-stage oocytes contained a fine reticular
network throughout the oocyte that had no distinct clusters of ER in the cortex (Figure
A.5, A and B). Clusters of ER were present throughout the oocyte interior (Figure A.5B).
The ER in vitrified GV-stage oocytes remained intact, as indicated by dye spreading, and
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the structure was similar to controls, with no distinct ER clusters in the oocyte cortex but
with clusters throughout the cytoplasm (Figure A.5, C and D).

Optimization of Culture Conditions to Obtain ER Reorganization During In Vitro
Maturation
The ER undergoes dramatic reorganization during meiotic maturation in vivo,
such that large clusters of ER form in the cortex opposite the meiotic spindle (Han and
Nuccitelli, 1990) (Figure A.6A). Therefore, we next examined the ability of the ER to
reorganize during spontaneous maturation of fresh (unfrozen) oocytes in vitro.
8QH[SHFWHGO\ZHIRXQGWKDWRQO\RIWKHRRF\WHVFXOWXUHGLQ0(0Į Q  IRUPHG
distinct cortical ER clusters following IVM, while the rest contained no apparent ER
clusters (Table A.2). Because of this, we next examined the ER structure in oocytes that
were matured in a different culture medium, CZB (Chatot et al., 1989). In contrast to
RRF\WHVPDWXUHGLQ0(0ĮRIRRF\WHVPDWXUHGLQ&=% Q  IRUPHGFRUWLFDO(5
clusters (Figure A.6B and Table A.2) compared with 94% of freshly ovulated MII-stage
oocytes (n = 18) (Table A.2). This is not significantly different from the number of
cortical clusters present in freshly ovulated MII-stage oocytes.
Because CZB contained 20% FBS and RXUVWDQGDUG0(0ĮPHGLXPFRQWDLQHG
only 5% serum, we examined whether the amount of serum in the culture medium
affected the formation of cortical clusters during in vitro maturation. Sixty-eight percent
RIRRF\WHV Q  PDWXUHGLQ0(0ĮFRQWDLQLQJFBS exhibited cortical ER clusters
(Table A.2). This percentage was not significantly different from that of CZB-matured
oocytes but is somewhat lower than the percentage of clusters present in freshly ovulated
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MII-stage oocytes. These data show that the amount of serum and the particular culture
medium used are important factors for successful reorganization of the ER during in vitro
maturation of mouse oocytes.

Cryopreservation Adversely Affects the Reorganization of Cortical ER Clusters During
In Vitro Maturation
We next examined the formation of ER clusters in oocytes that were vitrified
before IVM. For these experiments, we matured vitrified oocytes in CZB medium, as
oocytes matured in CZB most closely resembled those of in vivo-matured oocytes. We
found that a significantly lower percentage, only 29%, of vitrified oocytes had cortical
ER clusters following in vitro maturation compared with 78% of controls (n = 46) (Table
A.3). This result was unexpected because the continuity of the ER was not disrupted in
immature oocytes following vitrification (Figure A.5B) and suggests that some
components necessary for the reorganization and stability of the ER during oocyte
maturation are disrupted by the vitrification process. These factors could contribute to
the lower developmental competence of vitrified in vitro-matured oocytes that has been
reported previously (Aono et al., 2005; Vieira et al., 2002). We also examined if
vitrification affects the structure of cortical ER clusters in vitrified in vivo-matured MIIstage oocytes. Significantly fewer of these oocytes had cortical ER clusters compared
with fresh oocytes (56% vs. 94%) (Table A.3), showing that this process can also
interfere with the ER organization in mature oocytes that have previously formed ER
clusters.
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Discussion
In this study, we confirmed previous reports showing that mouse oocytes
cryopreserved at the GV stage can be vitrified to yield morphologically normal GV-stage
oocytes, that they mature at a high rate in vitro after vitrification, and that they
subsequently form morphologically normal bipolar meiotic spindles. We then extended
previous studies by examining if cytoplasmic structure is preserved during the
vitrification procedure. We found that the structure of the ER remains intact during
vitrification of GV-stage oocytes, indicating that this process does not damage these
intracellular membranes. In addition, oocytes vitrified at the GV stage and matured in
vitro are capable of releasing Ca 2+ in response to IP 3 and can be fertilized. Because the
P

P

R

R

ability to release Ca 2+ develops during oocyte maturation, vitrification does not appear to
P

P

adversely affect this important component of cytoplasmic maturation. However, the
reorganization of the ER that normally occurs during oocyte maturation was impaired by
this process. Although vitrification of immature oocytes followed by in vitro maturation
yields morphologically normal oocytes that exhibit some of the properties of early
development following fertilization, cytoplasmic maturation is disrupted, and this could
account for the reduced developmental potential observed previously following
vitrification and in vitro maturation (Abe et al., 2005; Aono et al., 2005; Kubota et al.,
1998; Suzuki et al., 1996; Vieira et al., 2008; Vieira et al., 2002).
During meiotic maturation in vivo, the ER undergoes reorganization, such that
clusters of ER form in the oocyte cortex opposite the meiotic spindle (FitzHarris et al.,
2007; Mehlmann et al., 1995). However, we found that the majority of oocytes that were
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QRWYLWULILHGEXWZHUHPDWXUHGLQRXUVWDQGDUG0(0ĮPHGLXPGLGQRWH[KLELW(5FOXsters
in the mature oocyte cortex (Figure A.6 and Table A.2). In contrast, the ER in oocytes
PDWXUHGLQ&=%DQGLQ0(0ĮFRQWDLQLQJ)%6UHRUJDQL]HGLQWRGLVWLQFWFRUWLFDO
clusters, similar to those seen in freshly ovulated MII-stage oocytes (Figure A.6B).
These latter results are in agreement with a recent study (FitzHarris et al., 2007) that
showed normal pattern and size of cortical ER accumulations in the mouse oocyte cortex
following in vitro maturation, although this study did not indicate the percentage of
oocytes that formed cortical ER. It is not clear in our study what effect an increased
amount of FBS in the culture medium has on the ability of oocytes to exhibit ER
reorganization during meiotic maturation. However, the difference in ER structure
following IVM in different culture media herein underscores the importance of
establishing culture conditions that yield consistent results during IVM before
cryopreservation. The ability to form normal ER clusters that are retained after
cryopreservation and in vitro maturation could be used as one criterion to assay how
closely various culture conditions simulate in vivo meiotic maturation.
The structure of the ER in GV-stage oocytes was similar between control and
vitrified oocytes, with continuous ER throughout the oocyte and around the GV in both
groups, as well as aggregations of ER throughout the cytoplasm (Figure A.5). The ability
of the ER to remain a continuous network throughout the vitrification process indicates
that at least one important component of the cytoplasmic structure can remain intact
following cryopreservation. However, the ability of the ER to reorganize into cortical ER
clusters following vitrification and in vitro maturation was impaired, even in oocytes
matured in CZB. This suggests that other components of cytoplasmic maturation could
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be affected by the vitrification process. The spindle morphology observed following
vitrification and IVM appeared normal, suggesting that microtubules are possibly
unaffected by this procedure. In oocytes maturing in vitro, microtubules are important
for ER reorganization during GVBD, but microfilaments are necessary for ER
remodeling into cortical clusters (FitzHarris et al., 2007). It is possible that
microfilaments or other proteins needed for actin polymerization could be disrupted by
vitrification, such that they are no longer able to regulate ER reorganization during
maturation. Moreover, a few studies (Albarracin et al., 2005; Rojas et al., 2004; Wu et
al., 2006) have shown that vitrification is detrimental to microfilament structure in bovine
and porcine oocytes. To date, it is unknown what the role of microfilaments might be for
ER reorganization. Other unknown proteins needed for the process of ER reorganization
could also be impaired.
It is also possible that microtubules are damaged during vitrification, at least
initially. This could explain why fewer oocytes vitrified at the MII stage displayed
cortical ER clusters compared with fresh MII-stage oocytes, as the ER and microtubules
are interdependent structures (Terasaki et al., 1986). Some studies (Eroglu et al., 1998b;
Gomes et al., 2008; Rienzi et al., 2004) have shown that, although microtubules are
disrupted immediately after cryopreservation of MII-stage oocytes, they are able to
reform after culturing at 37°, such that morphologically normal meiotic spindles become
apparent. In our study, we examined the ER in vitrified MII-stage oocytes 1–2 h after
oocyte warming. Even if microtubules are disrupted and a spindle is able to reform
within a few hours after oocyte warming, it is possible that the association between the
ER and microtubules does not reestablish within this time. However, other findings show
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no disruption of microtubules following cryopreservation (Larman et al., 2007a).
Nevertheless, disruption of microtubules could contribute to the lack of cortical clusters
seen in vitrified MII-stage oocytes and could help explain why cortical clusters do not
form in vitrified oocytes following in vitro maturation of GV-stage oocytes.
Despite the inability of the majority of oocytes cXOWXUHGLQ0(0ĮFRQWDLQLQJ
FBS to form cortical ER clusters during IVM, vitrified in vitro-matured oocytes released
Ca 2+ on injection of IP 3 , which is the physiological stimulus for Ca 2+ release at
P

P

R

R

P

P

fertilization (Runft et al., 2002). Indeed, these oocytes exhibited more transients than in
vivo-matured freshly ovulated MII-stage oocytes (Figure A.4). Because Ca 2+ release is
P

P

essential for several aspects of successful fertilization, including polyspermy prevention,
completion of meiosis, and early development (Ducibella et al., 2006), it is critical for
vitrified/in vitro-matured oocytes to develop the ability to release Ca 2+ during oocyte
P

P

maturation. While the ER is a major site of Ca 2+ storage (Han and Nuccitelli, 1990;
P

P

Terasaki and Sardet, 1991) and IP 3 receptors have been localized to the cortical ER
R

R

clusters (Mehlmann et al., 1996; Shiraishi et al., 1995), IP 3 receptors are also located on
R

R

the ER that does not form clusters (Kline et al., 1999). Because the amount of IP 3
R

R

receptor protein doubles during oocyte maturation (Mehlmann et al., 1996), it is possible
that the increased number of IP 3 receptors provides the oocyte with enough Ca 2+
R

R

P

P

releasing ability to allow for a normal pattern of Ca 2+ release in response to IP 3 following
P

P

R

R

IVM, even in the absence of cortical ER clusters. Moreover, vitrified in vitro-matured
oocytes formed second polar bodies and pronuclei, events that depend on release of
intracellular Ca 2+ (Ducibella et al., 2006).
P

P
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Deficiencies in the ability of the ER to reorganize following IVM and/or other
components of cytoplasmic maturation could help explain the low developmental rates
reported by others following oocyte cryopreservation and IVM (Abe et al., 2005; Aono et
al., 2005; Kubota et al., 1998; Suzuki et al., 1996; Vieira et al., 2008; Vieira et al., 2002).
Additional causes of low developmental competence in some cryopreserved oocytes
could be that the zona pellucida is modified, such that it hardens and prevents fertilization
in some cases (Carroll et al., 1990; Gardner et al., 2007; Ko et al., 2008; Larman et al.,
2007a; Larman et al., 2006). In this study, we were unable to remove zonae from oocytes
following cryopreservation using acid Tyrodes, suggesting that the zonae were modified
by some aspect of the vitrification procedure. The cause of zona hardening could be the
use of the cryoprotectants ethylene glycol and/or 1,2-propanediol, both of which have
been shown to cause Ca 2+ release when added to unfrozen oocytes (Larman et al., 2007a;
P

P

Larman et al., 2006). This, in turn, could cause premature release of cortical granules and
modification of the zona (Ghetler et al., 2006) and the plasma membrane. The ability of
zona-free oocytes to be fertilized in this study demonstrates that, even if release of
cortical granules modified the zona pellucida, sperm interaction with the plasma
membrane was not impaired by the vitrification procedure in most cases. Nevertheless,
release of Ca 2+ by cryoprotectants could potentially affect other aspects of egg activation
P

P

(Gardner et al., 2007).
Additional components of cytoplasmic maturation that are independent of
cryopreservation could also contribute to the low developmental potential following in
vitro maturation. For example, mouse oocytes matured in vitro have been shown to have
lower mitogen-activated protein kinase activity than those in controls, and this could
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contribute to a higher rate of parthenogenetic activation and reduced developmental
competence seen in in vitro-matured oocytes (Combelles et al., 2005). More studies will
be needed to clarify the normal events of cytoplasmic maturation (e.g., the effects on
other organelles and protein synthesis) to determine how well IVM mimics these events.
Development of culture media that more accurately simulate these normal cytoplasmic
events will be essential for obtaining in vitro-matured oocytes, whether cryopreserved or
not, that closely resemble those of freshly ovulated oocytes.
In summary, our results show that cryopreservation of GV-stage mammalian
oocytes can preserve intracellular membranes and that nuclear maturation of immature
oocytes matured following vitrification appears to be normal. However, this technique
disrupts the ability of the ER to reorganize during oocyte maturation, and this could
contribute to the low developmental competence that has been observed following
cryopreservation. Before this technique can become a reliable method for treating
infertility, further studies will need to be performed to improve the process of IVM in
fresh and frozen oocytes, as well as to assess other aspects of cytoplasmic maturation that
might contribute to the developmental competence of in vitro-matured oocytes.
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Figure A.1

Figure A.1. Vitrified GV-stage oocytes are morphologically indistinguishable from fresh
oocytes and mature to the MII stage in culture. A) Fresh oocyte. B) Vitrified oocyte. C)
Vitrified MII-stage oocyte following IVM. Note GVBD and first polar body formation.
Representative photographs from 265 vitrified oocytes are shown in B and C. Original
magnification ×120.
Figure A.2

Figure. A.2. Time course of GVBD following vitrification and in vitro maturation.
Fresh (n = 400) or frozen (n = 89) oocytes were incubated in medium containing
dbcAMP, and the time to GVBD was noted after washing the dbcAMP out of the culture
medium. Black squares, control oocytes; black circles, vitrified oocytes.
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Figure A.3

Figure A.3. In vitro-matured oocytes form morphologically normal MII spindles. Left:
in vivo-matured MII-stage oocyte. Right: vitrified in vitro-matured MII-stage oocyte.
Green, tubulin; blue, chromosomes. Original magnification ×120.

Figure A.4

Figure A.4. Vitrified oocytes matured in vitro develop the ability to release Ca 2+ in
response to IP 3. Oocytes were injected with the Ca 2+ indicator dye calcium green 10-kDa
dextran. The fluorescence intensity showing the relative Ca 2+ level in the oocyte
cytoplasm was measured during a subsequent injection of IP 3 (100 nM total in the
oocyte). A and B) Representative tracings from control freshly ovulated MII-stage
oocytes (n = 8). C) Representative tracing from vitrified oocytes matured in vitro (n = 5).
P

R

R

P

P

P

P

R
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Figure A.5

Figure A.5. The ER structure in GV-stage oocytes. The ER was labeled using the
lipophilic fluorescent dye DiI. A and B) Representative photograph from 25 fresh
oocytes showing a continuous ER but the absence of cortical ER clusters that are
characteristic of MII-stage oocytes in the cortex (A) and equator (B). C and D)
Representative photograph from 19 vitrified oocytes showing the absence of cortical
clusters in sections of the cortex (C) and equator (D). %DU ȝP A and C DQGȝP
for (B and D).

141

Figure A.6

Figure A.6. The structure of the ER following in vitro maturation in fresh oocytes. A)
Distinct ER clusters in an in vivo-matured oocyte are shown for reference. B and C)
Distinct ER clusters were found in the majority of oocytes matured in CZB medium (B)
but were sometimes absent (C). %DU ȝP
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Table A.1. Comparison of second polar body and pronuclear formation in fresh or
vitrified oocytes at the MII stage
Group

Treatment

No. oocytes
examined

Second polar
bodies (%)

Pronuclei
(%)†

Ovulated

Fresh

35

86

87

In vitro matured

Fresh

29

72

67

In vitro matured

Vitrified

43

67

76

*No significant differences were observed among any of the groups (p<0.05; Fisher’s
Exact Test).
†Pronuclear formation was determined as a percentage of oocytes that formed second
polar bodies.
Table A.2. Comparison of cortical endoplasmic reticulum clusters in oocytes at the
metaphase II stage.
Group

Culture Medium
0(0Į-HEPES

No. oocytes
examined
18

Percentage with
distinct clusters
94% a

In vivo matured
In vitro matured

0(0Į)%6

48

42% b

In vitro matured

0(0Į)%6

47

68% c

In vitro matured

CZB

46

P

P

P

78%

a,c
P

*Experiments were repeated at least 3 times.
a,b,c
Values with different superscript letters are significantly different (p<0.05; Fisher’s
Exact Test).
P

P
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Table A.3. Comparison of cortical endoplasmic reticulum clusters in in vivo- and in
vitro- matured oocytes following vitrification.
Group

Treatment
Fresh‡

No. oocytes
examined
46

Percentage with
distinct clusters
78% a

In vitro matured†
In vitro matured†

Vitrified

49

29% b

In vivo matured

Fresh‡

18

94% a,c

In vivo matured

Vitrified

16

56% a

P

P

P

P

* Experiments were repeated at least 2 times.
† Oocytes were matured in CZB medium.
‡ For comparison, the fresh oocytes matured in CZB, as well as the fresh, in vivo
matured MII-stage oocytes, were taken from Table 2.
a,b,c
Values with different superscript letters are significantly different (p<0.05; Fisher’s
Exact Test).
P

P
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